AP34A - Insectidical ethers. - Google Patents

Insectidical ethers. Download PDF

Info

Publication number
AP34A
AP34A APAP/P/1986/000041A AP8600041A AP34A AP 34 A AP34 A AP 34A AP 8600041 A AP8600041 A AP 8600041A AP 34 A AP34 A AP 34A
Authority
AP
ARIPO
Prior art keywords
nmr
ppm
cdc1
fluoro
compound
Prior art date
Application number
APAP/P/1986/000041A
Other versions
AP8600041A0 (en
Inventor
Michael John Bushell
Alan John Whittle
Robin Arthur Ellis Carr
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of AP8600041A0 publication Critical patent/AP8600041A0/en
Application filed by Ici Plc filed Critical Ici Plc
Application granted granted Critical
Publication of AP34A publication Critical patent/AP34A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/04—Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/14—Ethers
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
    • A01N33/10—Amines; Quaternary ammonium compounds containing oxygen or sulfur having at least one oxygen or sulfur atom directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/26—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
    • A01N43/28—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3
    • A01N43/30—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3 with two oxygen atoms in positions 1,3, condensed with a carbocyclic ring
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/295—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/60—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/546—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/55—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

The invention provides novel insecticidally useful fluorinated ethers of formula Ar-CX(Z)-CHX-O-CH2-Y where Ar and Y are both substituted aryl groups, Z is a lower fluoroalkyl group (eg. trifluoromethyl), X1 is hydrogen and X is hydrogen, halo, hydroxy, alkoxy or acyloxy, as well as the compounds where X and X1 form a second bond between the adjacent carbon atoms. A typical example is 1,1,1-trifluoro-2-(4-ethoxyphenyl)-3-(3-fluoro-3-phenoxybenzyloxy) propane. The invention also provides novel intermediates for the preparation of the compounds including those of formulae ArCH (CF3) CH2OH, ArC(OH) (CF3) CH2OH, ArC(OH) (CF3) CH2Hal

Description

INSECTICIDAL ETHERS
This invention relate*5 to novel fluorinated ethers useful as insecticides and their preparation, to insecticidal compositions thereof and to methods of combating and controlling insect pests therewith.
In a first aspect the invention provides compounds of formula :
, CX(Z)-CHX' -OCH2Y where W represents one or two substituents selected from halo, alkyl, alkoxy, alkoxyalkyl, haloalkyl and haloalkoxy, or W represents a bidentate group linking adjacent carbon atoms selected from alkylene and alkylenedioxy; Z represents a fluoroalkyl group of up to two carbon atoms; Y represents a substituted aryl group where each substituent • is selected from halo, alkyl, aryl, aralkyl, aryloxy and arylamino; and either X' is hydrogen and X is selected from hydrogen, halo, hydroxy, alkoxy and acyloxy, or X and X' together represent a second bond between the adjacent carbon atoms I-
Preferred conpounds are those wherein Z represents the tri fluoromethyl group, W represents fluoro, chloro, bromo, alkyl of up to four carbon atoms, alkoxy of up to four carbon atoms, alkoxyalkyl of up to a total of four carbon atoms, fluoroalkyl of up to two carbon atoms, fluoroalkoxy of up to two carbon atoms, alkylene of three or four carbon atoms, or alkylenedioxy of up to two carbon atoms, and Y represents an aryl group selected from phenyl, pyridyl and furyl substituted with fluoro, methyl, phenyl, benzyl, phenoxy, chlorophenoxy, fluorophenoxy, bromophenoxy or fluoroanilino.
Particularly preferred compounds are those wherein Z represents trifluoromethyl, W represents a substituent in the 4-position selected from chloro, methoxy, ethoxy, trifluoromethy1, trifluoromethoxy, and difluoromethoxy, Y represents a phenoxypheny 1 group in which each phenyl group may be unsubstituted or substituted with halogen, X' is hydrogen and X is selected from hydrogen, fluoro or chloro.
Particular examples of compounds according to the invention include those set out in Tables I and II below.
In Table I the compounds conform to the formula :
AP 0 0 0 0 3 4 and in Table II to the formula :
In these Tables Y is defined as R^· to r!4 wherein R^ to r!4 represent the following groups :
r! : 3-phenoxyphenyl : 3- (4-chlorophenoxy)phenyl r3 : 4-fluoro-3-phenoxypheny1 ; 3-( 4-bromophenoxy)phenyl r5 : 4-fluoro-3-(4-bromophenoxyJphenyl
R6 : 4-fluoro-3-(4-chlorophenoxy)phenyl r7 j 3-(2,4-difluorophenoxy)phenyL rS . 3-benzylphenyl
R9 : 3-benzyl-4-fluorophenyl
R^-θ : 3-(4-fluorophenylamino)phenyl
R11 : 6-phenoxypyrid-2-y1 r!2 . 2-methyl-3-phenylphenyl r13 . 4-methyl-2,3,5,6-tetrafluorophenyl rI·^ . 5-benzylf uran-3-yl
All of the compounds listed in Table I are in the form of racemic mixtures of the two optically active isomers (the R- and S-isomers), and all of the compounds in Table II can exist as E- and Z-isomers (or mixtures therepf). It is to be understood that the invention includes within its scope not only the above isomer mixtures but also any single isomer of an invention compound.
TABLE I cx(cf3)ch2och2y
W
Compound No. W X Y
1 4-oc2h5 H Rl
2 4-OC2H5 H R13
3 4-OC2H5 H R2
4 4-OC2H5 H R11
5 4-OC2H5 H R6
6 4-OC2H5 H R5
7 4-OC2H5 H R12
8 4-OC2H5 H R9
9 4-OC2H5 H R4
10 4-OC2H5 H R7
11 4 -OC2H5 H R10
12 4-OC2H5 H r8 /
13 3-F,4-OC2H5 H R2
14 3-F,4-OC2H5 H R1
15 4-Cl H R3
16 4-C1 H R1
17 2,4-Cl2 H R1
18 4-F H R3
19 3,4-(CH2)3 H R3
20 4-(CH2)2CH3 H R3
21 4-C(CH3)3 H R3
22 4-CH3 H R1
23 4-CH2OCH3 H R2
TABLE I (cont)
Compound No. W X Y
24 4-CH20CH3 H R1
25 4-OCF3 H R3
26 4^CF3 H R2
27 4-OCF3 H R1
28 4-OCF3 H R11
29 4-OCH3 H R3
30 4-OCH3 H R1
31 3,4-(OCH2O) H R1
32 3,4-(OCH2O) H R2
33 4-OC2H5 H R3
34 4-CF3 H R1
35 4-Br H R3
36 4-CF3 H R3
37 4-OC2H5 H R14
38 4-OC2h5 Cl R1 ,
39 4-OC2H5 Cl R1 3
40 4—OC2H5 Cl R3
41 4-OC2H5 Cl R1L
42 4-OC2h5 Cl R2
43 4-OC2H5 Cl R5
44 4—OC2h^ Cl R6
45 4-OC2H5 Cl R14
46 4-OC2H5 Cl R12
I
TABLE I (cont)
Compound No. W X Y
47 4—OC2H5 Cl R9
48 3-F,4-OC2H5 Cl R2
49 3-F,4-OC2H5 Cl R1
50 4-C1 Cl R3
51 4-F Cl R3
52 3,4-(CH2)3 Cl R3
53 4-(CH2)2CH3 Cl R3
54 4-C(CH3)3 Cl R3
55 4-CH3 Cl R1
56 4-CH2OCH3 Cl R2
57 4-CH20CH3 Cl R1
58 4-OCF3 Cl R3
59 4-OCF3 Cl R1
60 4-OCF3 Cl R2
61 4-OCF3 Cl R11
62 4-OCH3 Cl R3
63 4-OCH3 Cl R1
64 3,4-(OCH2°) Cl R1
65 3,4-(OCH2o) Cl R2
66 4-C1 Cl R1
67 2,4-Cl2 Cl R1
68 4-CF3 Cl R1
69 4-Br Cl R3
TABLE I (cont)
, i Compound No. W X Y
70 4-CF3 Cl R3
71 4-OC2H5 Cl R4
72 4-OC2h5 Cl R7
73 4-002^5 Cl R8
74 4-OC2H5 Cl R10
75 4-OC2H5 F R1
76 4-OC2H5 F R11
77 4-OC2H5 F R3
78 4-OC2H5 F R13
79 4-OC2H5 F R2
80 4-OC2H5 F R12
81 4-C1 F R3
82 4-OCF3 F R1
83 4-Br F R3
84 4-CF3 F R1
85 4-C1 F R1
86 2,4^12 F R1
87 4-CH3 F R1
88 4-OCH3 F R1
89 3-F,4-OC2H5 F R1
90 3,4-(OCH2O) F R1
91 4-CH2OCH3 F R1
92 3-F,4-OC2Hs F R2
TABLE I (cont)
Compound No. w X Y
93 3,4-(OCH2o) F R2
94 4-OCF3 F R2
95 4-CH2OCH3 F R2
96 4-F F R3
97 4-C(CH3)3 F R3
98 4-OCH3 F R3
99 4-(CH2)2CH3 F R3
100 3,4-(CH2)3 F R3
101 4-OCF3 F R3
102 4-CF3 F R3
103 4-OC2H5 F R4
104’ 4-OC2H5 F R5
105 4-OC2H5 F R6
106 4-OC2H5 F R7
107 4—OC2H5 F R8 *
108 4-k>C2H5 F R^
109 4-ΟΟ2 η5 F R10
110 4-OCF3 F R11
111 4-OC2H5 F R14
112 4-OC2H5 OH R1
113 4X)C2H5 OH R3
114 4-OC2H5 OH R1 3
115 4^C2 h5 OH R2
TABLE I (cont)
r-—--T Compound No. W X Y
116 4-OC2H5 OH R5
117 4-OC2H5 OH R6
118 4-OC2H5 OH R14
119 4-OC2H5 OH R9
120 4^H3 OH R1
121 3-F,4-OC2H5 OH R2
122 4-C(CH3)3 OH R3
123 4-(CH2)2CH3 OH R3
124 3,4-(CH2)3 OH R3
125 4-F OH R3
126 4-C1 OH R3
127 4-Br OH R3
128 3,4-(OCH2o) OH R1
129 3,4-(OCH2O) OH R2
130 4-OCH3 OH R1
131 4-OCH3 OH R3
132 4-CH2OCH3 OH R2
133 4-CH2OCH3 OH R1
134 4-OCF3 OH R3
135 4-OCF3 OH R2
136 4^)CF3 OH R11
137 4-CF3 OH R1
138 4-CF3 OH R3
139 4-OCF3 OH Rl
- 10 TABLE I (cont)
Compound No. W X Y
140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 3- F,4-OC2H5 4- OC2H5 4-OC2H5 4-C1 2,4-Cl2 4-OC2H5 4-OC2H5 4-OC2H5 4-OC2H5 4-OC2H5 4-OC2Hs 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 4-OCHF2 OH OH OH OH OH OH OH OH OH OCOCH3 OCH3 H H H Cl Cl Cl F F F OH OH OH R1 R11 R12 R1 R2 R4 R7 R8 R10 R3 R3 R1 R2 R3 ' R1 R2 R3 RL R2 R3 R1 R2 R3
TABLE II
Compound No. W Y
163 4-Cl -R3
164 3,4-(CH2)3 R3
165 4-(CH2)2CH3 r3
166 4-C(CH3)3 R3
167 4-OCF3 R3
168 4-OCF3 . R1
169 4-OCF3 R2
170 4-OCHF2 R1
171 4-OCHF2 R2
172 4-OCHF2 R3
It will be noted that the compounds of formula I fall into several types according to the nature of X and X'. These may be represented for the compounds of formula I wherein Z is tri fluoromethyl as follows :
Ar-CH(CF3)-CH2-OCH2Y (IA)
Ar-CF(CF3)-CH2-OCH2Y (IB)
Ar-CCl(CF3)-CH2-OCH2Y (IC)
Ar-C(CF3)=CH-OCH2Y (ID)
Ar-C(CF3)-CH2-OCH2Y (IE)
OH
Ar-C(CF3)-CH2-OCH2Y (IF)
Oalkyl
Ar-C(CF3)-CH2-OCH2Y (IG)
Oalkyl wherein Ar represents the group of formula
AP 0 0 0 0 3 A in formula I.
Compounds of formula (IE) may be converted to the corresponding compounds of formula IB, IC, ID, IF and IG by reaction with an appropriate reagent, and the compounds of formula IC and ID may be converted to the compounds of formula IA. Thus a compound of formula IB can be obtained by treating a compound of formula IE with a fluorinating agent such as diethylaminosulphur trifluoride (DAST), as follows :
Ar-C(CF3)-CH2-OCH2Y -DAST^ Ar-CF(CF3)-CH2-OCH2Y
OH
Similarly a compound of formula IC can be obtained by ie treating the corresponding compound of formula iti with a chlorinating agent such as thionyl chloride. Some compound of formula ID is also obtained in this process, presumably by dehydration of the hydroxy compound, and the two products can be separated by chromatographic means if desired.
>'
Ar-C(CF3)-CH2-OCH2Y S0C12 Ar-CCl-CH2-OCH2Y + Ar-C=CH-OCH2Y
OH CF3 CF3
The compounds of formula IF and IG can be obtained by conventional O-alkylation and O-acylation techniques from the corresponding compounds of formula IE. Thus reaction with a base such as sodium hydride in an aprotic solvent and an alkyl halide gives the compound of formula IF, for example :
t,
Ar-C(CF3)-CH2-OCH2Y CH3I v Ar-C (CF3 )-CH2-OCH2Y | NaH/DMF |
OH OCH3
Similarly the compound of formula IG can be obtained by 15 treating the corresponding compound of formula IE with an acyl haLide or acyl anhydride in the presence of a base and a solvent, such as pyridine containing a catalytic amount of 4-dimethylaminopyridine (DMAP), for example :
Ar-C(CF3)-CH2-OCH2Y
OH
CH3COC1 Ar-C(CF3)-CH2OCH2Y py/DMAP | ococh3
The preparation of the compounds of formula IE can be effected by a process in which either (i) a compound of formula :
Ar-C(CF3)-CH2OH (II)
OH is reacted with a compound of formula YCH2-Hal, where Hal 5 represents a halogen atom such as chlorine or bromine, in the presence of phase transfer catalyst, or (ii) a compound of formula :
Ar-C(CF3)-CHo-Ha1 (III)
I
OH is reacted with a compound of formula YCH2OH, where Hal represents a halogen atom such as chlorine or bromine, in the presence of a phase transfer catalyst, or (iii) a compound of formula :
K 1 /
Ar -C (IV) cf3 is reacted with a compound of formula YCH2OH, in the presence of a base, such as sodium hydride and an aprotic solvent such as dimethylformamide.
The preparation of the compounds II, III and IV is outlined in the following scheme :
(IV)
Ar-C(CF3)-CH2OH
OH (II)
Ar-C(CF3)-CH2Hal
OH (III) (a) CF3COC1/A1C13 (b) Grignard reaction using CF3CO2H or (CF3CO)2O (c) C(CH3)3SO]+.I/KOH/t-BuOH (d) C(CH3)3SO]+.I/NaH/DMF (e) Grignard reaction using CF3COCH2Hal
Further details of these processes, and variations thereof, are set forth in the Examples hereinafter.
The compounds of formula IA may also be prepared by reacting an alcohol of Formula :
Ar-CH-CH2OH (V)
with a benzyl halide of formula YCH2Hal where Hal represents chloro or bromo. The reaction preferably takes place in the presence of a base such as, for example, aqueous sodium hydroxide solution, and optionally in the presence of a quaternary ammonium salt which functions as a phase transfer catalyst.
The alcohols of formula V may be prepared by reduction of the acids of Formula :
Ar-CH-CO2H
(VI)
APO 0 0 0 3 A in the form of an ester thereof, e.g. the lower’ alkyl ester such as the ethyl ester. Suitable reducing agents for the esters include aluminium hydrides such as lithium aluminium hydride or diisobutylaluminium hydride (DIBAL), but the actual choice is dependent upon the robustness of the substituents in the group Ar in the presence of the particular agent used.
The acids of formula VI may be prepared by various procedures. One process (which may be generally applicable with appropriate variation), which is illustrated in detail in the Examples hereinafter, is set out in outline in the following Scheme :
Ar-H
CF3-C-CF2C1 aici3
OH
I
Ar-<j:-CF3 cf2ci
SOC12 Cl z I
-A Ar-C-CF,
Aci
Zn/ZnCl2 ch3oh
C2H5ONa
Ar-f=CF(OC2H5) + Ar-CH-CF(OC2H5
C2H5OH Ar-C-CF3
CFCFCFHI/CH3CO2H (VII) c2h5oh/h+
DIBAL
Ar-CH-CO2H
CF,
Ar-CH-CO,C-> H
2'“2n5
CF3
Ar-CHCH,OH I 4 CF3 (VIII)
The compound of Formula (VII) may also be obtained by reacting a ketone of Formula :
II
Ar —C — CF3 with chlorodifluoroacetic acid (in the form of a salt, e.g. the sodium salt) and triphenylphosphine, by a procedure similar to that shown in J.Org.Chem. (1967), vol.32, page 1311. The esters of Formula VIII may also be prepared by reacting an aryl substituted malonate with a bromofluoromethane by the process similar to that shown in Tetrahedron Letters (1984), vol.25, page 1329, thus
Ar-CH(CO2C2H5)2 NaH Ar-C(CO2C2H5)2 —> Ar-CH(CO2C2H5)2
CF2Br2 CF2Br CFj followed by partial saponification and decarboxylation.
Alternatively the alcohols of formula V may be prepared by direct reduction of the epoxide of formula IV using, for 'lsulphide/boron tri fluoride-diethyl
BH3.S(CH3)2 Ar —CH-CH2OH bf3.o(c2h5)2 cf3 f formulae II, III and IV are believed not to have been described before. In a further aspect therefore the invention provides each of the example, borane-dimethj ether complex, thus :
Ar-C— CH*
CFMany of the compounds c
compounds of formulae :
^.C(CF3)-CH2OH
w_O 1
OH
APd η η n ,u
C(CF3)-CH2Hal
OH
wherein W has any of the meanings given hereinbefore for the compounds of formula I.
Additionally the compounds of formulae V and VI have not been previously described. In a yet further aspect therefore the invention provides compounds of formulae :
where W has any of the meanings given hereinbefore and R represents hydrogen or alkyl of up to four carbon atoms, such as methyl or ethyl.
The compounds of formula I may be used to combat and control infestations of insect pests and also other invertebrate pests, for example, acarine pests. The insect and acarine pets which may be combated and controlled by the use of the invention compounds include those pests associated with agriculture (which term includes the growing of crops for food and fibre products, horticulture and animal husbandry), forestry, the storage of products of vegetable origin, such as fruit, grain and timber, and also those pests associated with the transmission of diseases of man and animals.
In order to apply the compounds to the locus of the pests they are usually formulated into compositions which include in addition to the insecticidally active ingredient or ingredients of formula I suitable inert diluent or carrier materials, and/or surface active agents.
The compounds of the invention may be the sole active ingredient of the composition or they may be admixed with one or more additional active ingredients such as insecticides, insecticide synergists, herbicides, fungicides or plant growth regulators where appropriate.
Suitable additional active ingredients for inclusion in admixture with the compounds of the invention may be compounds which will broaden the spectrum of activity of the compounds of the invention or increase their persistence in the location of the pest. They may synergise the activity of the compounds of the invention or complement the activity for example by increasing the speed of effect, improving knockdown or overcoming repellency.
Additionally multi-component mixtures of this type may help to overcome or prevent the development of resistance to individual components.
The particular insecticide, herbicide or fungicide included in the mixture will depend upon its intended utility and the type of complementary action required.
Examples of suitable insecticides include the following :
(a) Pyrethroids such as permethrin, esfenvalerate, deltamethrin , cyhalothrin, biphenthrin, fenpropathrin , cyfluthrin, tefluthrin, fish safe pyrethroids for example ethofenprox, natural pyrethrin, tetramethrin, sbiollethrin, fenfluthrin, prallethrin and 5-benzyl-3furylmethyl-(E)-(lR,3S)-2,2-dimethy1-3-(2-oxothiolan-3ylidenemethyl) cyclopropane carboxylate;
(b) Organophosphates such as profenofos, sulprofos, methyl parathion, azinphos-methyl, demeton-s-methyl, heptenophos, thiometon, fenamiphos, monocrotophos, profenophos, triazophos, methamidophos, dimethoate, phosphamidon, malathion, chlorpyrifos, phosalone, fensulfothion, fonofos, phorate, phoxim, pyrimiphos-methyl, fenitrothion o d iazinon;
(c) Carbamates (including aryl carbamates) such as pirimicarb, cloethocarb, carbofuran, ethiofencarb, aldicarb, thiofurox, carbosulfan, bendiocarb, fenobucarb, propoxur or oxamyl;
(d) Benzoyl ureas such as triflumuron, chlorofluazuron;
» .
(e) Organic tin compounds such as cyhexatin, fenbutatin oxide, azocyclotin;
(f) Macrolides such as avermectins or milbemyins, for example such as abamectin, avermectin, and milbemycin;
(g) Hormones such as juvenile hormone, juvabione, or ecdysones.
(h) Pheromones.
(i) Organochlorine compounds such as benzene hexachloride, DDT, chlordane or dieldrin.
In addition to the major chemical classes of insecticide listed above, other insecticides having particular targets may be employed in the mixture if appropriate for the intended utility of the mixture. For instance selective insecticides for particular crops, for example stemborer specific insecticides for use in rice such as cartap or buprofezin, can be employed.
Alternatively insecticides specific for particular insect species/stages for example ovolarvicides such as clofentazine, flubenzimine, hexythiazox and tetradifon, motilicides such as dicofol or propargite, acaricides such as bromopropylate, chlorobenzilate, or insect growth regulators such as hydramethylon, cyromazin, methoprene, chlorofluazuron and diflubenzuron may also be included in the compositions.
Examples of suitable insecticide synergists for use in the compositions include piperonyl butoxide, sesamex, and dodecyl imidazole.
Suitable herbicides, fungicides and plant growth regulators for inclusion in the compositions will depend upon the intended target and the effect required. An example of a rice selective herbicide which can be included *
is propanil, an example of a plant growth regulator for use in cotton is Pix, and examples of fungicides for use in rice include blasticides such as blasticidin-S. The choice of other ingredients to be used in mixture with the active ingredient will often be within the normal skill of the formulator, and will be made from known alternatives depending upon the total effect to be achieved.
The ratio of the compound of the invention to any other active ingredient in the composition will depend upon a number of factors including the type of insect pests to be controlled, and the effects required from the mixture.
AP 0 0 0 0 3 4
However in general, the additional active ingredient of the composition will be applied at about the rate it would usually be employed if used on its own, or at a lower rate if synergism occurs.
The compositions may be in the form of dusting powders wherein the active ingredient is mixed with a solid diluent or carrier, for example kaolin, bentonite, kieselguhr, or talc, or they may be in the form of granules, wherein the active ingredient is absorbed in a porous granular material, for example pumice.
Alternatively the compositions may be in the form of liquid preparations to be used as dips or sprays, which are generally aqueous dispersions or emulsions of the active ingredient in the presence of one or more known wetting agents, dispersing agents or emulsifying agents (surface active agents).
Wetting agents, dispersing agents and emulsifying agents may be of the cationic, anionic or non-ionic type. Suitable agents of the cationic type include, for example, quaternary ammonium compounds, for example cetyltrimethyl ammonium bromide. Suitable agents of the anionic type include, for example, soaps, salts of aliphatic monoesters or sulphuric acid, for example sodium lauryl sulphate, salts of sulphonated aromatic compounds, for example sodium dodecylbenzenesulphonate, sodium, calcium or ammonium 1ignosulphonate, or butyl naphthalene sulphonate, and a mixture of the sodium salts of diisopropyl- and triisopropylnaphthalene sulphonates. Suitable agents of the non-ionic type include, for example, the condensation products of ethylene oxide with fatty alcohols such as oleyl alcohol or cetyl alcohol, or with alkyl phenols such as octyl phenol, nonyl phenol and octyl cresol. Other non-ionic agents are the partial esters derived from long chain fatty acids and hexitol anhydrides, the condensation products of the said partial esters with ethylene oxide, and the lecithins.
The compositions may be prepared by dissolving the active ingredient in a suitable solvent, for example, a ketonic solvent such as diacetone alcohol, or an aromatic solvent such as trimethylbenzene and adding the mixture so obtained to water which may contain one or more known wetting, dispersing or emulsifying agents.
Other suitable organic solvents are dimethyl formamide, ethylene dichloride, isopropyl alcohol, propylene glycol and other glycols, diacetone alcohol, toluene, kerosene, white oil, methylnaphthalene, xylenes and trichloroethylene, N-methyl-2-pyrrolidone and tetrahydrofurfuryl alcohol (THFA).
The compositions which are to be used in the form of aqueous dispersions or emulsions are generally supplied in the form of a concentrate containing a high proportion of the active ingredient or ingredients, the said concentrate to be diluted with water before use. These concentrates are often required to withstand storage for prolonged periods and after such storage, to be /capable of dilution with water to form aqueous preparations which remain homogenous for a sufficient time to enable them to be applied by conventional spray equipment. The concentrates may contain 10-85% by weight of the active ingredient or ingredients. When diluted to form aqueous preparations such preparations may contain varying amounts of the active ingredient depending upon the purpose for which they are to be used. For agricultural or horticultural purposes, an aqueous preparation containing between 0.0001% and 0.1% by weight of the active ingredient is particularly useful.
AP 0 0 0 0 3 A
In use the compositions are applied to the pests, to the locus of the pests, to the habitat of the pests, or to growing plants liable to infestation by the pests, by any of the known means of applying pesticidal compositions, for example, by dusting or spraying.
The compositions of the invention are very toxic to wide varieties of insect and other invertebrate pests, including, for example, the following:
Myzus persicae (aphids)
Aphis fabae (aphids)
Megoura viceae (aphids)
Aedes aegypti (mosquitoes)
Dvsdercus fasciatus (capsids)
Musca domestica (houseflies)
Pieris brassicae (white butterfly, larvae)
Plutella maculipennis (diamond back moth, larvae)
Phaedon cochleariae (mustard beetle)
Tetranychus cinnabarinus (carmine spider mite) ' Tetranychus urticae (red spider mites)
Aonidiella spp. (scale insects)
Trialeuroides spp. (white flies)
Blattella germanica (cockroaches)
Spodoptera littoralis (cotton leaf worm)
He 1iothis virescens (tobacco budworms)
Chortiocetes terminifera (locusts)
Diabrotica spp. (rootworms )
Agrotis spp. (cutworms )
Chilo partellus (maize stem borers)
Nilaparvata lugens (plant hoppers)
The compounds of formula I and compositions comprising them have shown themselves to be particularly useful in controlling pests of maize and rice such as Chilo (stem borers) as well as lepidopteran pests of cotton, for example Spodoptera spp. and He 1iothis spp.
- 26 Although all of the invention compounds of formula I show insecticidal properties in the tests described hereinafter in the Examples they are not all equally effective at the particular rates tested to all of the test species. Thus it can be seen that the compounds of formula I wherein X is hydrogen, chloro or fluoro are usually more effective than those where X is hydroxy.
Some of the compounds are particularly useful for the control of insect pests of rice because they show high levels of activity against rice pests such as Chilo sp. and Nilaparvata sp. at rates which are not toxic to fish, thus enabling their use in paddy rice where fish are cultivated in the paddy.
In the following Examples, Gas Liquid Chromatography (GLC) retention times were determined on a Hewlett Packard 5890 Gas Chromatograph, using a Chromopak C.P. Sil 5 C.B. column of 12.5m length and 0.2 mm internal diameter.
Unless otherwise stated, the injection temperature was 100*C, and a temperature gradient of 15*C/minute employed, up to a maximum temperature of 280’C, maintained for 4 minutes. The carrier gas was helium at a column head pressure maintained at 11 psi. Alternative injection and maximum temperatures are indicated in the Examples where appropriate.
1H Nuclear Magnetic Resonance (NMR) spectrometry was performed at a frequency of 270MHz on a Jeol FX 270 NMR spectrometer, unless otherwise stated. 18F NMR spectrometry was performed on a Jeol FX90Q spectrometer at a frequency of 84.26 MHz.
EXAMPLE 1
This Example illustrates the preparation of 4-bromo- dt,, <X , oC , -trifluoroacetophenone.
Literature reference : Journal of Organometallic Chemistry, 251, 139-148, (1983).
A mixture of 1,4-dibromobenzene (64g), dry tetrahydrofuran (600 crn^) and dry diethyl ether (600 cm^) was cooled to -78’C under an atmosphere of nitrogen. n-Butyllithium (108.4 cm^ of a 2.5 molar solution in hexane) was added to the stirred mixture over 40 minutes, the temperature of the reaction mixture being maintained below -72’C by external cooling; the mixture was then stirred for a further 40 minutes. Methyl trifluoroacetate (35.4g) was then added over 40 minutes, and stirring continued for a further 30 minutes, the temperature being maintained below -68*C throughout. The reaction mixture was then carefully quenched by adding a mixture of concentrated hydrochloric acid (60 cm^) and ethanol (40 cm^ ), precooled to -78*C, over a period of 10 minutes. After stirring for a further minutes, the reaction mixture was allowed to warm to the * ambient temperature (ca. 22*C). The organic layer was separated and concentrated by evaporation under reduced pressure to leave a water-contaminated oil (70g). The oil was dissolved in diethyl ether, and the solution dried over anhydrous magnesium sulphate. Evaporation of the solvent under reduced pressure gave an orange oil, which was purified by distilLation under reduced pressure (ca. 15 mm Hg). Two fractions containing essentially the same material, 4-bromo- oi, ci , < -tri f luoroacetophenone, were obtained. The first fraction (17.19g), boiling within a range of 78-83*0, was shown to be 85% pure by gas liquid chromatography; the second fraction (41.13g), boiling range 83-84*0, was shown to be 99% pure by gas liquid chromatography. The second fraction crystallised on standing.
3Η NMR (CDC13) $ (ppm) : 7.7 (2H,m); 7.95 (2H,m) 19F NMR (CDCI3) £(Ppm - relative to CFCI3) · -72.1
EXAMPLE 2
By the use of a procedure similar to that illustrated in Example 1 above, the following compounds were prepared from the appropriate starting materials.
(i) 3-Fluoro-4-ethoxy- x, x ,x -trifluoroacetophenone, from 4-bromo-2-fluorophenetole.
The preparation of 4-bromo-2-fluorophenetole is described in Example 42.
In this case, the product was purified by column chromatography on a silica gel support, eluting with n-hexane containing 5% by volume ethyl acetate.
ΣΗ NMR (CDC13) $ (ppm) : 1.54 (3H,t); 4.2 (2H,q);
7.0 (lH,t); 7.7-7.95 (2H,m).
•r £ 0 0 0 0 dV (ii) 4-Methoxymethyl- «ί, X , < -trif luoroacetophenone, from 4-bromobenzyl methyl ether.
The preparation of 4-bromobenzylmethyl ether is described in Example 41.
lH NMR (CDCl^) $ (ppm) : 3.45 (3H,s); 4.57 (2H,s); 7.5, 8.05 (4H,A3q)
IR (liquid film) : 1722 cm-1 (C=O)
GLC retention time : 1.67 minutes ( i i i ) 3,4 - (Methylenedioxy )- e*, x , X -tri fluoroacetophenone, from 4-bromo-l,2-(methylenedioxy)benzene.
1H NMR (CDC13) S(ppm) : 6.12 (2H,s); ca. 6.9 (lH,d); 7.5 (1H,broad,s) ca. 7.7 (1H,broad d)
GLC retention time : 1.87 minutes (iv) 4-Trifluoromethoxy- X, Χ,Χ. -trifluoroacetophenone, from 4-bromotrifluoromethoxybenzene.
4-Bromotrifluoromethoxybenzene may be prepared 15 from trifLuoromethoxybenzene by the process described in the Journal of Organic Chemistry, 29, 1, (1964).
Boiling point : 164-166*C (atmosphere pressure).
XH NMR (CDC13) S(ppm) : 7.35, 8.14 (4H,d)
NMR (CDC13) (ppm relative to CFC13) :
-58.1 (s) CF3O -72.1 (s) CF3
GLC retention time : 1.50 minutes (50*C-280*C run)
EXAMPLE 3
This Example illustrates the preparation of 4ethoxy- <Λ, X -trifluoroacetophenone.
A. From trifluoroacetic acid.
Literature reference : Journal of Organic Chemsitry,
3_2, 1311, (1967).
A solution of 4-bromo-ethoxybenzene (60g) in diethyl ether (100 cm3) was added slowly to a stirred mixture of magnesium turnings (7.4g), diethyl ether (50 cm3) and a crystal of iodine (ca. 0.5g) under a nitrogen atmosphere.
After ca. 15 cm3 of the solution had been added the mixture was warmed gently until the reaction commenced and the rate of addition was thereafter adjusted to maintain a gentle reflux. After the completion of the addition (ca. 30 minutes) the mixture was stirred for a further 20 minutes at the ambient temperature (ca. 22*C), following which a solution of trifluoroacetic acid (12.Og) in diethyl ether (25 cm3) was added dropwise over a period of one hour. The mixture was then heated at the reflux temperature for a further one hour after which the mixture was poured into crushed ice and acidified with concentrated hydrochloric acid. The organic layer was separated, and the aqueous layer extracted three times with diethyl ether and the extracts combined with the organic layer, and the ethereal solution washed twice with saturated sodium bicarbonate, and dried over anhydrous sodium sulphate. After removal of the solvent by evaporation under reduced pressure the residual oil (48g) was subjected to fractional distillation. Three fractions were collected at 64*C/0.1-0.2 mg Hg, containing 1.2g (75% pure by gas-liquid chromatography), 13g (91% pure) and 2.4g (85% pure) of 4-ethoxytri fluoroacetophenone respectively. The major fraction was used without further purification.
AP 0 0 0 0 3 4 ΓΗ NMR (CDC13) S : 1.46 (3H,t); 4.15 (2H,q); 7.0 (2H,m);
8.05 (2H,m).
Infra red (liquid film) : 1710 cm'l·.
B. From trifluoroacetic anhydride.
A solution of 4-bromoethoxybenzene (150g) in diethyl ether (200 cm^) was added slowly to a stirred mixture of magnesium turnings (20.Og), diethyl ether (50 cm^) and a crystal of iodine (ca. 0.5g) under a nitrogen atmosphere. After ca.
cm3 of the solution had been added the mixture was warmed gently until the reaction commenced and the rate of addition was adjusted to maintain a gentle reflux. After the addition was complete the mixture was stirred for a further one hour at the ambient temperature (ca. 22*C) after which the mixture was cooled at 0*C by external cooling and a solution of trifluoroacetic.anhydride (2O3g) in diethyl ether’(100 cm^) was added, initially drop by drop, and then at a faster rate so as to maintain a gentle reflux. The addition was completed over a period of 20 minutes after which the mixture was stirred for a further 45 minutes. The r .
mixture was then poured onto crushed ice and the product worked up in the manner set out in Part A above, to give, after distillation, 4-ethoxytrifluoroacetophenone (35g).
EXAMPLE 4
By the use of procedures similar to those set out in parts A and B of Example 3 above, the following compounds were prepared from the appropriate starting material.
(i) 4-Methoxy-, o< ,x -trifluoroacetophenone, from
4-bromomethoxybenzene and trifluoroacetic anhydride.
1H NMR (CDC13) £ (ppm) : 3.90 (3H,s); 7.02 (2H,d);
8.05 (2H,d)
GLC retention time : 3.75 minutes (5Q*C-2Q0*C run) (ii) 4-t-Butyl- X,X -trifluoroacetophenone, from 4bromo-t_-butylbenzene and trifluoroacetic anhydride.
GLC retention time : 1.83 minutes (iii) 4-Trifluoromethoxy- X, X ,x -trifluoroacetophenone, from 4-bromotrifluoromethoxybenzene and trifluoroacetic anhydride.
In this case, the product was purified by distillation in a Kugelrohr apparatus, under reduced pressure (ca. 12 mm Hg), at an oven temperature of 5O-7O*C.
XH NMR (CDC13) £ (ppm) . 7.35, 8.14 (4H,d) 19F NMR (CDC13) : (ppm-relative to CF,C13) :
-58.1 (CF3O, S)
-72.1 (CF3, S)
IR : 1730, 1610, 1270, 1150-1250 cm-1 (iv) 4-Chloro- x, , -trif luoroacetophenone, from
4-bromochlorobenzene and trifluoroacetic anhydride.
3H NMR (CDC13) S(ppm) : ca. 7.6, 8.1 (each 2H, ABq)
APO 0 0 η Λ 4
GLC retention time : 2.56 minute (50*C-280*C run)
EXAMPLE 5
This Example illustrates the preparation of 4-methylX , (X , cfi -trif luoroacetophenone.
Literature reference : Tetrahedron, 42, 547, (1986)
A stirred mixture of aluminium chloride (8.33g) toluene (20 cm3) and carbon disulphide (10 cm3) Was cooled to -40’C (+ 5*C). Tri fluoroacetyl chloride (6.92g) was condensed into the reaction vessel from a cylinder and the reaction mixture was stirred at -40* for 3 hours. The mixture was carefully poured into a mixture of ice and concentrated hydrochloric acid; caution was necessary during the quenching in view of the observed exothermic reaction. The organic layer was separated and the aqueous layer extracted with diethyl ether (3 x 100 cm3). The combined organic layers were washed with saturated sodium carbonate solution, then water, and finally dried over anhydrous sodium sulphate to give a pale yellow solution.
Removal of the solvent by distillation at atmospheric pressure gave an oil, which was shown by gas liquid chromatography to consist of a mixture of toluene and the required product, 4-methy 1- X, X , o( -tri fluoroacetophenone.
The product was purified by distillation, and identified as the required product by gas liquid chromatographic comparison with an authentic sample.
GLC retention time : 2.37 minutes (50’C-280*C run)
EXAMPLE 6
By use of a procedure similar to that described in Example 5 above, the following compound was prepared from the appropriate starting material.
(i) 4-n-Propyl- ck, , -tri f luoroacetophertone from 4bromo-n-propylbenzene.
NMR (CDClj) S(ppm) : 0.95 (3H,t); ca. 1.68 (2H,m); 2.7 (2H,t)j
7.35 (2H,d); 8.0 (2H,d).
EXAMPLE 7
This Example illustrates the preparation of 1,1,1tri fluoro-2-(4-ethoxypheny1)prop-2-ene oxide.
Trimethylsulphoxonium iodide (8.1g) was added to a stirred solution of 4-ethoxy- *<, e< , -trifluoroacetophenone (8g) in t-butanol (25 cm3). When the addition was complete, potassium hydroxide pellets (2g) were added, and the reaction mixture was heated at the refLux temperature for one hour. The mixture was cooled, and poured into a dilute aqueous solution of hydrochloric acid. The aqueous mixture was extracted eight times with diethyl ether and the combined extracts were dried over anhydrous magnesium sulphate. Removal of the solvent by evaporation under reduced pressure gave a pale yellow oil (5.5g) containing a small amount of solid residue. The crude produc€ residue was passed through a plug of silica gel, using n-hexane containing 10% by volume ethyl acetate as eluent. Further purification by chromatography using a silica gel column eluted with jn-hexane containing 10% by volume ethyl acetate gave two fractions containing 1,1,1-trifluoro-2-(4-ethoxy25 phenyl)prop-2-ene oxide. The first fraction was shown by gas liquid chromatography to be 79% pure, the second 98% pure.
huuu udV LH NMR (CDC13) S(ppm) : 1.42 (3H,t); 2.9 (lH,dq); 3.38 (lH,d); 4.07 (2H,q); 6.9, 7.4 (4H,m).
EXAMPLE 8
By use of a procedure similar to that described in 5 Example 7 above, the following compounds were prepared from the appropriate starting materials.
( i ) 1, 1, 1-Tri fluoro-2-(4-methylphenyl)prop-2-ene oxide, from 4-methyl- X,X , x -trifluoroacetophenone 1H NMR (CDC13) S(ppm) : 2.4 (3H,s); ca. 2.9 (lH,dq); ca. 3.4 (lH,d); ca. 7.3 (4H,A3q)
GLC retention time : 3.02 minutes (5O’C-28O*C run)
X6 (ii) 1,1, 1-Trifluoro-2-(4-ethoxy-3-f luorophenyl)prop-2ene oxide, and 1,1,1-trifluoro-2-(4-ethoxy-315 fluorophenyl)propan-2, 3-diol from 4-ethoxy-3fluoro-i<,X -trifluoro-acetophenone.
In this case, the reaction mixture was heated at the reflux temperature for 3 hours, under an atmosphere of nitrogen. Analysis of the reaction mixture by gas liquid chromatography showed 2 major products. The first product was identified as the expected epoxide, and was purified by distillation in a Kugelrohr apparatus, under reduced pressure (ca. temperature of 120*C, purity :
mmHg), at an oven to give the epoxide in 85% ΣΗ NMR (CDC13)€ (ppm)
1.45 (3H,t); 2.92 (lH,m); 3.4 (lH,m); 4.12 (2H,q); 6.95 (lH,t); 7.2-7.3 (2H,m)
The second product was purified by further distillation under high vacuum (0.1 mmHg) at an oven temperature of 130’C, and identified as 1, 1,1-tri fluoro-2-(4-ethoxy-3-fluorophenyl) propan2,3-diol (85% pure).
1H NMR (CDC13)£ (ppm) : 1.45 (3H,t); 1.9 (1H, broad); 3.5-4.5 (5H,inincorporating 1H broad, 2H,m and 2H,q); 6.97.5 (3H,m)
AP 0 0 0 0 3 4 (iii) 1,1,1-Tri fluoro-2-(4-£-butylphenyl)propq2-ene oxide, from 4-t-butyl- -tri f luoroaceto20 phenone.
In this case, the product was obtained in 50% purity, shown by gas liquid chromatography to be mixed primarily with unreacted starting ketone. The product was used without further purification.
(iv) k
>
(v)
NMR (CDC13) S(ppm) : 1.4 (9H,s); 2.9 (lH,m);
3.4 (1H,broad d); 7.5 (4H,m); other signals due to starting material also recorded
GLC retention time : 2.21 minutes (GLC retention time of starting ketone : 1.73 mi nutes ) .
1, 1, 1 -Tr i f luoro-2- ( 4 -n-propylphenyl) prop-2 -er.e oxide, from 4-n-propyl- trifluoroacetophenone.
1H NMR (CDC13) £(ppm) : 0.9 (3H,t); ca. 1.6 (2H, m); 2.58 (2H,t); ca.
2.9 (lH,m); 3.4 (lH,d);
7.1-7.5 (4H,ABq)
GLC retention time : 2.06 minutes
1,1,1-Trifluoro-2-(5-indanyl)prop-2-ene,oxide, from 5-trifluoroacetylindane.
1H NMR (CDC13) £(ppm) : 2.1 (2H,m); 2.9 (5H,m);
3.4 (lH.d); 7.26 (2H, ABq); 7.38 (lH,s).
1 ^F NMR (CDC13) $(ppm - relative to CFC13) : -75.1 (cf3,s).
GLC retention time : 2.61 minutes.
(vi) 1,1,1-Trif luoro-2-(4-fluorophenyl)-prop-2-ene oxide, from 4-fluoro- X-, X ,X -tri fluoroacetophenone.
NMR (CDClj) X (ppm) : 2.9 (lH,m); 3.4 (lH,d);
7.0-7.6 (4H,m).
18F NMR (CDC13) $ (ppm - relative to CFC13) : -75.2 (CF3,S); -111.7 (lF,m).
GLC retention time : 2.18 minutes (50’C-280*C run) (vii) 1,1,1-Trif luoro-2-(4-chlorophenyl)prop-2-ene oxide, from 4-chloro- e<, «X ,<X.-tri fluoroacetophenone.
*Η NMR (CDC13)$(ppm) : 2.9 3.42 (lH,d);
7.2-7.6 (4H,m) 19F NMR (CDC13)S (ppm) - relative to CFC13) -75.0 (CF3, S).
. . '
GLC retention time : 1.42 minutes (3.59 minutes for 5O*C-28O‘C run ).
AP 0 0 0 0 3 4
EXAMPLE 9
This Example illustrates the preparation of 1,1,1tri fluoro-2-(4-ethoxyphenyl)-3-(3-phenoxybenzyloxy)propan-2 ol.
A mixture of 3-phenoxybenzyl alcohol (0.84g) and sodium hydride (0.25g - prepared by washing 0 . 5g of a 50% dispersion in oil with petroleum ether of boiling range 6080eC under an atmosphere of nitrogen) in dry N,N-dimethyl5 formamide (15 cm^) was stirred at the ambient temperature (ca. 22*C) until evolution of hydrogen had ceased (30 minutes). A solution of 1,1,1-trifluoro-2-(4ethoxyphenyl)prop-2-ene oxide (lg) in N,N-dimethylformanide (5 cm^) was then added to the stirred mixture. After one hour, analysis by gas liquid chromatography indicated that no starting materials remained in the reaction mixture. The mixture was quenched with water and extracted three times with ethyl acetate. The combined extracts were dried over anhydrous sodium sulphate, and concentrated by evaporation of the solvent under reduced pressure.. The residual, pale yellow oil was purified by flash column chromatography on a silica gel support, using n-hexane containing 15% by volume ethyl acetate as eluent, to give 1,1,1-trifluoro-2-(4ethoxyphenyl )-3-(3-phenoxybenzyloxy)propan-2-ol (1.85g) as a colourless oil.
ΧΗ NMR (CDC13) $ (ppm) : 1.44 (3H,t); 3.65 (lH,s); 3.67 (lH,d); 4.0-4.2 (3H,m); 4.6 (2H,s); 6.8-7.5 (13H,m)
The signal at 3.65 disappeared on shaking the sample will 25 D2O, revealing the signal at 3.67.
19F NMR $ (ppm - relative to CFC13) : -77.9 (CF3)
IR (liquid film) : 3540, 1620, 1592, 1520, 1493, 1260,
1170 cm-1
GLC retention time : 11.90 minutes.
EXAMPLE 10
By the use of a procedure similar to that illustrated in Example 9 above, the following compounds were prepared from the appropriate starting materials.
(i)
1,1,1-Tri fluoro-2-(4-ethoxyphenyl)-3-(4-fluoro-3phenoxybenzyloxy)propan-2-ol, from 1,1,1trifluoro-2-(4-ethoxyphenyl)prop-2-ene oxide and 4-fluoro-3-phenoxybenzy1 alcohol.
XH NMR (CDC13) S (ppm)
1.41 (3H,t); 3.6 (lH,s) 3.63 (lH,d - small coupling to CF3); 4.02 (2H,q); 4.04 (lH,d); 4.62 (2H,s); 6.8-7.5 (12H,m) 19F NMR (CDC13)S (ppm - relative to CFC13) : -77.9 (3F); -132.18 (lF,m)
AP 0 0 0 0 3 4
IR (liquid film)
3540, 1613, 1591, 1514, 1427, 1282, 1254, 1210, 1180,
1166 cm
GLC retention time : 11.85 minutes (ii) 1, 1,1-Trifluoro-2-(4-ethoxyphenyl)-3-(4-methyl2,3,5,6-tetrafluorobenzyloxy)propan-2-ol from 1, 1,1-trifluoro-2-(4-ethoxyphenyl) prop-2-ene oxide and 4-methyl-2,3,5,6-tetrafluorobenzyl alcohol.
1H NMR (CDC1-.) $ (ppm) : 1.41 (3H,t); 2.27 (3H,t)
3.55 (1H,s ) ; ca. 3.7 (1H,broad d); 4.04 (2H,q); 4.12 (lH,d)?
4.7 (2H,ABq); 6.9-7.4 (4H,m) l9F NMR (CDCI3) £ (ppm - relative to CFCI3) :
-78 (3F); -143.6-145.8 (4F,m)
IR (liquid film) : 3550 cnfl (OH)
GLC retention time : 8.31 minutes.
(ii i) 1,1,1-Tri fluoro-2-(4-methylpheny1)-3-(3-phenoxybenzyloxy)propan-2-ol, from 1,1,1-trifluoro-2(4-methylpheny1)prop-2-ene oxide and 3-phenoxybenzyl alcohol.
LH NMR (CDC13) £ (ppm) : 2.33 (3H,s); 3.66 (lH,d); 3.76 (lH,s);
4.08 (lH,d); ,4.56 (2H,s); 6.9-7.4 (13H,m).
GLC retention time : 10.76 minutes.
(iv) 1,1,1-Tri fluoro-2-{3-fluoro-4-ethoxyphenyl )-3-(3(4-chlorophenoxy)benzyloxy ) propan-2-ol, from
1,1,1-trifluoro-2-(3-fluoro-4-ethoxyphenyl)prop2-ene oxide and 3-(4-chlorophenoxy)benzyl alcohol.
LH NMR (CDC13) £ (ppm) : 1.46 (3H,t); 3.64 (lH,d); 3.65 (lH,s); 4.04 (lH,d); 4.1 (2H,q); 4.57 (2H,ABq); 6.9-7.35 (HH,m).
GLC retention time : 12.68 fhinutes.
(v) 1,1,1-Tri fluoro-2-(4-t-butylphenyl)-3-(3-phenoxy4-f luorobenzyloxy)propan-2-ol, from 1,1,1trifluoro-2-(4qt-butylphenyl)prop-2-ene oxide and
3-phenoxy-4-fluorobenzyl alcohol.
In this case the epoxide starting material used was that prepared in Example 8 (iii) above, and was contaminated with ca. 40% unreacted 4-£-butylei, X. -trifluoroacetophenone. The acetophenone was, surprisingly, found to react with the alcohol in preference to the epoxide. It was therefore necessary to isolate the unreacted epoxide and repeat the reaction in the absence of acetophenone.
NMR (CDC13) 2 (ppm) : 1.3 (9H,s); 3.62 (lH,s);
3.64 (1H,broad d); 4.08 (lH,d); 4.52 (2H,s); 7.07.5 (12H,m).
19F NMR (CDC13) $ (ppm - relative to CFC13) :
-77.5 (CF3-S)
-132.1 (lF,m).
APO 0 0 0 3 4
GLC retention time : 11.78 minutes.
(vi ) 1, 1, 1 -Tr if luoro-2 -( 4-n-propylphenyl )-3-(3 -phenoxy4-fluorobenzyloxy)propan-2-ol, from 1,1,1trifluoro-2-(4-n-propylpheny1)prop-2-ene oxide and 3-phenoxy-4-fluorobenzyl alcohol.
I-H NMR (CDCl^) $ (ppm) : 0.93 (3H,t); ca. 1.6 <2H,m); 2.6 (2H,t); 3.64 (lH,d); overlapping with 3.62 (lH,s); 4.08 (lH,d);
4.5 (2H,s); 6.9-7.4 (12H,m).
19F NMR (CDC13) £ (ppm - relative to CFC13) :
-77.6 (CF3,S);
-132.1 (lF,m).
GLC retention time : 11.66 minutes (vii) 1,1,1-Tri fluoro-2-(5-indanyl)-3-(3-phenoxy-415 fluorobenzyloxy)propan-2-ol, from 1,1,1-trifluoro2 - (5-indanyl)prop-2-ene oxide and 3-phepoxy-4fluorobenzyl alcohol.
1H NMR (CDC13) £ (ppm) : 2.08 (2H,m); 2.90 (4H,m);
3.64 (lH,d); 3.63 (lH,s);
4.08 (lH.d); 4.55 (2H,s)?
6.95-7.4 (11H , m) .
GLC retention time : 12.18 minutes.
(vi i i) 1,1,1-Trifluoro-2-(4-fluorophenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol, from 1,1,1-trifluoro25 2-(4-fluorophenyl)prop-2-ene oxide and 3-phenoxy4-fluorobenzyl alcohol.
NMR (CDCl^) £ (ppm) : 3.62 (lH,d); overlapping with 3.65 (lH,s); 4.06 (lH,d); 4.52 (2H,s); 6.97.5 (12H,m).
GLC retention time : 10.6 minutes.
(ix) 1,1,1-Tri fluoro-2-(4-chlorophenyl)-3-(3-phenoxy-4f luorobenzyloxy)propan-2-ol, from 1,1,1trifluoro-2-(4-chlorophenyl)prop-2-ene oxide and
3-phenoxy-4-fluorobenzyl alcohol.
NMR (CDClj) (ppm) : 3.62 (lH,d); overlapping with 3.64 (lH,s); 4.03 (lH,d); 4.52 (2H,s); 6.97.5 (12H,m).
,19F NMR (CDCI3)S (ppm - relative to CFCI3) :
-77.7 (CF3»s).
GLC retention time : 11.16 minutes. * (x) 1, 1, 1-Trifluoro-2-(4-bromopheny1 )-3- (3-phenoxy-4fluorobenzyloxy)propan-2-ol, from 1,1,1trifluoro-2-(4-bromopheny1)prop-2-ene oxide and 320 phenoxy-4-fluorobenzyl alcohol.
XH NMR (CDC13) S (ppm) : 3.62 (lH,d); 3.67 (lH,s);
4.02 (lh,d); 4.50 (2H,s); 6.9-7.5 (12H,m).
APO 0 0 0 3 4
GLC retention time : 11.7 minutes.
(xi) 1,1,1-Trifluoro-2-(4-ethoxypheny1)-3-(3-(4chlorophenoxy)benzyloxy)propan-2-ol, from 1,1,1trifluoro-2-(4-ethoxyphenyl)prop-2-ene oxide and 3-(4-chlorophenoxy)benzyl alcohol.
NMR (CDC13) $ (ppm) : 1.42 (3H,t); 3.63 (lH,s);
3.66 (lH,d); ca. 4.0 (2H,q); overlapping with (lH,d); 4.58 (2H,ABg); 6.8-7.5 (12H,m).
NMR (CDCIj) S (ppm - relative to CFClg) :
-77.9 (CF3,S).
GLC retention time : 13.07 minutes.
(xii) 1,1,l-Trifluoro-2-(4-ethoxyphenyl)-3-(3-(4-bromophenoxy)-4-fluorobenzyloxy)propan-2-ol, from
,. 1,1,1-trifluoro-2-(4-ethoxyphenyl )prop-2-ene oxide and 3-(4-bromophenoxy)-4-fluorobenzyl alcohol.
The preparation of 3-(4-bromophenoxy)-4-fluorobenzyl alcohol is described in Example B8.
1H NMR (CDC13) S (ppm) : 1.42 (3H,t); 3.60 (lH,s);
3.65 (lH,d); 4.02 (2H,q); overlapping with 4.04 (lH,d); 4.52 (2H,s); 6.8-7.5 (HH,m).
19F NMR (CDC13) (ppm - relative to CFC13) :
-77.8 (CF3,s)
-131.7 (lF,m).
GLC retention time : 13.41 minutes.
(xiii) 1,1,1-TrifLuoro-2-(4-ethoxyphenyl )-3-(3-(4chlorophenoxy)-4-fluorobenzyloxy)propan-2-ol, from 1, 1, 1-trifluoro-2-(4-ethoxyphenyl)prop-2-ene oxide and 3-(4-chlorophenoxy)—4—fluorobenzyl alcohol.
The preparation of 3-(4-chlorophenoxy)-4-fluorobenzyl alcohol is described in Example 39.
XH NMR (CDC13) S (ppm) : 1.43 (3H,t); 3.6 (lH,s);
3.65 (lH,d); 4.04 (2H,q); overlapping with (lH,d);
4.52 (2H,s); 6.8-7.4 (llH,m).
X^F NMR (CDC13) S (ppm - relative to CFC13) :
-77.8 (CF3,s)
-131.8 (lF,m).
I •Ί
f.
GLC retention time : 12.78 minutes.
(xiv) 1,1,1-Tri fluoro-2-(4-ethoxypheny1)-3-(5-benzyl-3furanylmethyloxy)-propan-2-ol, from 1,1,1trifluoro-2-(4-ethoxyphenyl)prop-2-ene oxide and 5-benzyl-3-hydroxymethyl furan.
1H NMR (CDCI3) S (ppm) : 1.41 (3H,t); 3.65 (lH,s);
overlapping with 3.63 (lH,d); 3.95 (2H,s); 4.04.1 (2H,q) overlapping with (lH,d); 4.2 (2H,s);
6.0 (lH,s); 6.9 (2H,d);
7.2-7.4 (8H,m) 19F NMR (CDCI3) S>(ppm - relative to CFCI3) *
-78.0 (CF3,g).
GLC retention time : 11.37 minutes.
(xv) 1,1,1-Trifluoro-2-(4-ethoxypheny1) -3-(3-benzy1-4fluorobenzyloxy)propan-2-ol, from 1,1,1-trifluoro2-(4-ethoxyphenyl)prop-2-ene oxide and 3-benzyl-4fluorobenzyl alcohol.
The preparation of 3-benzyl-4-fluorobenzyl alcohol is described in Example 40.
ΣΗ NMR (CDC13) $ (ppm) : 1.4 (3H,t); 3.6 (2H,s);
4.0 (4H,m); 4.5 (2H,s); 7.4-6.8 (12H,m).
19F NMR (CDC13) (ppm - relative to CFC13) :
-77.9 (CF3,s);
-119.0 (lF,m)
IR (liquid film) : 3600-3300 cm-1 (OH)
EXAMPLE 11
This Example illustrates the preparation of 1,1,115 trifluoro-2-(4-bromophenyl)prop-2-ene oxide.
Trimethylsulphoxonium iodide (2.2g) was added gradually to a stirred suspension of sodium hydride (O.25g - prepared by washing 0.5g of a 50% dispersion in oil with petroleum ether of boiling range 60-80’C under an atmosphere of nitrogen) in dry N,N-dimethylformamide (10 cm3). After evolution of hydrogen had ceased, a solution of 4-bromo-X,
X , X-trifluoroacetophenone (2.53g) in dry N, N-dimethylformamide (10 cm3) was added to the reaction mixture. A solid precipitate was redissolved by the addition of further
N,N-dimethylformamide (10 cm3), and the mixture was stirred at the ambient temperature (ca. 22’C) for a further one hour. After cautious addition of water, the reaction mixture was poured onto ice, and the aqueous mixture extracted three times with diethyl ether. The combined extracts were dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure. The residual yellow oil (2.1g) was purified by filtration through silica gel, using diethyl ether as eluent. The major product-containing fraction was concentrated by evaporation of the eluent under reduced pressure, and purified by distillation of the residual oil (1.4g) in a Kugelrohr apparatus, under reduced pressure (2010 30 mmHg), at an oven temperature of 150‘C to give 1,1,1trifluoro-2-(4-bromopheny1)prop-2-ene oxide (0.785g) as a colourless oil.
7H NMR (CDC13) & (ppm) : 2.9 (lH,m - probably dq); 3.4 (lH,d); 7.3-7.6 (4H,aromatic m).
NB. The propene oxides prepared by the method of this
Example need not be isolated but may be used directly as t, formed', in solution in N,N-dimethylformamide, for reaction with alcohols as described in Example 12.
EXAMPLE 12 * .
This Example illustrates the two stage preparation of
0 1,1,1-tri fluoro-2-(3,4-methylenedioxyphenyl)-3-(3phenoxybenzyloxy)propan-2-ol.
Stage 1 : Preparation of 1,1,1-trifluoro-2-(3,4methylenedioxyphenyl)prop-2-ene oxide.
Sodium hydride (0.22g, in the form of 0.44g of a 50% dispersion in oil) was added to a stirred suspension of trimethylsulphoxonium iodide (2g) in dry N,NAPO 0 0 0 3 A dimethylformamide (50 cm^) at the ambienet temperature (ca. 22*C) and under an atmosphere of nitrogen. When evolution of hydrogen had ceased, 3,4-methy lenedioxy- <x, x , at trifluoroacetophenone (2g) was added to the reaction mixture. After 5 minutes, analysis of the reaction mixture by gas liquid chromatography showed a major signal at a retention time of 2.26 minutes corresponding to 1,1,1trifluoro-2-(3,4-methylenedioxy)prop-2-ene oxide, but no trace of the ketone starting material (expected retention time 1.87 minutes). The solution of the epoxide was used immediately in stage 2 of the reaction.
Stage 2 :
3-Phenoxybenzyl alcohol (l.Og) was added to a stirred suspension of sodium hydride (0.22g, in the form of O.44g of a 50% dispersion in oil) in dry N,N-dimethylformamide (40 cm^), under an atmosphere of nitrogen. The mixture was stirred for a 'further 2 hours, during which time evolution of hydrogen occurred, and then added dropwise to the epoxide solution prepared in Stage 1. After a further 2 hours stirring at the ambient temperature (ca. 22*C), the reaction mixture was poured into water, and the aqueous mixture acidified with dilute hydrochloric acid. This mixture was extracted with diethyl ether and the organic layer washed with water, dried over anhydrous magnesium sulphate, and concentrated by evaporation under reduced pressure to give an oil. The oil was purified by column chromatography on a silica gel support, eluting with nhexane containing 15% by volume ethyl acetate, to give 1, 1,1-trifluoro-2-(3,4-methylenedioxypheny1 )-3-(3phenoxybenzyloxy)propan-2-ol (1.83g^ as a colourless oil.
ΣΗ NMR (CDC13) % (ppm) : 3.62 (1H,d); 3.68 (1H,s) ; 4.04 (lH,d); 4.57 (2H,s); 5.96 (2H,s);
5.8-7.4 (12H,m).
19F NMR (CDC13) S (ppm - relative to CFC13) -77.8 (CF3, S).
EXAMPLE 13
By use of the two stage procedure described in Example
12, the following compounds were prepared from the appropriate starting material.
( i ) 1,1,1-Tri fluoro-2-(3,4-methylenedioxyphenyl )-3-(3(4-chlorophenoxy)benzyloxy)propan-2-ol, from 3,410 methylenedioxy- ,* -trifluoroacetophenone and
3-(4-chlorophenoxy)benzyl alcohol.
1H NMR (CDC13) $ (ppm) : 3.62 (lH,d); 3.65 (ΙΗ,β);
4.03 (lH,d); 4.58 (2H,s); 5.98 (2H,s); 6.8-7.4 (llH,m).
GLC retention time : 13.09 minutes.
(i i) 1,1,1-Tri fluoro-2- (4-methoxyphenyl )-3-(3-phenoxybenzyloxy )propan-2-ol, from 4-methoxy- ,Χ trifluoroactophenone and 3-phenoxybenzyl alcohol.
NMR (CDC13) S (ppm) : 3.66 (lH,d with extra fine coupling); 3.72 (lH,s); 3.76 (3H,s);
4.05 (lH,d); 4.55 (2H, ABq); 6.8-7.5 (13H,m).
GLC retention time : 11.54 minutes.
APO 0 0 0 3 A (iv
l) 1,1,1-Trifluoro-2-(4-methoxyphenyl)-3-(3-phenoxy4-fluorobenzyloxy)propan-2-ο 1, from 4-methoxy- <X
X , X -trifluoroacetophenone and 3-phenoxy-4fluorobenzyl alcohol.
lfi NMR (CDCl-j) S (ppm) : 3.62 (lH,s); 3.64 (lH,d) 3.76 (3H,s); 4.05 (lH,d) 4.50 (2H,s); 6.8-7.5 (12H,m)
GLC retention time : 10.77 minutes.
I 1,1,1-Trifluoro-2-(4-methoxymethylphenyl)-3-(3-(4chlorophenoxy )benzyloxy)propan-2-ol, from 4me thoxyme thy 1-X., <x , -trifluoroacetophenone and 3-(4-chlorophenoxy)benzy1 alcohol.
,ΧΗ NMR (CDC13) S (ppm) : 3.4 (3H,s); 3.65 (lH,d);
3.7 (lH,s); 4.12 (lH,d); 4.45 (2H,s); 4.57 (2H,s);
6.9-7.5 (12H,m).
GLC retention time : 12.79 minutes (GLC retention time of intermediate epoxide : 2.17 mi nutes ).
1, 1, l-Trifluoro-2-(4-methoxymethylphenyl)-3-(3phenoxybenzyloxy)propan-2-ol, from 4roe thoxyme thy 1 - oC, X -tri f luoroacet ophenone and
3-phenoxybenzyl alcohol.
(v) (vi (vi XH NMR (CDC13) £ (ppm) ; 3.39 (3H,s); 3.66 (lH,d); 3.7 (lH,s); 4.12 (lH,d); 4.45 (2H,s); 4.58 (2H,s); 6.9-7.55 (13H,m)
GLC retention time : 11.76 minutes ) 1,1,1-Tri fluoro-2-(4-trifluoromethoxyphenyl )-3-(3phenoxy-4-fluorobenzyloxy)propan-2-ol, from 4trifluoromethoxy-X,x -trifluoroacetophenone and 3-phenoxy-4-fluorobenzyl alcohol.
XH NMR (CDC13) £ (ppm) : 3.61 (lH,d); 3.65 (lH,s);
4.03 (lH,d); 4.5 (2H,s);
6.9-7.6 (12H,m).
19F NMR (CDC13) & (ppm - relative to CFC13) :
-58.3(CF3O, s);
-77.6 (CF3,s);
-131.8 (lF,m)
Λ » .
GLC retention time : 9.88 minutes (GLC retention time of intermediate epoxide : 2.34 minutes - 50*C-280*C run)
l) 1,1,1-Trifluoro-2-(4-tri fluoromethoxyphenyl )-3-(3(4-chlorophenoxy)benzyloxy)propan-2-ol, from 4trifluoromethoxy-X,X ,X -tri fluoroacetophenone and 3-(4-chlorophenoxy)benzyl alcohol.
i-H NMR (CDCI3) $ (ppm) : 3.65 (lH,d); 3.73 (lH,s);
4.1 (lH,d); 4.57 (2H,ABq);
6.9-7.6 (12H,m).
NMR (CDC13) S(ppm - relative to CFClj) :
-58.3 (CF3,s);
-77.7 (CF3,s)
GLC retention time : 11.06 minutes (viii) l,l,l-Trifluoro-2-(4-tri fluoromethylpheny1)-3-(3phenoxybenzyloxy)propan-2-ol, from 4tri fluoromethyl-o< , (X ,<x -trif luoroacetophenone and 3-phenoxybenzyl alcohol.
NMR (CDC13) S (ppm) ; 3.68 (lH,d); 3.78 (lH,s);
4.1 (lH,d); 4.58 (2H,ABq); 6.8-7.4 (9H,m); 7.63 (4H,S)
,. 19F NMR (CDCI3) $ (ppm - relative to CFC13) :
-63.3 (CF3,S);
-77.5 (CF3,s) *
GLC retention time : 9.88 minutes (GLC retention time of intermediate epoxide : 2.27 minutes ) ( ix) 1.1,1-Trifluoro-2-(4-trifluoromethylphenyl)-3-( 3phenoxy-4-fluorobenzyloxy)propan-2-ol, from 4trifluoromethyl- <<, ct ,<< -trifluoroacetophenone and 3-phenoxy-4-fluorobenzyl alcohol.
XH NMR (CDC13) 5 (ppm) : 3.65 (lH,d); 3.72 (lH,s);
4.08 (lH.d); 4.52 (2H,s);
6.9-7.4 (8H,m); 7.6 (4H,s).
19F NMR (CDC13) S (ppm - relative to CFC13) :
-63.3 (CF3,s);
-77.5 (CF3,s);
-131.8 (lF,m).
GLC retention time : 9.88 minutes (x) 1,1,1-Trifluoro-2-(4-trifluoromethoxyphenyl)-3-(6phenoxy-2-pyridylmethyloxy)propan-2-ol, from 4trifluoromethoxy- «<,»<,<< -trifluoroacetophenone > and 6-phenoxy-2-hydroxymethylpyridine.
XH NMR (CDC13) £ (ppm) : 3.89 (lH,d); 4.22 (lH,d);
4.64 (2H,ABq); ca. 5.4 (1H,broad s); 6.7-7.7 (12H,m). ' 19F NMR (CDC13) S (ppm - relative to CFC13) :
-58.3 (CF3,s);
-77.7 ( 3F , s).
GLC retention time : 9.82 minutes
EXAMPLE 14
This Example illustrates the preparation of 1,1,1trifluoro-2-(4-trifluoromethoxyphenyl)propan-2,3-diol.
A mixture of 4-trifluoromethoxy- «/,<?<,«X trifluoroacetophenone (4g), trimethylsulphoxonium iodide (3.4g) and potassium hydroxide pellets (0.85g) in t-butanol (20 cm3) was heated at the reflux temperature for two hours. After cooling, the reaction mixture was poured into water, and the aqueous mixture extracted with diethyl ether. The combined extracts were washed twice with water, dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure. The residual oil (4.1g) was purified by distillation in a Kugelrohr apparatus, under reduced pressure (0.2 mmHg), at an oven temperature of 110-130’C. The purified oil (1.3g) was identified as 1,1,1-trifluoro-2-(4-trifluoromethoxyphenyl)propan-2,3-diol, rather than the expected epoxide.
NMR (CDC13) s (ppm) : 2.5 (1H,broad); 3.9, 4.3 (lH,d);
4.1 (1H,broad); 7.2-7.6 (4H,q)
A
The signals at 2.5 and 4.1 disappeared on shaking the sample with ϋ2θ·
IR (liquid film) : 3430 cral (OH)
EXAMPLE 15
This Example illustrates the preparation of 1,1,1tri fluoro-2-(4-tri fluoromethoxyphenyl )-3-(3phenoxybenzyloxy)-propan-2-ol.
1, 1, 1-TrifLuoro-2-(4-trifluoromethoxyphenyl)propan2,3-diol (O.eg), prepared as described in Example 14, 3phenoxybenzy1 bromide (0.54g), 40% sodium hydroxide solution (7 cn?) and a catalytic amount of tetra-n -butylammonium hydrogen sulphate (ca. 0.06g) were mixed, then stirred vigorously at the ambient temperature (ca. 22*C) for 36 hours. The mixture was poured into water, acidified using concentrated hydrochloric acid and extracted into diethyl ether. The combined ether extracts were washed twice with water, then dried over anhydrous magnesium sulphate.
Evaporation of the solvent under reduced pressure gave an oil (0.82g), from which the volatile components were removed by distillation in a Kugelrohr apparatus under reduced pressure (0.2 mmHg), at an oven temperature of 150*C. The residual oil was purified by chromatography on a silica gel support, eluting with n-hexane containing 5% by volume ethyl acetate, to give 1,1,1-trifluoro-2-(4-trifluoromethoxyphenyl)-3-(3-phenoxybenzyloxy) )propan-2-ol as a colourless oil (0.2g).
^H NMR (CDCl^) S (ppm) : ca. 3.7 (lH,dm); 3.74 (lH,s); ca.
4.08 (lH,d); 4.6 (2H,ABq); 6.97.6 (13H,m) 19F NMR (CDCI3) S (relative to CFCI3) :
-58.3 (OCF3)
-77.7 (CF3)
IR (liquid film) : 3350 (OH), 1590, 1516, 1492, 11501290 era1
GLC retention time : 9.92 minutes.
EXAMPLE 16
This Example illustrates the preparation of 1,1,1tri fluoro-2-(3-fluoro-4-ethoxyphenyl )-3-(3-phenoxybenzyloxy)propan-2-ol.
1,1, 1-Trifluoro-2-(3-fluoro-4-ethoxyphenyl)propan-2,35 diol (0.4g), prepared as described in Example 8 (ii), 3phenoxybenzy1 bromide (0.39g), 40% sodium hydroxide solution (5 cm^), dichloromethane (5 cm3) and tetra-n-butylammonium hydrogen sulphate (50 mg) were mixed, and stirred at room temperature under an atmosphere of nitrogen for 4¼ hours.
The reaction mixture was partitioned between water and dichloromethane. The organic layer was separated and the aqueous layer washed with dichloromethane. The combined organic layers were dried over anhydrous sodium sulphate and concentrated by evaporation under reduced pressure to give
1,1,1-tri fluoro-2-(3-fluoro-4-ethoxyphenyl)-3-(3phenoxybenzyloxy)propan-2-ol as an oil (0.67g). The product was purified by column chromatography on a silica gel support, using n-hexane containing 15% by volume ethyl acetate as eluent.
* * .
XH NMR (CDC13) $ (ppm) : 1.44 (3H,t); 3.64 (lH,d); 3.65 (lH,s); 4.0-4.2 (lH,d and 2H,q); 4.57 (2H,ABq); 6.9-7.4 (12H,m).
GLC retention time : 11.61 minutes
EXAMPLE 17
This Example illustrates the preparation of 1,1,1trifluoro-2-(4-ethoxyphenyl)-3-bromopropan-2-ol.
A solution of 4-bromophenetole (2Og) in dry diethyl ether (25 cm3) was added over 15 minutes to a mixture of magnesium (2.5g) and dry diethyl ether (100 cm3) containing iodine (O.lg). The reaction was carried out under a nitrogen atmosphere. After gently warming the reaction vessel for a few minutes, the Grignard reaction began, and the addition rate was adjusted to maintain a gentle reflux.
After all the 4-bromophenetole had been added the mixture was stirred for 1 hour at the ambient temperature (ca. 22*C) and a solution of l-bromo-3,3, 3-trifluoropropan-2-one (19g) in dry diethyl ether (20 cm3) was then added dropwise over 40 minutes. The reaction mixture was then heated gently at the reflux temperature for 1 hour. After cooling, the reaction mixture was poured onto ice and acidified with hydrochloric acid. The layers were separated and the aqueous layer was extracted with diethyl ether (3x). The combined organic layers were washed with water, dried over anhydrous sodium sulphate and concentrated by evaporation of the solvent under reduced pressure. The residual oil was purified by chromatography on a silica gel support to give the product as a pale brown oil (14g).
NMR (CDC13) (ppm) : 1.44 (3H,t); 3.12 (lH,s); 3.9-4.2 (4H,m); ca. 6.9 (2H,m); 7.5 (2H,m).
APO 0 0 0 3 4
GLC retention time : 7.39 minutes (50*-280*C run).
EXAMPLE 19
Thia Example illustrates the preparation of 1,1,1t ri fluoro-2-(4-ethoxyphenyl )-3-(6-phenoxy-2pyridylmethyloxy)propan-2-ol.
1, 1,1-Trifluoro-2-{4-ethoxyphenyl)-3-bromopropan-2-ol 5 (lg), prepared as described in Example 17, 6-phenoxy-2pyridylmethanol (0.64g), 40% sodium hydroxide solution (10 cm9) and a catalytic amount of tetra-n-butylammonium hydrogen sulphate (ca. O.lg) were mixed at room temperature and stirred vigorously for 36 hours. The mixture was then poured into water and acidified with concentrated hydrochloric acid. The product was then extracted into diethyl ether. The combined ether extracts were washed with water, then dried over anhydrous magnesium sulphate. The solvent was removed by evaporation under reduced pressure to give an oil (1.2g), from which volatile components were removed by distillation in a Kugelrohr apparatus under reduced pressure (0.2 mmHg), at an oven temperature of 150*C. The residual oil was purified by chromatography on a silica gel support, eluting with n-hexane containing 12.5% by volume ethyl acetate, to give l,l,l-trifluoro-/-(4ethoxyphenyl)-3-(6-phenoxy-2-pyridylmethoxy)propan-2-ol as a colourless oil (0.7g).
NMR (CDCl^) S (ppm) : 1.4 (3H,t); 3.82 (1H,broadened d);
4.02 (2H,q); 4.12 (lH,d); 4.64 (2H,ABq); 4.83 (lH,s); 6.7-7.7 (12H,m).
19F NMR (CDC13) S (relative to CFC13) : -77.8
IR 3200-3600 cm-1 (broad OH).
GLC retention time : 11.86 minutes.
EXAMPLE 19
By a procedure similar to that described in Example 18 above, the following compounds were prepared from the appropriate starting materials.
(i) 1,1,1-Trif luoro-2-{4-ethoxyphenyl)-3-(2-methyl-35 phenylbenzyloxy)propan-2-ol, from 1,1,1-trifluoro2-(4-ethoxyphenyl)-3-bromopropan-2-ol and 2methyl-3-phenylbenzyl alcohol.
XH NMR (CDC13) S (ppm) : 1.4 (3H,t); 2.14 (3H,s);
3.7 (lH,s); 3.72 (lH,d);
4.04 (2H,q); 4.15 (lH,d);
4.64 (2H,ABq); 6.87 (2H,d); 7.2-7.5 (10H,m) 19 NMR (CDCI3)& (ppm - relative to CFC13) : -77.9 (CF3,s)
GLC retention time : 12.01 minutes.
*
EXAMPLE 20
This Example illustrates the preparation of 1,1,1,2tetrafluoro-2-(4-ethoxyphenyl )-3-(3-phenoxybenzyloxy)propane.
A solution of 1,1,1-trifluoro-2-(4-ethoxyphenyl)-3-(3 20 phenoxybenzyl)propan-2-ol (O.35g) in dry dichloromethane (3 cm3) was added to a solution of diethylaminosulphurtrifluoride (0.2 cm3) in dry dichloromethane (4 cm3), at a temperature of -78*C, under an atmosphere of nitrogen. The
V £ 0 0 0 OdV stirred mixture was allowed to warm to the ambient temperature (ca. 22*C) over a period of 30 minutes, and was then stirred for a further 3 hours. After standing overnight, the reaction mixture was poured into water, and further dichloromethane, together with a saturated aqueous solution of sodium bicarbonate were added. The organic layer was separated, and the aqueous layer extracted twice with dichloromethane. The combined organic layers were dried over anhydrous sodium sulphate, and concentrated by evaporation under reduced pressure. Analysis of the residual oil by gas liquid chromatography and thin layer chromatography showed two principal components. These were separated by column chromatography on a silica gel support, using n-hexane containing 6% by volume ethyl acetate as eluent. The first component eluted (rf. 0.27 on silica gel plates eluted with n-hexane containing 5% ethyl acetate) was isolated as a colourless oil, and identified as the expected product, 1,1,1,2-tetrafluoro-2-(4-ethoxyphenyl)-3-(3phenoxybenzyloxy)propane.
NMR (CDCl^) (ppm) : 1.42 (3H,t); 4.0-4.1 (4H,m); 4.56 (2H,ABq); 6.9-7.4 (13H,m);
19F NMR (CDCI3) S(ppm - relative to CFCI3) :
-78.7 (CF3,d);
-175.4 (lF,m)
IR (liquid film) : 1618, 1590, 1520, 1492, 1260, 1185 cm-1
GLC retention time : 10.96 minutes.
The second component (rf. 0.21) was not isolated, but shown by mass spectrometry to be 1,1,1-tri£luoro-2-(4ethoxyphenyl)-3-(3-phenoxybenzyloxy) prop-2-ene, presumably resulting from de-hydrofluorination of the major product.
EXAMPLE 21
By use of a procedure similar to that described in
Example 20 above, the following compounds were prepared from the appropriate starting materials.
(i) 1,1,1,2-Tetrafluoro-2-(4-ethoxyphenyl)-3-(6phenoxy-2-pyridylmethyloxy)propane, from 1,1,ΙΙΟ trifluoro-2-(4-ethoxyphenyl)-3-(6-phenoxy-2pyridylmethyloxy)propan-2-όΐ.
XH NMR (CDClj) § (ppm) : 1.42 (3H,t); 4.05 (2H,q); ca. 4.16 (2H,d, Jhf = 22 Hz) ; 4.6 (2H,s); 6.7-7.77 (12H,m)
NMR (CDC13) & (ppm - relative to CFC13) :
-78.5 (3F,d)
-100.3 (lF,m)
GLC retention time : 10.98 minutes.
(ii) 1,1,1,2-Tetrafluoro-2-(4-ethoxyphenyl)-3-(3phenoxy-4-fluorobenzyloxy)propane, from 1,1,1trifluoro-2-(4-ethoxyphenyl )-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
AP 0 0 0 0 3 4
NMR (CDC13) (ppm) : 1.42 (3H , t) ; 4.04 ( 4H,m ) 4.52 (2H,ABq); 6.8-7.4 (12H,m)
NMR (CDCI3) S(ppm - relative to CFCI3) :
-78.7 (3F,d);
-132.4 (lF,m);
-175.5 (lF,m)
XR (liquid film): 1617, 1593, 1515, 1493, 1430, 1290, 1260, 1180 cm'1
GLC retention time : 10.88 minutes z
(iii) 1,1,1,2-Tetrafluoro-2-(4-ethoxyphenyl )-3-(4methyl-2,3,5,6-tetrafluorobenzyloxy)propane, from
1,1,1-trifluoro-2-(4-ethoxypheny1)-3-(4-methy12,3,5, 6-tetrafluorobenzyloxy)propan-2-ol.
XH NMR (CDCI3) S (ppm) : 1.42 (3H,t); 2.27 (3H,t);
4.05 (2H,q); overlapping with 4.0 (1H,broad s); and 4.22 (1H, broad s); 4.68 (2H,m); ca. 6.9, 7.4 (4H,ABq) 39F NMR (CDC13) £ (ppm - relative to CFCI3) :
-78.7 (3F,d); ca. -144.8 (4F,m) ca. -17 5.2 (IF,m)
IR (liquid film) : 1617, 1520, 1492, 1290, 1260, 1180 cm'1
GLC retention time : 7.27 minutes
- (iv) 1,1,1,2-tetrafluoro-2-(4-chlorophenyl )-3-(3phenoxy-4-fluorobenzyloxy)propane from 1,1,1tri fluoro-2-(4-chlorophenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
XH NMR (CDC13) £ (ppm) : 3.98 (lH,s); 4.07 (lH.ABq); 4.5 (2H,ABq); 6.85-7.4 (12H,m)
NMR (CDC13) £> (ppm - relative to CFC13) :
-78.6 (CF3, d);
-132.3 (lF,m);
176.3 (lF,m) ✓
(v) 1,1,1,2-Tetrafluoro-2-(4-trifluoromethoxy pheny1)3-(3-phenoxybenzyloxyJpropane, from 1,1,1trifluoro-2-(4-trifluoromethoxyphenyl)-3-(315 phenoxybenzyloxy)propan-2-ol.
1H NMR (CDC13) S (ppm) : 4.02 (lH,s); 4.1 (lH,ABq);
4.54 (2H, ABq);'6.8-7.5 (1 3H, m)
GLC retention time : 8.95 minutes (vi)
1,1,1,2-Tetrafluoro-2-(4-bromophenyl)-3-(3phenoxy-4-fluorobenzyloxy)propane, from 1,1,1tri fluoro-2-(4-bromophenyl )-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
XH NMR (CDC13) $ (ppm) : 3.98 (lH,s); 4.06 (lH,d);
ca. 4.5 (2H, ABq);
6.9-7.6 (12H,m)
GLC retention time : 10.62 minutes
- (vii) 1,1,1,2-Tetrafluoro-2-(4-ethoxyphenyl)-3-(3-(4chlorophenoxy)benzyloxyIpropane, from 1,1,1trifluoro-2-(4-ethoxyphenyl)-3-(3-(4chlorophenoxy)benzyloxy)propan-2-ol.
1H NMR (CDC13) S (ppra) : 1,4 (3H,t); 4.0-4.1 (4H,m); 4.56 (2H,ABq); 6.8-7.4 (12H,m) 19F NMR (CDC13) S(ppm - relative to CFC13) :
-78.7 (CF3,d);
-175.5 (lF,m)
GLC retention time : 11.97 minutes (viii) 1,1,l,2-Tetrafluoro-2-(4-ethoxyphenyl)-3-(2methyl-3-phenylbenzyloxyJpropane, from 1,1,1trifluoro-2-(4-ethoxyphenyl)-3-(2-methyl-3 15 phenylbenzyloxy)propan-2-ol.
3H NMR (CDC13) $ (ppm) : 1.42 (3H,t); 2-.06 (3H,s);
4.04 (2H,q); ca. 4.12 (2H,d, J=23Hz) ; 4,66 (2H,ABq); 6.9 (2H,d);
7.2-7.5 (10H,m) ^9F NMR (CDCl3)S(ppm - relative to CFC13) :
-78.7 (CF3,d,J=7Hz);
-175.4 (lF,tq,J=7Hz and 23Hz)
GLC retention time : 11.17 minutes
- ( iχ ) 1,1,1,2-Tetrafluoro-2- (4-tri f iuoromethylphenyl)-3 (3-phenoxybenzyloxy)propane.
NMR (CDC13) *6 (ppm) : 4.0-4.2 (2H,m); 4.35 (2H,ABq); 6.8-7.7 (13H,m)
GLC retention time : 8.68 minutes
EXAMPLE 22
This Example illustrates the preparation of 1,1,1tri fluoro-2-acetoxy-2-(4-ethoxyphenyl )-3-(3-phenoxy-4fluorobenzyloxy)propane.
1, 1, 1-Trifluoro-2-(4-ethoxyphenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol (0.3g), pyridine (1 cm^), acetic anhydride (10 cnP) and a catalytic amount of 4-N,Ndimethylaminopyridine (ca. 0.015g) were mixed at the ambient temperature (ca. 22*C), then heated at the reflux temperature for 6 hours. The mixture was allowed to stand overnight at the ambient temperature, and was then heated at reflux for a further 6 hours. Analysis by gas liquid
V .
chromatography showed 94% conversion to the product. Water was added and the product was extracted into diethyl ether (5 x 50 cm^). The combined ether layers were dried over anhydrous sodium sulphate and concentrated by evaporation under reduced pressure. The residual oil was purified by column chromatography on a silica gel support, eluted with n-hexane containing 12% by volume ethyl acetate, to give 1, 1, l-trifluoro-2-acetoxy-3-(3-phenoxy-4-fluorobenzyloxy )propane (0.29g) as a viscous oil.
hi
- Jrf 1H NMR (CDCL3) f(ppm) : 1.4 (3H,t); 2.13 (3H,s); 4.0 (2H,q); 4.39 (2H,broad 9); 4.51 (2H, broad s); 6.8-7.5 (12H,m) 19F NMR (CDC13) S (ppm - relative to CFC13)
-78.0 (3F,i+ -132.9 (lF,m)
IR (liquid film) 1760, 1614, 1592, 1515, 1492, 1427, 1370, 1150-1300 cm-1
GLC retention time : 12.22 minutes.
EXAMPLE 23
This Example illustrates the preparation of 1,1, ΙΙΟ trifluoro-2-methoxy-2 - (4-ethoxypheny 1)-3-(3-phenoxy-4fluorobenzyloxy)propane.
1,1,1-Trifluoro-2-(4-ethoxyphenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol (0.2g) in dry N,N-dimethy1formamide (2 cm3) was added to a suspension of sodium hydride (O.lg of a 50% dispersion in oil - washed,free of oil with n -hexane) in Ν,Ν-dimethylformamide (2 cm3) at the ambient temperature (ca. 22*C) under an atmosphere of nitrogen. After stirring for 20 minutes a solution of methyl iodide (O.lg) in Ν,Ν-dimethylformamide (3 cm3) was added in one portion. After 20 minutes no starting material could be detected by gas liquid chromatographic analysis.
The mixture was carefully diluted with water (30 cm3) then solid sodium chloride was added and the mixture shaken with diethyl ether. The layers were separated and the aqueous layer extracted with a further three portions of diethyl ether. The combined organic extracts were dried over anhydrous magnesium sulphate and the solvent removed by evaporation under reduced pressure. The resulting pale
AP 0 0 0 0 3 4
- VS yellow oil was purified by chromatography on silica gel, eluting with n-hexane containing 10% by volume ethyl acetate to give 1,1,1-trifluoro-2-methoxy-2-(4-ethoxyphenyl)-3 - (3 phenoxy-4-fluorobenzyloxy)propane as a colourless oil (0.2g).
NMR (CDC13) $ (ppm) : 1.42 (3H,t); 3.34 (3H,s); 3.94 (2H,ABq) overlapping with 4.03 (2H,q); 4.52 (2H,s); 6.9-7.4 (12H,m)
NMR (CDCI3) S (ppm - relative to CFCI3) :
-74.4 (CF3,S)
-132.7 (lF,m)
GLC retention time : 11.73 minutes
EXAMPLE 24
This Example illustrates the preparation of 1,1,115 tri fluoro-2-chloro-2 -(4-ethoxyphenyl )-3-(3-phenoxybenzyloxy) propane.
A solution of 1,1,1-trifluoro-2-(4-ethoxyphenyl)-3-(3phenoxybenzyloxy)propan-2-ol (0.65g) and imidazole (0.612g) were dissolved in dry acetonitrile (30 cm^), and the solution cooled to ca. 0’C. Thionyl chloride (1.21g) was added dropwise, with stirring. The reaction mixture was allowed to warm to the ambient temperature (ca. 22*C) and was stirred for a further three hours. Analysis of the reaction mixture by thin layer chromatography and gas liquid chromatography at that time showed no starting tertiary alcohol to be present. The reaction mixture was quenched with water, and a small volume of saturated sodium chloride
- j<rsolution was added. The aqueous mixture was extracted four times with diethyl ether and, finally, once with ethyl acetate. The combined organic layers were dried over anhydrous sodium sulphate and concentrated by evaporation of the solvent under reduced pressure to give an oil. The product was purified by column chromatography on a silica gel support, using n-hexane containing 6% by volume ethyl acetate as eluent, to give l,l,l-trifluoro-2-chloro-2-(4ethoxyphenyl)-3-(3-phenoxybenzyloxy)propane (0.48g) as a colourless oil.
LH NMR (CDC13) ζ (ppm) : 1.41 (3H,t); 4.03 (2H,q); 4.06,
4.22 (2H,ABq); 4.62 (2H,ABq); 6.8-7.55 (13H,m) 19F NMR (CDC13) S (ppm - relative to CFC13) :
-73.7 (CF3)
IR (liquid film) : 1617, 1590, 1518, 1492, 1260, 1220,
1185 cm-1
GLC retention time : 11.90 minutes.
EXAMPLE 25
By use of a procedure similar to that described in 20 Example 24 above, the following compounds were prepared from the appropriate starting materials.
(i) 1,1,l-Trifluoro-2-chloro-2-(4-ethoxyphenyl)-3-(4methy1-2,3,5,6-tetrafluorobenzyloxy)propane, f rom
1,1,1-tri fluoro-2-(4-ethoxyphenyl)-3-(4-methy12,3,5,6-tetrafluorobenzyloxy)propan-2-ol.
AP 0 0 0 0 3 4
7© XH NMR (CDClj) (ppm) : 1.41 (3H,t); 2.28 (3H,t); 4.04 (2H,q) overlapping with 4.2 (2H,q); 4.73 (2H,m); ca. 6.9, 7.6 (4H,ABq) 19F NMR (CDCI3) S (ppm - relative to CFCI3) :
-73.7 (CF3);
ca. -144.7 (4F,m)
IR (liquid film) : 1615, 1517, 1492, 1290, 1260, 1185 era'1
GLC retention time : 8.32 minutes.
(i i) 1,1,1-Trifluoro-2-chloro-2-(4-ethoxyphenyl )-3-(3phenoxy-4-fluorobenzyloxy)propane, from 1,1,1tr i f luoro-2 - (4-ethoxyphenyl )-3- (3-phenoxy-4fluorobenzyloxy)propan-2-ol.
XH NMR (CDC13) S (ppm) : 1.42 (3H,t); 4.02 (2H,q); overlapping with 4.02 (lH,d); 4.2 (lH,d); 4.57 (lH,ABq); 6.8-7.6 (12H,m).
19F NMR (CDC13) S(ppm - relative to CFC13) :
-73.66 (CF3);
-132.4 (lF,m) (iii) 1,1,1-Trifluoro-2-chloro-2 -(4-ethoxyphenyl)-3-(6phenoxy-2-pyridylmethyloxy (propane, from 1,1,1tri fluoro-2-chloro-2 -(4-ethoxyphenyl)-3-(6phenoxy-2-pyridylmethyloxy )propan-2-ol.
lH NMR (CDC13) £ (ppm) : 1.42 (3H,t)j 4.05 (2H,q);
4.2, 4.35 (2H,ABq); 4.64 (2H,s); 6.7-7.7 (12H,m) 39F NMR (CDCl3)S(ppm - relative to CFCI3) :
-73.6 (CF3,S)
GLC retention time : 11.92 minutes.
(iv) 1,1,1-Trifluoro-2-ch loro-2-(3-fluoro-4-ethoxyphenyl )-3-(3- (4-chlorophenoxy Jbenzyloxy Jpropane, , from 1,1, 1-trifluoro-2-(3-fluoro-4-ethoxyphenyl,3-(3- (4-chlorophenoxy Jbenzyloxy) propan-2 -ο 1.
J-H NMR (CDC13) j (ppm) : 1.45 (3H,t); 4.0-4.22 (4H,m); 4.62 (2H,ABq);
’ 6.9-7.5 (HH,m)
GLC retention time : 12.70 minutes (NB. some decomposition on column to an olefin of retention time 11.99 minutes).
(v) 1,1,l-Trifluoro-2-chloro-2-(3-fluoro-4ethoxyphenyl )-3-(3-phenoxybenzyloxy)propane, from 1, 1, l-trifluoro-2-(3-fluoro-4-ethoxyphenyl)-3-(3phenoxybenzyloxy)propan-2-ol.
1H NMR (CDC13) $ (ppm) : 1.45 (3H,t); 4.02 (lH,d);
4.11 (2H,q); 4.2 (lH,d); 4.62 (2H,ABq); 6.9-7.45 (12H,m)
NMR (CDCI3) S (ppm - relative to CFCI3) :
-73.7 (CF3,s)
-134 (lF,m)
GLC retention time : 11.69 minutes (vi) 1,1,1-Tri fluoro-2-chloro-2-(4-chlorophenyl )-3-(3phenoxy-4-fluorobenzyloxyJpropane (A) and 1,1,1trifluoro-2-(4-chlorophenyl )-3-(3-phenoxy-4fluorobenzyloxy)prop-2-ene (B), from 1,1,1trifluoro-2-(4-chlorophenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
The two products obtained in this case were separated by high pressure liquid chromatography on a silica gel support, using n-hexand containing 1% by volume ethyl acetate as eluent.
Product A :
NMR (CDC13) £ (ppm) : ca. 4.0, 4.2 (2H,ABq);
4.55 (2H,s); 6.97.6 (12H,m) 19F NMR (CDCI3) (ppm - relative to CFC13) :
-73.6 (CF3,s).
-132.4 (lF,m)
- Λί GLC retention time : 11.07 minutes.
Product B :
NMR (CDCI3) $ (ppm) : 4.89 (2H,s); 6.9-7.5 (13H,m)
19F NMR (CDCI3) $ (ppm - relative to CFCI3) :
-61.9 (CF3,s)
-131.5 (lF,m)
GLC retention time : 10.42 minutes.
(vi i) 1,1,1-Trifluoro-2-chloro-2-(4-fluorophenyl )-3-(310 phenoxy-4-fluorobenzyloxy)propane, from 1,1,1trifluoro-2-(4-fluorophenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
A small amount of enol ether (analogous to that isolated in (vi) above) was detected in the reaction mixture, but not isolated. Purification of the principal product was achieved by column chromatography on a silica gel support, using nhexane containing 10% by volume ethyl acetate as e luent.
!h NMR (CDC13)$ (ppm) : 4.02, 4.20 (2H,ABq); 4.55 (2H,ABq); 6.9-7.6 (12H,m) 19F NMR (CDCI3) S (ppm - relative to CFCI3) :
-73.7 (CF3>s). -112.5 (lF,m); -132.4 (lF,m)
GLC retention time : 10.08 minutes.
(viii) 1,1,1,-Tri fluoro-2-chloro-2 -(5-indanyl)-3-(3phenoxy-4-fluorobenzyloxy)propane (A) and 1,1,1· trifluoro-2-(5-indany1)-3-(3-phenoxy-4fluorobenzyloxy)prop-2-ene (B) from 1,1,15 tri fluoro-2-(5-indanyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
Products A and B were separated by preparative high pressure liquid chromatography on a silica gel support, using n-hexane containing 1% by volume ethyl acetate as eluent.
Product A :
1H NMR (CDCl-j) % (ppm) : 2.09 (2H,m); 2.90 (4H,m) 4.05, 4.22 (2H,ABq); 4.5 (2H,ABq); 6.95-7.5 (HH,m)
NMR (CDC13) S(ppm - relative to CFC13) :
-73.3 (CF3,s)
-132.4 (lF,m)
GLC retention time : 12.18 minutes
Product B :
1H NMR (CDC13) S (ppm) : 2.08 (2H,m); 2.90 (4H,m)
4.88 (2H,s); 6.9-7.4 (12H,m)
NMR (CDC13) 5 (ppm - relative to CFClg) :
-62.2 (CF3,s); -131.7 (lF,m).
GLC retention time : 11.42 minutes (ix) 1,1,1-Trifluoro-2-chloro-2-(4-n-propylphenyl)-35 (3-phenoxy-4-fluorobenzyloxy)propane (A) and
1, 1, 1-trifluoro-2-(4-n-propylphenyl )-3-(3-phenoxy4-fluorobenzyloxy)prop-2-ene (B), from 1,1,1tri fluoro-2-(4-n-propylphenyl)-3-(3-phenoxy-4fluorobenzyloxy)propan-2-ol.
Products A and B were separated as described in (viii) above.
Product A :
1H NMR (CDC13) S(ppm) : 0.96 (3H,t); 1.64 (2H,m);
2.61 (2H,t); 4.05, 4.20 (2H,ABq); 4.56 (2H,ABq);
6.9-7.5 (12H,m>.
19F NMR (CDC13) S(ppm - relative to CFC13) :
-73.4 (CF3,s): -132.5 (lF,m)
GLC retention time : 11.64 minutes.
Tb
- *1 Product B :
ΣΗ NMR (CDC13) $(ppm) : 0.95 (3H,t); 1.64 (2H,m);
2.58 (2H,m); 4.9 (2H,s);
6.9-7.4 (13H,m) 19F NMR (CDC13) S (ppm - relative to CFC13) :
-62.0 (CF3/S); -131.7 (lF,m).
GLC retention time : 10.95 minutes.
( x) 1,1,1-Trifluoro-2-chloro-2-(4-t-butylphenyl)-3-(3phenoxy-4-fluorobenzyloxy)propane (A) and 1,1,ΙΙΟ tri fluoro-2-(4-t-butylphenyl)-3-(3-phenoxy-4fluorobenzyloxy)prop-2-ene (B), from 1,1,1trifluoro-2-(4-t-butylphenyl)-3-(3-phenoxy-4tri fluorobenzyloxy)propan-2-ol.
Products A and B were separated as described in (viii) above.
r .
Product A :
XH NMR (CDC13) $ (ppm) : 1.28 (9H,s); 4.05, 4.2 (2H,ABq); 4.55 (2H,ABq);
6.9-7.6 (12H,m) 19F NMR (CDCIj) S (ppm - relative to CFC13) :
-73.3 (CF3,s); -132.4 (lF,m)
GLC retention time : 11.78 minutes.
Product B :
1H NMR (CDC13) 5 (ppm) : 1.28 (9H,s); 4.9 (2H,s);
6.9-7.4 (lH,m)
GLC retention time : 11.02 minutes.
(xl) 1,1,l-Trifluoro-2-chloro-2-(4-methylphenyl)-3-( 3phenoxybenzyloxy)propane, from 1,1,1-trifluoro-2(4-methylphenyl)-3-(3-phenoxybenzyloxy)propan-2-ol.
A small amount of enol ether (analogous to that isolated in (vi) above) was detected in the reaction mixture, but not isolated. The principal product was purified as described in (vii) above.
ςΗ NMR (CDC13)S (ppm) : 2.35 (3H,s); ca. 4.16 ' (2H,ABq); 4.6 (2H,ABq);
6.9-7.6 (13H,m)
GLC retention time : 10.81 minutes.
APO 0 0 0 3 A (GLC retention time for the enol ether : 10.00 minutes).
(xi i) 1,1,1-Tr ifluoro-2-chloro-2 -(4-methoxymethylpheny1)-3-(3-(4-chlorophenoxy Jbenzyloxy)propane, from 1,1,1-trifluoro-2-(4-methoxymethylpheny 1)-3(3 -(4-chlorophenoxy Jbenzyloxy)propan-2-ol.
NMR (CDC13)S (ppm) ; 3.40 (3H,s); 4.08, 4.26 (2H,ABq); 4.48 (2H,s); 4.62 (2H,ABq); 6.9-7.7 (12H,m)
GLC retention time : 12.74 minutes.
( xi ii) 1,1,1-Trifluoro-2-chloro-(4-methoxymethylphenyl) 3-(3-phenoxybenzyloxy)propane, from 1,1,1tri fluoro-2-(4-methoxymethylphenyl)-3-(3phenoxybenzyloxy)propan-2-ol.
NMR (CDCL3) $ (ppm) : 3.39 (3H,s); 4.06, 4.24 (2H,ABq); 4.46 (2H,s);
4.61 (2H,ABq); 6.9-7.7 (13H,m)
GLC retention time : 11.75 minutes.
(xiv) 1,1,1-Trifluoro-2-chloro-2-(4-trifluoromethoxyphenyl )-3-(3-phenoxy-4-fluorobenzyloxy)propane (A) and 1,1,1-trifluoro-2-(4-trifluoromethoxyphenyl) 3-(3-phenoxy-4-fluorobenzyloxy)prop-2-ene (B) from
1,1,1-trifluoro-2-(4-tri fluoromethoxyphenyl )-3-(3phenoxy-2-fluorobenzyloxy)propan-2-ol.
t.
Products A and B were separated as described in (viii) above.
Product A :
XH NMR (CDC13) S(ppm) : 4.03, 4.24 (2H,ABq); 4.56 (2H,ABq); 6.95-7.7 (12H,m) 39F NMR (CDC13) (ppm - relative to CFCI3) :
-58.3 (CF30,s); -73.5 (CF3,s); -132.9 (F,broad)
GLC retention time : 9.72 minutes
Ή - >S<3
Product B :
NMR (CDClj) $ (ppm) : 4.9 (2H,s); 6.9-7.4 (13H,m) 19F NMR (CDC13)£ (ppm - relative to CFC13) :
-58.3 (CF3o,s); -62.00 (CF3,s); -132.0 (F,broad)
GLC retention time : 9.13 minutes.
(xv) 1,1,1-Trifluoro-2-chloro-2-(4-trifluoromethoxyphenyl)-3-(3-phenoxybenzyloxyJpropane (A) and
1,1,1-trifluoro-2-(4-trifluoromethoxyphenyl )-3-(310 phenoxybenzyloyx)prop-2-ene'(B) from 1,1,1trifluoro-2-(4-trifluoromethoxyphenyl)-3-(3phenoxybenzyloxy)propan-2-ol.
Products A and B were separated as described in (viii) above.
Product A : » ΣΗ NMR (CDC13) $(ppm) : 4.03, 4.24 (2H,ABq); 4.61 (2H,ABq); 6.9-7.7 (llH,m); 7.66 (2H,d) L9F NMR (CDC13)$ (ppm - relative to CFC13) :
-58.3 (CF3O, s); -73.6 (CF3,s)
APO 0 0 0 3 4
GLC retention time : 9.88 minutes.
Product B :
NMR (CDCL3) S (ppm) : 4.96 (2H,s); 6.9-7.5 (14H,m)
Ι·9Ρ NMR (CDCI3) $ (ppm - relative to CFCI3 :
-58.3 (CF3,s): -61.9 (CF3,s)
GLC retention time : 9.26 minutes (xvi ) 1,1,1-Tri fluoro-2-chloro-2 -(4-tri fluoromethoxyphenyl ) - 3-(3-(4-chlorophenoxy)benzyloxy)propane (A) and 1,1,1-trifluoro-2-(4-trifluoromethoxy✓ phenyl)-3-(3-(4-chlorophenoxy)benzyloxy)prop-2-ene (B) from 1,1,1-trifluoro-2-(4-trifluoromethoxyphenyl)-3-(3 -(4-chlorophenoxy)benzyloxy)propan-2, ol.
t.
Products A and B were separated as described in 15 (viii) above.
Product A :
1H NMR (CDC13) $(ppm) : 4.06, 4.26 (2H,ABq); 4.6 (2H,ABq); 6.9-7.7 (12H,m) 19F NMR (CDCI3) (pPm “ relative to CFCI3) :
-58.3 (CF30,s); -73.5 (CF3,s)
GLC retention time : 10.81 minutes.
Product B :
XH NMR (CDClj) (ppm) : 4.96 (2H,s); 6.9-7.5 (14H, m) x9F NMR (CDC13) S (ppm - relative to CFCI3) :
-58.3 (CF3O,s); -61.9 (CF3,s); -66.0 (weak signal due to E isomer?) (xvii) 1,1,1-Trifluoro-2-chloro-2 -(4-methoxyphenyl)-3-(3phenoxy-4-fluorobenzyloxyJpropane, from 1,1,1trifluoro-2-(4-methoxyphenyl)-3-(3-phenoxy-410 fluorobenzyloxy)propan-2-ol.
LH NMR (CDC13)^ (ppm) : 3.82 (3H,s); 4.05, 4.20 (2H,ABq); 4.56 (2H,ABq);
6.8-7.6 (12H,m) 19F NMR (CDCl3)S(ppm - relative to CFCI3) :
-73.6 (3F,s); -132.5 (lF,m)
«.
GLC retention time : not determinable - compound decortposed on the column.
(xvi ii) 1,1,1-Tri fluoro-2-chloro-2 -(4-methoxyphenyl)-3-(3phenoxybenzyloxy)propane, from 1,1,1-trifluoro-22 0 (4-methoxyphenyl )-3- (3-phenoxybenzyloxy )propan-2 ol.
AP 0 0 0 0 3 4 ex - X XH NMR (CDC13) S(ppm) : 3.82 (3H, s) ; 4.05, 4.22 (2H,ABq); 4.64 (2H,ABq);
6.8- 7.6 (13H,m).
X9F NMR (CDC13) £ (ppm - relative to CFCI3) : -73.7 (CF3)
GLC retention time : Not determinable - compound decomposed on the column.
( xi x) 1, 1, 1-Tri fluoro-2-chloro-2-(3,4-methylenedioxyphenyl)-3-(3-phenoxybenzyloxy)propane, from 1,1,1 tri fluoro-2-(3,4-methylenedioxyphenyl)-3-(3phenoxybenzyloxy)propan-2-ol.
XH NMR (CDC13) £ (ppm) : 4.02, 4.2 (2H,ABq); 4.60 (2H,ABq); 5.98 (2H,s);
6.8- 7.4 (12H,m)
NMR (CDClg)^ (ppm - relative to CFCI3) :
-73.6 (CF3)
GLC retention time : 12.07 minutes.
(xx) 1,1,1-Tri fluoro-2-chloro-(4-ethoxyphenyl)-3 - (3 - (4 chlorophenoxy)benzyloxy)propane, from 1,1,1tri fluoro-2-(4-ethxoyphenyl)-3-(3-(4-ch lorophenoxy )benzyloxy)propan-2-ol.
lH NMR (CDC13) S (ppm) : 1.43 (3H,t); 4.0-4.1 (2H,q) overlapping with (lH,d); 4.22 (lH,d); 4.63 (2H,ABq); 6.8-7.6 (12H,m) 19 20F NMR (CDCI3) S (ppm - relative to CFCI3) :
-73.6 (CF3,S)
GLC retention time : 12.93 minutes (xx i) 1,1,l-Tr i fluoro-2-chloro-2 -(4-ethoxyphenyl)-3-(3(4-bromophenoxy)-4-fluorobenzyloxyJpropane, from
1,1,1-tri fluoro-2- (4-ethoxyphenyl)-3-(3-(4bromophenoxy)-4-fluorobenzyloxy)propan-2-ol.
✓
NMR (CDC13) S (ppm) : 1.42 (3H,t); 4.02 (2H,q);
overlapping with 4.04 (lH,d); 4.20 (lH,d); 4.56 (2H,ABq); 6.8-7.5 (llH,m) 19F NMR (CDC13) { (ppm - relative to CFCI3) :
*
-73.6 (3F,s); -131.1 (lF,m)
GLC retention time : 13.43 minutes (xxii) 1,1,1-Tri fluoro-2-chloro-2-(4-ethoxyphenyl)-3-(320 (4-chlorophenoxy)-4-fluorobenzyloxy)propane, from
1,1,l-trifluoro-2-(4-ethoxyphenyl)-3-(3-(4chlorophenoxy)-4-fluorobenzyloxy)propan-2-ol.
APO 0 0 0 3 4
- S5 -
ΤΗ NMR (CDC13) £ (ppm) : 1.42 (3H,t); 4.02 (2H,q); overlapping with 4.34 (lH,d); 4.22 (lH,d); 4.56 (2H,s); 6.8-7.6 (llH.m)
5 ^9F NMR (CDCI3) (ppm - relative to CFCI3) : -73.6 (CF3,s); -132.1 (lF,m) GLC retention time : 12.67 minutes.
10 (xxiii) 1,1,1-Trifluoro-2-chloro-2-(4-ethoxyphenyl )-3-(5- benzyl-3-furanylmethyloxy)propane, from 1,1,1trifluoro-2-(4-ethoxyphenyl )-3-(5-benzyl-3furanylmethyloxy)propan-2-ol.
C 15 XH NMR (CDC13) S (ppm) : 1.41 (3H,t); 3.95 (2H,s); ca. 4.05 (2H,q); overlapping with (lH,d); 4.20 (lH,d); 4.45 (2H,ABq) 6.0 (lH,s); 6.86 (2H,m); ca. 7.25 (6H,m); 7.56 (2H,m)
20 19F NMR (CDCI3) S (ppm - relative to CFCI3) : -73.8 (CF3»s) (xxiv) 1,1,1-Trifluoro-2-chloro-2-(4-ethoxyphenyl)-3-(2 - methyl-3-phenylbenzyloxyJpropane, from 1,1,1trifluoro-2-(4-ethoxyphenyl )-3-(2-methyl-3phenylbenzyloxy)propan-2-ol.
<3S
- K -
ΧΗ NMR (CDC13) $(ppm) : 1.42 (3H,t); 2.15 (3H,s) 4.04 (2H,q); 4.14, 4.3 (2H,ABq); 4.7 (2H,ABq); 6.87 (2H,d); 7.2-7.6
5 (10H,m) X9F NMR (CDC13) £ (ppm - relative to CFCI3) : -73.7 (CF3»s) GLC retention time : 12.08 minutes
(χχν) 1,1,1-Tri fluoro-2-chloro-2-(3,4-
10 methy1enedioxyphenyl)-3-(3-(4-chlorophenoxy) benzyloxy)propane, from 1,1,1-trifluoro-2-(3,4methylenedioxyphenyl)-3-(3-(4-chlorophenoxy )benzyloxy)propan-2-ol.
15 XH NMR (CDC13) $ (ppm) · 4.04, 4.20 (2H,d); 4.61 (2H,ABq); 5.98 (2H,s); 6.77 (lH,d); 6.9-7.4 (10H,m)
20 19F NMR (CDCI3) S(ppm - relative to CFCI3) : -73.6 <CF3,S) GLC retention time : 13.07 minutes
(xxvi) 1,1,l-Trifluoro-2-chloro-2-(4-trifluoromethoxy )-3 (6-phenoxy-2-pyridylmethyloxy)propane from 1,1,1trifluoro-2-(4-tri fluoromethoxy)-3-(6-phenoxy-2pyridylmethyloxy)propan-2-ol.
AP Ο Ο Ο Ο 3 4 1HNMR (CDC13) S(ppm) : 4.16 (lH,d); 4.36 (lH,d) 4.61 (2H,s); 6.7-7.8 (12H,m)
NMR (CDC13) S(ppm - relative to CFC13) :
-58.3 (CF3o,s); -73.5 (CF3,s)
GLC retention time : 9.60 minutes.
(xxvii) 1,1,l-Trifluoro-2-chloro-2-(4-ethoxyphenyl)-3-(3 benzyl-4-fluorobenzyloxyJpropane, from 1,1,1tri fluoro-2-(4-ethoxyphenyl)-3-(3-benzyl-410 fluorobenzyloxy)propan-2-ol.
1H NMR (CDC13) S (ppm) : 1.4 (3H,t); 3.9-4.2 (6H,m); 4.6 (2H,q); 6.87.6 (12H,m) 19F NMR (CDC13) 5(ppm - relative to CFC13) :
-73.6 (3F); -119.5 (IF) r .
EXAMPLE 26
This Example illustrates the preparation of 1,1,1tr i fluoro-2- (4-ethoxypheny1)-3-(3-phenoxybenzyloxy Jpropane.
A few crystals of c< ’-azoisobutyronitri le (AIBN) were added to a solution of 1, 1,1-trifluoro-2-chloro-2-(420 ethoxyphenyl)-3-(3-phenoxybenzyloxyJpropane (0.36g) in toluene (15 cm3), and the mixture was cooled in an ice bath whilst tri-n-butyl tin hydride (0.25 cm3) was added. The reaction mixture was heated at the reflux temperature for 1.5 hours under an atmosphere of nitrogen. Analysis by gas liquid chromatography at this time showed no trace of the starting chloro compound. The mixture was cooled, poured into water (50 cm3), and extracted with diethyl ether (4 x 30 cm3). The combined organic layers were dried over anhydrous sodium sulphate and the residual oil after evaporation of the solvent under reduced pressure was purified by column chromatography on a silica gel support, eluting with n-hexane containing 6% by volume diethyl ether, to give 1, 1, 1-trifluoro-2-(4-ethoxyphenyl)-3-(3phenoxybenzyloxy)-propane (0.3g) as an oil.
lH NMR (CDC13)S (ppm) : 1.42 (3H,t); 3.55 (lH,q); 3.8 (lH,m); 3.95 (lH,m); 4.0 (2H,q); 4.46 (ABq,2H); 6.8-7.4 (13H,m)
IR (liquid film) : 1617, 1590, 1520, 1490, 1260, 1220,
1170, 1126, 700 cm-1
GLC retention time : 11.15 minutes.
EXAMPLE 27
By use of a procedure similar to that described in Example 26 above, the following compounds were prepared from the appropriate starting materials :
( i ) 1,1,1-Tri f luoro-2-(4-ethoxyphenyl)-3-(4-methyl20 2,3,5,6-tetrafluorobenzyloxy)propane, from 1,1,1tri fluoro-2-chloro-2-(4-ethoxyphenyl )-3-(4-methyl2,3,5,6-tetrafluorobenzyloxyJpropane. The product was obtained in the form of a white crystalline solid of melting point 77-78*C.
LH NMR (CDC13) $ (ppm) : 1.4 (3H,t); 2.26 (3H,t);
ca. 3.52 (lH,m); 3.8 (lH,m); 4.02 (2H,q) overlapping with ca. 4.0 (lH,m); 4.58 (2H,s); ca.
- 6.85, 7.2 (4H,ABq) ~
IR: 1615, 1516, 1490, 1290, 1260, 1186 cm'1
GLC retention time : 7.30 minutes.
(i i) 1,1,1-Tri fluoro-2-(3-fluoro-4-ethoxyphenyl )-3-(310 (4-chlorophenoxy)benzyloxyJpropane, from 1,1,1tri fluoro-2-chloro-2-(3-fluoro-4-ethoxyphenyl)-3(3-(4-chlorophenoxy)benzyloxy)propane.
NMR (CDC13)S (ppm) ’· 1.44 (3H,t); 3.52 (lH,m);
3.77 (lH,t); 3.92 (lH,dd);
“ 4.1 <2H,q); 4.45 (2H,ABq);
6.8-7.3 (llH,m)
GLC retention tine : 11.90 minutes.
* ( iii) 1,1,1-Trifluoro-2-(3-fluoro-4-ethoxypheny1)-3-(3 phenoxybenzyloxyJpropane, from 1,1,1-trifluoro-22 0 chloro-2-(3-fluoro-4-ethoxyphenyl)-3-(3-phenoxybenzyloxy Jpropane.
1H NMR (CDC13) $ (ppm) : 1.44 (3H,t); 3.5 (lH,m);
3.76 (lH,dd); 3.9 (lH,dd); 4.08 (2H,q); 4.46 (2H,ABq); 6.8-7.4 (12H,m)
AP 0 0 0 0 3 4
- KJ 19F NMR (CDClj) (ppm - relative to CFCI3) :
-68.5 (3F,d); -134.1 (lF,m)
GLC retention time : 10.91 minutes.
(iv) 1,1, l-Trifluoro-2-(4-chlorophenyl)-3-(3-phenoxy-4 fluorobenzyl)propane, from 1,1,1-trifluoro-2chloro-2 -(4-chlorophenyl)-3-(3-phenoxy-4-fluorobenzyloxy) propane.
1HNMR (CDClj)? (ppm) : 3.55 (lH,m); 3.76 (lH,t);
3.9 (lH,dd); 4.2 (2H,ABq)
6.8-7.4 (12H,m) 19F NMR (CDC13)^ (ppm - relative to CFC13) :
-68.2 (CF3,d); -132.6 (lF,m)
GLC retention time : 10.45 minutes (v) 1,1,1-Trifluoro-2-(4-fluorophenyl)-3-(3-phenoxy-4 fluorobenzyloxyJpropane, from 1,1, l-tri*f luoro-2 chloro-2-(4-fluorobenzyl)-3-(3-phenoxy)-4-fluorobenzyloxy )propane.
1H NMR (CDC13) S (ppm) : 3.58 (lH,m); 3.78 (lH,t);
3.9 (lH.dd); 4.40 (2H,ABq); 6.8-7.4 (12H,m) <\O
- X J-9F NMR (CDC13)£ (ppm - relative to CFC13) : -68.4 (CF3,d); -114.1 (lF,m); -132.7 (lF,m)
GLC retention time : 9.31 minutes.
(vi) 1,1,1-Tr if luoro-2 -(5-indanyl )-3-(3-phenoxy-4fluorobenzyloxy)propane, from l,l,l-trifluoro-2chloro-2-(5-indanyl)-3-(3-phenoxy-4fluorobenzyloxy)propane.
1H NMR (CDC13)£ (ppm)
2.07 (2H,m); 2.86 (4H,m); 3.55 (lH,m); 3.78 (lH,t);
3.95 (lH,dd)r 4.44 (2H,ABq); 6.9-7.4 (llH,m)
NMR (CDC13) $ (ppm - relative to CFC13) :
-68.1 (CF3f<j). -132.7 (lF,m)
GLC retention time : 11.37 minutes.
(vii) 1, 1, l-Trifluoro-2-(4-n-propylphenyl )-3-( 3-phenoxy4-fluorobenzyloxy)propane, from 1,1,1-trifluoro-2 chloro-2-(4-n-propylphenyl )-3 - (3-phenoxy-4fluorobenzyloxy)propane.
lH NMR (CDC13)$ (ppm) : 0.95 (3H,t); 1.62 (2H,m);
2.58 (2H,t); 3.55 (lH,m);
3.8 (lH,t); 3.96 (lH,dd);
4.4 (2H,ABq); 6.9-7.4 (12H,m) 19F NMR (CDC13) & (pprn - relative to CFC13) :
-68.1 (CF3, d); -132.8 (lF,m)
GLC retention time : 10.84 minutes.
Al
Ή.
(viii) 1,1,1-Trifluoro-2-{4-t-butylphenyl)-3-(3-phenoxy4-fluorobenzyloxy)propane, from 1,1,1-trifluoro-2 chloro-2- (4-t-butylpheny1)-3-(3-phenoxy-4fluorobenzyloxy)propane.
NMR (CDC13) 2 (ppm) : 1.24 (9H,s); 3.5 (lH,m);
3.71 (lH,dd); 3.9 (lH,dd) 4.36 (2H,ABq); 6.8-7.3 (12H,m) 19F NMR (CDCI3) S(ppm - relative to CFCI3) :
-68.1 (CF3,d); -132.7 (lF,m)
GLC retention time : 10.91 minutes ( ix) 1,1,1-Trifluoro-2-(4-methylpheny1)-3-(3-phenoxybenzyloxyJpropane, from 1,1, i-trifluoro-2-chloro2 - (4-methy lpheny 1) -3- (3-phenoxybenzy loxy )propane t
NMR (CDCI3) 5> (ppm) : 2.32 (3H,s); 3.58 (lH,m);
3.81 (lH,m); 3.97 (lH,m);
,. 4.48 (2H,ABq); 6.9-7.4 (13H,m) 19F NMR (CDC13) $ (ppm - relative to CFCI3)
GLC retention time : 9.85 minutes
- S3 (x) 1,1,1-Trifluoro-2- (4-methoxymethylphenyl )-3-(3-(4chlorophenyl)benzyloxy)propane, from 1,1,1tri fluoro-2-chloro-2 -(4-methoxyme thylphenyl)-3-(3(4-chlorophenoxy)benzyloxy)propane.
lH NMR (CDC13)£ (ppm) : 3.39 (3H,s); 3.64 (lH,m);
3.82 (lH,t); 4.0 (lH.dd);
4.43 (2H,s); overlapping with 4.45 (2H,ABq); 6.87.4 (12H,m)
GLC retention time : 12.10 minutes (xi) 1,1,1-Trifluoro-2-(4-methoxymethylphenyl)-3-(3phenoxybenzyloxy)propane, from l,l,l-trifluoro-2chloro-2-(4-me thoxyme thy lphenyl )-3-(3phenoxybenzyloxy)propane.
XH NMR (CDC13)(ppm) . 3.38 (3H,s); 3.64 (lH,m);
3.82 (lH,t)r 4.0 (lH,dfi);
4.44 (2H,s); overlapping with 4.46 (2H,ABq); 6.97.4 (13H,m)
GLC retention time : 11.09 minutes (xii) 1,1,1-Trifluoro-2-(4-trifluoromethoxyphenyl )-3-(3phenoxy-4-fluorobenzyloxy)propane, from 1,1,1tri fluoro-2-chloro-2-(4-tri fluoromethoxyphenyl)-3(3-phenoxy-4-fluorobenzyloxy)propane.
AP 0 0 0 0 3 A ΣΗ NMR (CDC13) S (ppm) : 3.64 (lH,m); 3.8 (lH,t);
3.95 (lH.dd); 4.4 (2H,ABq)
6.9-7.4 (12H,m)
GLC retention time : 9.03 minutes (xiii) 1,1,1-Trifluoro-2-(4-trifluoromethoxypheny1)-3-(3(4-chlorophenoxy)benzyloxy)propane, from 1,1,1tri fluoro-2-chloro-2-(4-tri f luoromethoxypheny1)-3(3 -(4-chlorophenoxy Jbenzyloxy)propane.
ΤΗ NMR (CDC13) £ (ppm) : 3.65 (lH.m); 3.82 (1H , t) ; 10 3.98 (lH,dd); 4.5 (2H,ABq); 6.8-7.4 (12H,m)
GLC retention time : 10.17 minutes (xiv) 1,1, l-Trifluoro-2-(4-trifluoromethoxyphenyl )-3-( 315 phenoxybenzyloxy)propane, from l,l,l-trifluoro-2chloro-2-(4-trifluoromethoxypheny1)-3-(3phenoxybenzyloxy)propane.
1H NMR (CDC13)£ (ppm) : 3.65 (lH,m); 3.82 (lH,t);
3.95 (LH.dd); 4.48 (2H,ABq); 6.9-7.4 (l3H,m) 19F NMR (CDC13) S (ppm - relative to CFCl-j) :
-58.3 (CF3O,s); -68.2 (CF3,d)
GLC retention time : 9.24 minutes
Am· (xv) 1, L, 1-Tr if luoro-2 - ( 4-me thoxy phenyl)-3-( 3-phenoxy4-fluorobenzyloxy)propane, from 1, 1,1-trifluoro-2 chloro-(4-methoxyphenyl )-3-(3-phenoxy-4fluorobenzyloxy)propane.
XH NMR (CDCI3) &(ppm) : 3.56 (lH,m); 3.8 (3H,s)? overlapping with (lH,m);
3.95 (lH,m); 4.42 (2H,ABq);
6.8-7.4 (12H,m) 19F NMR (CDCI3) & (ppm - relative to CFCI3) ’·
-68.5 (CF3,d); -132.7 (lF,m)
GLC retention time : 10.76 minutes (xvi ) 1, 1,1-Trif luoro-2 -(4-me thoxy phenyl )-3-( 3-phenoxybenzyloxy)propane, from 1,1,l-trifluoro-2-chloro2-(4-methoxypheny1)-3-(3-phenoxybenzyloxy)15 propane.
NMR (CDC13)£ (ppm) : 3.58 (lH,ra); 3.80 (3H,s) overlapping with (lH,m);
3.96 (lH,m); 4.48 (2H,ABq); 6.8-7.4 (13H,m)
GLC retention time : 10.84 minutes (xvii ) 1,1,1-Tr ifluoro-2-(3,4-methylenedioxyphenyl)-3-(3phenoxybenzyloxy)propane from 1, 1,1-trifluoro-2chloro-2-(3,4-methylenedioxyphenyl)-3-(3phenoxybenzyloxy)propane.
AS
- X *Η NMR (CDC13) $ (ppm) : 3.52 (lH,m); 3.77 (lH,t);
3.95 (lH,dd); 4.48 (2H,Abq); 5.95 (2H,9);
6.7- 7.4 (12H,ra)
GLC retention time : 11.20 minutes (xviii) 1,1,1-Tri fluoro-2-(3,4-methylenedioxyphenyl)-3-(3(4-chlorophenoxyJbenzyloxyJpropane, from 1,1,1trif luoro-2 -ch loro-2 -(3,4-methylenedioxyphenyl )-3(3 -(4-chlorophenoxy)benzyloxy) propane.
NMR (CDC13) £(ppm) : 3.55 (lH,m); 3.77 (lH,t);
3.94 (lH,dd); 4.48 (2H,ABq); 5.95 (2H,s); 6.75-7.4 (HH,m) 19F NMR (CDC13) $ (ppm - relative to CFC13) :
-68.4 (CF3,d)
GLC retention time : 12.16 minutes *
(xix) 1,1,1-Tri fluoro-2-(4-ethoxyphenyl )-3-(3-(4chlorophenoxy)benzyloxy)propane, from 1,1,1tri fluoro-2-chloro-2-(4-ethoxyphenyl)-3-(3-(4chlorophenoxy)benzyloxy)propane.
1H NMR (CDC13) & (ppm) : 1.41 (3H,t); 3.56 (lH,m);
3.80 (lH,t); 3.9-4.1 (2H,q) overlapping with (lH.dd); 4.48 (2H,ABq);
6.8- 7.4 (12H,m)
- 9*f X9F NMR (CDC13) £(ppm - relative to CFCI3) : -68.4 (CF3»d)
GLC retention time : 11.92 minutes.
(xx) 1,1,l-Trifluoro-2-(4-ethoxyphenyl)-3-(6-phenoxy-25 pyridylmethyloxy)propane, from 1,1,1-trifluoro-2chloro-2-(4-ethoxyphenyl)-3-(6-phenoxy-2pyr idylmethyloxy)propane.
XH NMR (CDC13)S (ppm) : 1.41 (3H,t); 3.6 (lH,m);
3.88 (lH,dd); ca. 4.02 (3H,m); 4.52 (2H,s);
6.7-7.7 (12H,m) X9F NMR (CDCl^) (ppm - relative to CFCI3) :
-68.3 (CF3,d)
GLC retention time : 11.28 minutes.
* (xxi) 1, lw.l-Trifluoro-2-(4-ethoxyphenyl)-3-(3-(4chlorophenoxy)4-fluorobenzyloxy)propane, f rom 1,1,1-tri fluoro-2-chloro-2-(4-ethoxyphenyl)-3-(3(4-chlorophenoxy)-4-fluorobenzyloxy)propane.
1H NMR (CDCI3) S (ppm) : 1.42 (3H,t); 3.56 (lH,m);
3.78 (lH,t); 3.95 (lH,dd) overlapping with 4.02 (2H,q); 4.4 (2H,ABq);
6.8-7.3 (llH,m) 19F NMR (CDCL3)£ (ppm - relative to CFCI3) :
-68.4 (CF3»d)? -132.4 (lF,m)
GLC retention time : 11.91 minutes.
(xxii) 1,1,1-Trifluoro-2-(4-ethoxyphenyl)-3-(3-(45 bromophenoxy)-4-fluorobenzyloxy)propane, from
1,1,1-tri fluoro-2-chloro-2 -(4-ethoxyphenyl)-3-(3(4-bromophenoxy)-4-fluorobenzyloxy) propane.
1H NMR (CDC13) S(ppm) : 1.40 (3H,t); ca. 3.55 (lH,m); 3.78 (lH,t); 3.94 (lH,dd) overlapping with
4.0 (2H,q); 4.4 (2H,ABq);
6.8-7.45 (llH,m) 19F NMR (CDCI3) S(ppm - relative to CFCI3) :
-68.4 (3F,d); -132.3 (lF,m)
GLC retention time : 12.47 minutes *
(xxiii) 1,1,1-Trifluoro-2-(4-ethoxyphenyl)-3-(2-methyl-3phenylbenzyloxy)propane, from 1, 1,1-trifluoro-2chloro-2-(4-ethoxyphenyl)-3-(2-methyl-3phenylbenzyloxy)propane.
NMR (CDC13)£ (ppm) : 1.42 (3H,t); 2.06 (3H,s);
3.6 (lH,m); 3.88 (lH,t); 3.95-4.1 (2H,q) overlapping with (lH,m); 4.55 (2H,ABq); 6.86 (2H,d); 7.2-7.5 (10H,m)
NMR (CDC13)£ (ppm - relative to CFC13) :
-68.5 (CF3«d)
GLC retention time : 11.39 minutes (xx iv) 1,1,1-Tri fluoro-2-(4-tri fluoromethoxyphenyl)-3-(65 phenoxy-2-pyridylmethyloxy(propane, from 1,1,1tri fluoro-2-chloro-(4-tri fluoromethoxypheny1)-3(6-phenoxy-2-(pyridylmethyloxy(propane.
1H NMR (CDC13)S (ppm) : 3.66 (lH,m); 3.9 (lH,dd);
4.06 (lH,dd); 4.48 (2H,ABq); 6.7-7.65 (12H,m)
GLC retention time : 8.89 minutes (xxv) 1,1,1,-Tri fluuoro-2-(4-ethoxyphenyl)3-(3-benzy1-4fluorobenzyloxy)propane, from 1,1,1-trifluoro-215 chloro-2-(4-ethoxyphenyl)-3-(3-benzyl-4~ fluorobenzyloxy(propane.
» XH NMR (CDC13) $(ppm) : 1.4 (3H,t); 3.5 (lH,m);
3.75 (lH.dd); 4.0 (5H,m); 4.4 (2H,q); 6.8-7.3 (12H,m) 19F NMR (CDC13) $ (ppm - relative to CFC13) :
-68.45 (3F,d); -119.89 (lF,q)
GLC retention time : 9.98 minutes ieo EXAMPLE 28
This Example illustrates the steps in the preparation of 1,1,1-trifluoro-2-(4-ethoxyphenyl) propan-3-ol.
Stage 1 : Preparation of 1,1,1,3,3-pentafluoro-2-(4ethoxyphenylphenyl)-3-chloropropan-2-ol.
A mixture of ethoxybenzene (67g), chloropentafluoroacetone (lOOg) and aluminium chloride (7g) was charged to a Hastalloy lined cell at -78*C, the cell sealed and heated to 120*C for 8 hours. After cooling and venting, the residue was taken up in chloroform and filtered through silica gel.
After removal of the solvent by evaporation the residual solid was recrystallised from n-hexane to yield several crops of 1,1, 1, 3,3-pentafluoro-2-(4-ethoxyphenyl)-3-chloropropan-2-ol. (Total 70g) mp. 84-86*C.
<· 1H NMR (CDCI3)$ (ppm) : 1.43 (t,3H); 3.44 (s,lH); 4.07 (q,2H); 6.95, 7.8 (m,2H)
19F NMR (CDCl3)^(ppm - relative to CFCI3) :
-62.4 (q,2F); -76 (t,CF3) \oo - 10ί Stage 2 : Preparation of 1, 1, 1,3, 3-pentafluoro-2,3-dichloro2 -(4-ethoxyphenyl)propane
A mixture of 1,1,1, 3,3-pentafluoro-2-(4-ethoxyphenyl) 3-chloropropan-2-ol (28g), thionyl chloride (45 cm3) and pyridine (3 cm3) wa3 heated at the reflux temperature for 4 hours, diluted with toluene and the volatile components removed by evaporation under reduced pressure. The residual oil was dissolved in chloroform, washed with water and dried over anhydrous magnesium sulphate. Removal of the solvent by evaporation under reduced pressure yielded 1,1,1,3,3pentafluoro-2,3-dichloro-2-(4-ethoxyphenyl)propane (29.5g) as a residual oil.
IR (liquid film) : 1616, 1516, 1305, 1180-1270,
1050, 924, 825, 736, 701 cm-1 rH NMR (CDC13) (ppm) : 1.42 4.06 (q,2H); 6.9,
7.72 (m,4K) 19F NMR (CDCI3$ (ppm - relative to CFCI3) :
—68.42 (t,3F:Jpp J = 12Hz)
-56.8 (dd,2F:Jpp J = 12Hz and 170Hz)
Stage 3 : Preparation of 1,1,1,3,3-pentafluoro-2,3-dichloro2 -(4-ethoxyphenyl )prop-2-ene.
A solution of 1,1,1,3,3-pentafluoro-2,3-dichloro-2-(4ethoxypheny1)propane (29.5g) in methanol (40 cm3) was added dropwise to a suspension of zinc powder (9.1g) and zinc chloride (0.45g) in methanol (80 cm3) whilst the temperature was maintained at 35*C. After the addition was complete the
ΙΟΙ lei mixture was stirred at the ambient temperature (ca. 23’C) for 2 hours. After dilution with water and filtering off the zinc, the mixture was extracted with chloroform, the extracts washed with water, dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent to yield 1,1,1,3, 3-pentafluoro-2-(4-ethoxypheny1)prop-2-ene (19.Og) as a mobile liquid.
IR (liquid film) : 1735, 1250,
1617, 1520, 1360, 1295, 1180, 1130, 1075, 950 cnT1
NMR (CDC13) δ (ppm)
1.41 (t,3H); 4.05 (q,2H); 6.9, 7.25 (m,4H, AB System).
19F NMR (CDCljl^ippm - relative to CFC13) :
-60.1 (dd,3F, J=25 and 10.5Hz)
-76.86 (dq.lF, J=25 and 15Hz)
-78.60 (dt,lF, J=12.5 and 10.5Hz)
Stage 4 : Preparation of a mixture of 1,1,1,3,3-pentafluoro2-(4-ethoxyphenyl)-3-ethoxypropane and (Z)- and (E)-isomers of 1,1,1,3-tetrafluoro-2-(4-ethoxypheny 1)-3-ethoxyprop-2-ene.
A solution of sodium ethoxide obtained by dissolving sodium (1.74g) in ethanol (100 cm3) was added dropwise to a stirred solution of 1, 1, 1,3,3-pentafluoro-2-(4-ethoxyphenyl)prop-2-ene (19g) in ethanol (100 cm3) at 10’C after which the mixture was allowed to warm to the ambient temperature over a period of one hour. The mixture was quenched with water, acidified with concentrated hydrochloric acid (15 cm3), and extracted with chloroform.
to£ 1&Γ The extracts were washed with water twice, dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure to yield a mobile oil (19.7g). Gas liquid chromatographic and mass spectrographic analysis indicated this to be a mixture comprising
1,1,1,3,3-pentafluoro-2-(4-ethoxypheny 1 )-3-ethoxypropane (16% by weight), (Z )-1, 1,1,3-tetra f luoro-2-(4-ethoxyphenyl) 3-ethoxyprop-2-ene (61% by weight and (E)-l,l,l,3tetrafluoro-2-(4-ethoxyphenyl)-3-ethoxyprop-2-ene (16% by 10 weight). This was used without further purification in the next stage.
Stage 5 : Preparation of 1,1,1-trifluoro-2-(4ethoxyphenyl)propionic acid
The mixture obtained in the previous stage (19g) was 15 heated with glacial acetic acid (75 cm3) and hydriodic acid (58%, w/v, 18g) at the reflux temperature for 24 hours.
After cooling, the mixture was-·diluted with water and extracted with chloroform. The extracts were washed with water three times, dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure to yield an oil (18.lg) which was redissolved in chloroform and extracted with aqueous saturated sodium bicarbonate solution. The aqueous solution was acidified with hydrochloric acid and extracted with chloroform. The chloroform extracts were dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure to yield 1, 1,1-trifluoro-2-(4-ethoxyphenyl)propionic acid (7.5g ) .
1h NMR (CDCI3) S (ppm) : 1.39 (t,3H); 3.95 (q,2H); 4.20 (q,lH); 6.8, 7.2 (m,4H); 8.65 (broad s, 1H) io3
1^4
The chloroform phase remaining after extraction with sodium bicarbonate was dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure to yield ethyl 1,1,l-trifluoro-2-(45 ethoxyphenylJpropionate, purified by distillation in a kugelrohr apparatus at 0.2 mm (oven temperature 80-100’C).
Stage 6 : Preparation of ethyl 1,1,l-trifluoro-2-(4ethoxyphenyl)propionate
A mixture of 1,1,1-trif luoro-2-{4-ethoxyphenyl) 10 propionic acid (6.5g), ethanol (100 cm3) and concentrated hydrochloric acid (2.0 cm3) was heated at the reflux temperature for 5 hours after which the excess of ethanol was removal by evaporation under reduced pressure. The residue was partitioned between water and chloroform and th chloroform layer washed with water, dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure to yield an oil (6.7g) which was further purified by distillation in a kugelrohr apparatus at 0.2 mm (oven temperature 100-120’C) to yield ethyl 1,1,1-trifluoro-2-(4-ethoxypheny1)propionate (5.6g).
LH NMR (CDC13) S (ppm) : 1.25 (t,3H); 1.41 (t,3H); 3.9-4.4 (m,5H); 6.9, 7.35 (m,4H) 19F NMR (CDC13) $ (ppm - relative to CFCI3) :
-68.53 (d,3F, JHF=8.37Hz).
Stage 7 : Preparation of 1,1,1-trifluoro-2-(4ethoxyphenyl)propan-3-ol
Diisobutylaluminium hydride (30 cm3 of a 1M solution in n-hexane) was added dropwise to a stirred solution of lOU- ethyl 1,1,1-trifluoro-2-(4-ethoxyphenyl)propionate (4.1g) in toluene (100 cm3) under a nitrogen atmosphere at -70*C and the mixture stirred for a further 1 hour. After quenching with dilute hydrochloric acid the organic phase was separated, washed with water, dried over anhydrous magnesium sulphate, and concentrated by evaporation of the solvents under reduced pressure to give an oil which was purified by distillation at 0.2 mm using a kugelrohr apparatus (oven temperature 110-130’C) to yield 1,1,1-trifluoro-2-(410 ethoxyphenyl)-propan-3-ol as a colourless oil (2g).
IR (liquid film) : 3400 (broad), 1620, 1520, 1310, 1255,
1166, 1120, 1050 cm1
EXAMPLE 29
This Example illustrates the stages in the preparation of 1,1,l-trifluoro-2-(4-chlorophenyl)propan-3-ol.
Τ» 1
Stage 1: Preparation of 1,1,1,3,3-pentafluoro-2-(4-chloropheny1)-3-chloropropan-2-ol
Chlorobenzene (31g), chloropentafluoroacetone (50g) and aluminium chloride (3g) were placed in a digestion cell and heated in an autoclave at 120*C for 8 hours. After cooling and venting, the crude mixture was poured into ice water and extracted into chloroform. The extracts were washed with water, dried over anhydrous magnesium sulphate and the solvents evaporated to leave a black oil (45g). Analysis by gas liquid chromatography showed 2 main components, retention times 1.77 minutes (56%) and 10.71 minutes (32%). The volatile material was isolated by distillation in a kugelrohr apparatus at 0.1 mmHg, oven temperature 100-120*C, to give a colourless oil 22.4g.
AP 0 o o 0 3 A lH NMR (CDC13) (ppm) : 7.0-7.4 (4H,ABq) 19F NMR (CDC13)£ (ppm - relative to CFC13:
-62.3 (2F,m)
-73.8 (3F,t)
Stage 2 : Preparation of 1,1,1,3,3-pentafluoro-2, 3-dichloro 2 - (4-chlorophenyl)propane
Prepared as described in Stage 2 of Example 28 above, from 1,1,1,3,3-pentafluoro-2-(4-chlorophenyl)-3chloropropan-2-ol.
GLC retention time : 1.95 minutes
Stages 3, 4, 5 and 6 : Preparation of ethyl 1,1,1-trifluoro· 2-(4-chlorophenyl)propionate and ethyl 1,1,1-trifluoro-2-(2,4dichlorophenyl)propionate
These stages were carried out as described in stages 36 of Examples, 2 8 above. At the end of Stage 6, three principal reaction products were present in the reaction mixture:
Product A : Ethyl 1,1,1-trifluoro-2-(4-chlorophenyl) 20 propionate (GLC retention time: 2.59 minutes
- 50%).
Product B : Ethyl 2-(4-chlorophenyl)acetate (GLC retention time : 3.05 minutes - 30%)
Product C : Ethyl 1 ,1,1-trifluoro-2-(2,425 dichlorophenylJpropionate (GLC retention time :
3.28 minutes - 10%)
10G
- Xrf Products A and C were isolated by preparative high pressure liquid chromatography, using n-hexane containing 4% by volume ethyl acetate as eluent.
Product A : 1H NMR (CDC13) (ppm) : 1.18 (3H,t); 3.9-4.2 (3H,m); 7.04 (4H,s)
Product C : 1-H NMR (CDC13)£ (ppm) : 1.25 (3H,t); 4.1-4.3 (2H,m); 5.03 (lH,q); 7.2-7.6 (3H,m)
Stage 7 : Preparation of 1,1,1-trifluoro-2-(410 chlorophenyl)propan-3-ol
Prepared as described in Stage 7 of Example 28 above from ethyl 1,1,l-trifluoro-2-(4-chlorophenyl)propionate
GLC retention time s 2.12 minutes
EXAMPLE 30
This Example illustrates the preparation of 1,1,115 trifluoro-2-(2,4-dichlorophenyl)propan-3-ol. *
This compound was prepared by the method described in stage 7 of Example 28 above, from ethyl l,l,l-trifluoro-2(2,4-dichlorophenyl)propionate. The starting material itself was product C, isolated in stage 6 of Example 29 above.
GLC retention time ; 2.99 minutes.
\O7 leff EXAMPLE 31
This Example illustrates the preparation of 1,1,1tri fluoro-2-(4-ethoxyphenyl)propan-3-ol.
A solution of boron trifluoride etherate (0.12 cm9) in tetrahydrofuran (2 crax) was added to a one molar (1M) solution of borane-methyl sulphide complex in tetrahydrofuran (1 cm3) under an atmosphere of nitrogen.
The temperature of the mixture was cooled to 0*C by external cooling, and a solution of 1,1,1-trifluoro-2-(4ethoxyphenyl)prop-2-ene oxide (O.lg) in tetrahydrofuran (1 cm2) was added with stirring. The mixture was allowed to warm to the ambient temperature (ca. 22*C) and stirred overnight. The mixture was then partitioned between saturated potassium carbonate solution (6 cm3) and diethyl ether (10 cm3). The aqueous layer was separated and z
extracted twice with diethyl ether (id cm3). The combined organic layers were dried over anhydrous sodium sulphate and the solvent evaporated under reduced pressure to give a pale yellow oil (0.09g). This oil was purified by column chromatography on a silica gel support, eluting with n20 hexane containing 30% diethyl ether, to give 1,1,1trifluoro-2-(4-ethoxyphenyl)propan-3-ol (0.05g) as a colourless oil. * 1H NMR (CDC13) S (ppm) : 1.4 (3H,t); 1.6 (1H,broad s);
3.5 (lH,m); 4.0 (2H,q) overlapping with 2H,m)? 7.0 (2H,d); 7.2 (2H,d)
IR (liquid film) : 3400 (broad), 1620, 1520, 1310, 1255,
1166, 1120, 1050 cm1
GLC retention time : 6.06 minutes (50*C-280*C run) tos lei EXAMPLE 32
This Example illustrates the preparation of 1,1,1trifluoro-2-(4-ethoxyphenyl )-3-(3-phenoxybenzyloxyJpropane from 1,1,l-trifluoro-2-(4-ethoxyphenyl)propan-3-ol.
A mixture of 1,1,1-trifluoro-2-(4-ethoxyphenyl)propan5 3-ol (0.4g), 3-phenoxybenzyl bromide (0.45g), tetra-n-butylammonium hydrogen sulphate (0.05g) and aqueous sodium hydroxide solution (40% w/v, 5.0 cm3) was stirred at the ambient temperature for 6 hours after which it was partitioned between water and diethyl ether. The ethereal phase was separated, washed twice with water, dried over anhydrous magnesium sulphate and concentrated by evaporation of the solvent under reduced pressure. The residual oil (0.75g) was purified by chromatography on a silica gel column eluted with a mixture of hexane (23 parts by volume) and ethyl acetate (2 parts by volume) to yield 1,1,1trifluoro-2-(4-ethoxyphenyl)-3-(3-phenoxybenzyloxyJpropane (0.21g) as a viscous oil.
AP 0 0 0 0 3 4
IR (liquid film) : 1617, 1590, 1520, 1490, 1448, 1260,
1220, 1170, 1126, 1076, 1050, 700 cm-1
20 *Η NMR (CDC13) V (ppm) : 1.42 (3H,t) ; 3.55 * (lH,q); 3.8
(lH,ra); 3.95 (lH,m); 4.0 (2H,q); 4.46 (ABq,2H); 6.8-7.4 (13H,m) 19F NMR (CDC13)S (ppm - relative to CFC13) : ~68·43 (3F,d)
GLC retention time : 11.15 minutes.
EXAMPLE 33
By a procedure similar to that described in Example 32 above, the following compounds were prepared from the appropriate starting materials.
(i) 1,1,l-Trifluoro-2-(4-ethoxyphenyl)-3-(3-(4bromophenoxy)benzyloxy) propane, from 1,1,1trii luoro-2-(4-ethoxypheny1) propan-3-ol and 3-(4 bromophenoxy)benzyl bromide.
The preparation of 3-(4-bromophenoxy) benzyl bromide is described in Example 34.
NMR (CDC13) £ (ppm) : 1.43 (3H,t); 3.4-4.1 (5H,m); 4.47 (2H,s); 4.8-7.5 (12H,m) 19F NMR (CDC13)S (ppm - relative to CFC13) :
-68.4 (CF3,d)
GLC retention time : 12.53 minutes (ii) 1,1,l-Trifluoro-2-(4-ethoxyphenyl)-3-(3-{2,4difluQrophenoxy)benzyloxy)propane, from 1,1,115 trifluoro-2-(4-ethoxyphenyl)propan-3-ol and 3(2,4-difluorophenoxy)benzyl bromide
The preparation of 3-(2,4-dif luorophenoxy) benzyl bromide is described in Example 35.
1H NMR (CDC13) £ (ppm) : 1.41 (3H,t); 3.56 (lH,m) 20 3.8 (lH,t); 3.98 (lH,dd)
4.03 (2H,q); 4.47 (2H,ABq); 6.8-7.3 (llH,m)
19f NMR (CDC13)S (ppm - relative to CFC13) :
-68.4 (CF3,d); -115.4 (lF,m); -126.1 (lF,m)
GLC retention time : 10.65 minutes ho - >n (iii) 1,1,1-Trifluoro-2-(4-ethoxyphenyl)-3-(3-(4fluorophenylamino)benzyloxy)propane, from 1,1,1trifluoro-2-(4-ethoxyphenyl)propan-3-ol and 3-(4fluorophenylamino)benzyl bromide.
The preparation of 3-(4-fluorophenylamino)benzyl bromide is described in Example 36.
NMR (CDC1,) J (ppm)
1.40 (3H,t); 3.56 (lH,m); 3.80 (lH,m); 3.99 (3H,m); 4.44 (2H,ABq); 5.52 (1H,broad s); 6.7-7.3 (12H,m) 19F NMR (CDC13) £(ppm - relative to CFC13)
-68.4 (CF3,d); -122.0 (lF,mf
GLC retention time : 11.92 minutes (iv)
1,1,l-Trifluoro-2-(4-chlorophqnyl)-3-(3phenoxybenzyloxy)propane, from 1,1,1-trifluoro-2 · (4-chlorophenyl)propan-3-ol and 3-phenoxybenzy1 bromide. In this case the compound was purified by high pressure liquid chromatography,* eluting with n-hexane containing 20% by volume dichloromethane.
NMR (CDC13) ζ (ppm)
3.57 (lH,m); 3.8 (lH,t) 3.95 (lH,dd); 4.45 (2H,ABq); 6.8-7.4 (13H,m)
GLC retention time : 10.40 minutes
1,1,1-Tri fluoro-2-(2,4-dichlorophenyl )-3-(3phenoxybenzyloxyJpropane, from l,l,l-trifluoro-2(2,4-dichlorophenyl)propan-3-ol and 3-phenoxybenzyl bromide.
(v) tit
- -W7Z :H NMR (CDC13) $ (ppm) : 3.7-4.0 (2H,m); 4.3-4.5 (3H,m); 6.8-7.5 (12H,m) ^9F NMR (CDC13) £ (ppm - relative to CFC13)
GLC retention time : 10.97 minutes (vi) 1,1,l-Trifluoro-2-(4-ethoxyphenyl)-3-(3benzylbenzyloxy)propane, from 1, 1,1-trifluoro-2(4-ethoxyphenyl)propan-3-ol and 3-benzylbenzyl bromide.
The preparation of 3-benzylbenzyl bromide is 10 described in Example 37.
1H NMR (CDC13) £ (ppm) : 1.4 (3H,t); 3.55 (lH,m);
3.78 (lH,m); 3.9-4.1 (5H,m); 4.45 (2H,d);
£>. 6.85 (2H,d); 7.0-7.4 (HH,m) 19F NMR (CDC13)£ (ppm - relative to CFCI3) :
-68.45 (CF3,d) (vii) 1,1,1-Trifluoro-2-(4-ethoxyphenyl)-3-(3-phenoxy-4 fluorobenzyloxy)propane, from 1,1,1-trifluoro-220 (4-ethoxyphenyl)propan-3-ol and 3-phenoxy-4-
fluorobenzyl bromide.
1H NMR (CDC13)£ (ppm) : 1.42 (t,3H ) ; 3.55 (m,1H)
3.78 (m,1H); 3.95 (m,1H)
4.0 (q,2H); 4.43 (ABq,
2H); 6.8-7.4 (m,12H)
19F NMR (CDCL3) ^”(ppm - relative to CFC13) :
-68.43 (d,3F,JHF=8.38Hz); -132.7 (m,lF).
IR (liquid film) : 1616, 1595, 1518, 1486, 1253, 1216, 1170, 1135 cm-1.
GLC retention time : 11.04 minutes.
EXAMPLE 34
This Example illustrates the stages in the preparation of 3-(4-bromophenoxy)benzyl bromide.
Stage 1 : Preparation of 3-(4-bromophenoxyJbenzaldehyde
This compound was prepared by a standard bromination reaction from 3-phenoxybenzaldehyde.
1H NMR (CDC13) S (ppm) . 6.8-7.7 (8H,m); 10.0 (lH,s)
Stage 2 : Preparation of 3-(4-bromophenoxy)benzyl*alcohol.
This compound was prepared by a standard sodium borohydride reduction from 3-(4-bromophenoxy)benzaldehyde.
XH NMR (CDC13) S(ppm) : 1.95 (1H,broad t - disappears on shaking with D2O) : 4.7 (2H, broad d, - collapses to singlet on shaking with D2O); 6.8-7.6 (8H,m)
AP 0 0 0 0 3 4
Stage 3 : Preparation of 3-(4-bromophenoxy)benzyl bromide.
H'S
This compound was prepared from 3-(4-bromophenoxy)benzy1 alcohol by a standard reaction with phosphorus tribromide.
1H NMR (CDC13) S (ppm) ; 4.43 (2H,s); 6.8-7.5 (8H,m)
EXAMPLE 35
The following Example illustrates the stages of the preparation of 3-(2,4-difluorophenoxy)benzyl bromide.
Stage 1 : Preparation of 2-(3-(2,4-difluorophenoxyJphenyl) 1,3-dioxolane
A solution of 2,4-difluorophenol (lOg) in dry Ν,Νdimethylformamide (30 cm3) was added dropwise, over 15 minutes to a suspension of sodium hydride (2.2g, prepared from a 50% dispersion in oil (4.4g) by washing with dry petroleum ether of boiling range 60-80’C) in dry Ν,Νdimethylformamide (20 cm3); the addition was performed under
Λ an atmosphere of nitrogen at a temperature maintained at 0*C. After stirring for a further 10 minutes at 0*C, a solution of 2-(3-bromophenyl )-1,3-dioxolane (17.6g, prepared by a standard reaction between 3-bromobenzaldehyd§ and ethylene glycol) in dry Ν,Ν-dimethylformamide (20 cm3) was added at 0*C over 5 minutes. A catalytic amount of anhydrous cuprous chloride was added, and the reaction mixture was heated at 100*C for 28 hours. The mixture was cooled, added to water, and extracted with diethyl ether.
The ether layers were washed firstly with sodium chloride solution, then 2 molar sodium hydroxide solution, and dried over anhydrous magnesium sulphate. Evaporation of the solvent under reduced pressure gave 2-(3-(2,4difluorophenoxy)phenyl)-1,3-dioxolane as an oil (8.5g), which was used without further purification.
vu.
- liT ΧΗ NMR (CDC13) ί (ppm) : ca. 3.95 (4H,m); 5.65 (lH,s); 6.67.5 (7H,m)
Stage 2 : Preparation of 3-(2,4-difluorophenoxy)benzaldehyde.
Concentrated sulphuric acid (0.18g) was added to a solution of 2-(3-(2,4-difluorophenoxy)pheny1)-1,3-dioxolane in acetone (200 cm^). The stirred mixture was heated at 55’C for 5 hours. After cooling, the solvent was evaporated under reduced pressure, and the residue neutralised by addition of an aqueous solution of sodium hydrogen carbonate. This aqueous mixture was partitioned between diethyl ether and water. The ether layer was separated, dried over anhydrous magnesium sulphate and the solvent evaporated under reduced pressure to give 3-(2,4-di f luoro15 phenoxy)benzaldehyde as an oil (6.4g). The product was shown to be 85% pure by gas liquid chromatography, and was used without further purification.
1H NMR {CDCI3) S (PPm) : 6-8-8.0 (7H,m); 9.95 (lH,s)
Stage 3 : Preparation of 3-(2,4-difluorophenoxy)benzyl alcohol.
Sodium hydroxide solution (2 molar, 0.5 cm3) was added to a solution of 3-(2,4-difluorophenoxy)benzaldehyde (2g) in methanol (20 cm3) and the mixture was cooled to 0*C. Sodium borohydride (0.5g) was added, and the mixture stirred for 30 minutes. After this time, water was added, and the mixture acidified to pH 4 by addition of dilute hydrochloric acid. This mixture was extracted with diethyl ether (5 x 50 cm3). The combined orga:ic layers were dried over anhydrous sodium
APO 0 0 0 3 A sulphate, and the solvents evaporated under reduced pressure. The residue was purified by column chromatography on a silica gel support, using n-hexane containing 20% by volume ethyl acetate as eluent, to give 3-(2,45 difluorophenoxy(benzyl alcohol as a colourless oil.
XH NMR (CDC13) ζ (ppm) : 1.7 (lH,t); 4.65 (2H,d); 6.8-7.4 (7H,m)
GLC retention time : 5.29 minutes
Stage 4 : Preparation of 3-(2,4-difluorophenoxy(benzyl bromide
3-(2,4-Difluorophenoxy)benzyl alcohol (l.Og) and triphenylphosphine (1.15g) were dissolved in dry dichloromethane (40 cm3 used in total) and the solution was cooled to -10’C in an ice/salt bath. A solution of 1,215 dibromotetrachloroethane (l,5g) in dichloromethane was added simultaneously with a*solution of triethylamine in dichloromethane from separate dropping funnels, maintaining the temperature below 0*C. After 30 minutes the reaction was allowed to warm to room temperature. The mixture was
A poured into ice-cold water (70 cm3), and after 5 minutes the layers were separated. The aqueous phase was extracted with dichloromethane (2 x 40 cm3) and the combined organic layers were dried over anhydrous sodium sulphate and the solvent was removed by evaporation under reduced pressure. Analysis of the residue by gas liquid chromatography indicated a major component (75%) of triphenylphosphine oxide, the main product (20%) with a GLC retention time of 5.65 minutes and a minor component (2-3%) with a GLC retention time of 4.99 minutes. Separation by chromatography on a silica gel support, eluting with 2-liexane containing 10% by volume ethyl acetate, yielded a main product fraction (0.36g) containing 71% 3-(2,4-difluorophenoxy)benzyl bromide and 29% of the minor component, which was identified by gas chromatography - mass spectrometry as 3-(2,4difluorophenoxy)benzyl chloride. This mixture was used without further purification.
1H NMR (CDCI3) 5 (ppm) : 4.43 (CH2-Br,s); and 4.55 (CH2~
Cl,s) in a ratio of 26:10;
6.8-7.3 (7H,m)
EXAMPLE 36
This Example illustrates the stages in the preparation of 3-(4-fluorophenylamino)benzyl bromide.
£
Stage 1 : Preparation of methyl 3-(4t.
fluorophenylamino)benzoate
4-Fluoroaniline (88g), 3-iodobenzoic acid (40g), potassium carbonate (24g), cuprous chloride (2g) and copper-powder (4.5g prepared as in Organic Syntheses Collective Volume II, p. 446), were mixed at room temperature, then heated up to
180*C for 3 hours before allowing to cool overnight. The mixture was diluted in water (75 cm3) containing potassium carbonate (5g) and then steam distilled to remove the excess aniline (about 1 litre of distillate collected in 65 minutes). The residue was boiled with activated charcoal for 5 minutes, then cooled and filtered through celite. The celite was washed with dilute potassium carbonate solution.
\\Ί
ΧΜΓ The filtrate was acidified with concentrated hydrochloric acid to pH 2, and the gummy solid that separated was dissolved in diethyl ether. The layers were separated and the aqueous layer was washed twice with diethyl ether. The combined organic layers were washed twice with water, dried over anhydrous sodium sulphate and the solvent evaporated under reduced pressure to give a dark blue oil (32g). The oil was dissolved in methanol (133 cm3) and concentrated sulphuric acid (7 cm3) was added carefully. The mixture was heated at reflux for 90 minutes, then cooled and poured into water. The product was extracted into dichloromethane, and the organic layer separated and dried over anhydrous sodium sulphate. After evaporating the solvent under reduced pressure, the residual oil was purified by passing through a column of silica gel, eluting with dichloromethane. The product was crystallised from a dichloromethane - petroleum ether (boiling range 60-80*C) mixture to give methyl 3-(4fluorophenylamino)benzoate (14g) as large plates. A further 12g of the substantially pure product was removed from the mother liquors.
1H NMR (CDC13) V (ppm) : 3.9 (3H,s); 6.9-7.8 (9H/m).
Stage 2 : Preparation of 3-(4-fluorophenylamino)benzyl alcohol.
The ester (4.85g) was added to lithium borohydride (lg) in tetrahydrofuran (25 cm3). The mixture was heated at the reflux temperature for 1 hour, when analysis by thin layer chromatography showed no trace of starting material. Water and dichloromethane were added and the mixture was poured into water. Th«j layers were separated and the aqueous layer
AP 0 0 0 0 3 4
VS
- extracted with further portions of dichloromethane. The combined organic layers were washed with water, dried over anhydrous sodium sulphate, then the solvents were removed by evaporation under reduced pressure to give an oil that crystallised on scratching (4.7g). Crystallisation from a mixture of dichloromethane and petroleum ether (boiling range 60-80’C) gave 3-(fluorophenylamino)benzy1 alcohol (4.lg).
XH NMR (CDC13) $ (ppm) : 4.60 (2H,s); 6.8-7.4 (10H,m)
Stage 3 : Preparation of 3-(4-fluorophenylamino)benzyl bromide
- ( 4-Fluorophenylamino)benzyl alcohol (l.Og) was dissolved in toluene (10 cm ). A solution of phosphorous tribromide (0.42g) in toluene (10 cm3) was added dropwise. After a few moments, pyridine (0.36g) in toluene was added dropwise. The reaction was stirred at room temperature for 2 hours, at which time no starting material could be detected by thin layer chrotnatography.
The mixture was poured into water and the products were extracted intp chloroform. The combined organic extracts were washed with water then dried over anhydrous magnesium sulphate, then the solvents were evaporated under reduced pressure to leave a viscous oil (l.lg). This oil was purified by passing through a short column of silica gel eluting with n-hexane contain 20% by volume ethyl acetate, to give 3-(4-fluorophenylamino)benzyl bromide (0.2g). the product (rf. 0.8 on silica gel plates, with n-hexane containing 30% by volume ethyl acetate as eluent), was shown to contain minor impurities, but was used without further puri ficat.ion.
NMR (CDCl^) S (ppm) : major peaks at 4.43 (2H,s);
6.8-7.3 (8H,m)
EXAMPLE 37
This Example illustrates the stages in the preparation of 3-benzylbenzyl bromide.
Stage 1 : Preparation of 2-(3-benzylbenzyl)-1,3-dioxolane.
This compound was prepared by a method analogous to that reported by Minato et al in Tetrahedron Letters, 21, 845, 1980.
Benzyl bromide (25.69g) was added to a suspension of activated zinc powder (19.48g) in dry tetrahdyrofuran (180 cm3) under an atmosphere of nitrogen. The mixture was sonicated for 1 hour and then allowed to stand for a further hour. The solution was carefully decanted from the insoluble residue (under an atmosphere of nitrogen) into a second reaction vessel, and a mixture of 2-(3-bromophenyl)1,3-dioxolane (lOg), palladium (Pd*) tetrakis triphenylphosphine (0.2g) and tetrahydrofuran (50 cm3) was added.
The stirred mixture was heated at the reflux temperature for 5 hours, at which time analysis of the reaction mixture by gas liquid chromatography showed no trace of the principal starting materials. The mixture was cooled, added to diethyl ether, washed with ammonium chloride solution, water and brine, and dried over anhydrous magnesium sulphate. Evaporation of the solvents under reduced pressure gave the product as a yellow oil, which was purified by column chromatography on a silica gel support using petroleum ether (boiling range 60-80*C) containing 10% by volume (progressively increased to 20% by volume) of diethyl ether, to give 2-(3-benzylbenzyl)-1,3-dioxolane (8.2g), which was immediately used in the next stage of the reaction.
Ί £ 0 0 0 0 dV \Ώ-Ο
Stage 2 : Preparation of 3-benzylbenzaldehyde
A mixture of 2-(3-benzylbenzy1)-1,3-dioxolane (8.2g), acetone (100 cm3), water (10 cm3) and concentrated sulphuric acid (20 drops) was stirred overnight, then added to diethyl ether. The resultant mixture was washed with sodium bicarbonate solution, water and brine, and dried over anhydrous magnesium sulphate. Evaporation of the solvents under reduced pressure gave 3-benzylbenzaldehyde (6.5g), which was used without further purification.
1H NMR (CDC13) <6 (ppm) : 4.0 (2H,s); 7.1-8.0 (9H,m);
10.0 (lH,s)
IR (liquid film) : 1700 cm-3· (C=O)
Stage 3 : Preparation of 3-benzylbenzyl alcohol.
3-Benzylbenzaldehyde (5.5g) was dissolved in methanol (75 cm^) and cooled to 0*C. Sodium borohydride (1.29g) was added gradually in small portions, and stirring was continued for one hour. The reaction mixture was cautiously poured into a water/diethyl ether mixture, and the resulting ethereal solution was washed with water and brine, and dried over anhydrous magnesium sulphate. Evaporation of the solvents under reduced pressure gave 3-benzylbenzyl alcohol as a pale yellow oil (5.2g). The product was used without further purification.
LH NMR (CDC13) £ (ppm) : 1.8 (1H,broad s); 4.0 (2H,s);
4.6 (2H,s); 7.1-7.4 (9H,m)
IR (liquid film) : 3350 cm 1 (OH) \2Λ
W2
Stage 4 : Preparation of 3-benzylbenzyl bromide
A solution of 3-benzylbenzyl alcohol (1.98g) in diethyl ether (60 cm3) was cooled in an ice bath, and 1, 1,2,2-tetrachloro-l,2-dibromoethane (3.90g) added. When the addition was complete, triphenyl phosphine (3.14g) was added to the cooled mixture. The reaction mixture was stirred for 10 minutes, then filtered and the solvent evaporated under reduced pressure. The resultant yellow oil was purified by column chromatography on a silica gel support, eluting with petroleum ether (boiling range 6080’C) containing 10% by volume diethyl ether, to give 3benzylbenzyl bromide (2.62g).
60MHz XH NMR (CDC13) £ (ppm) : 3.95 (2H,s); 4.45 (2H,s);
7.25 (9H,s)
EXAMPLE 38 «I fi
This Example illustrates the stages in the preparation of 3-(4-bromophenoxy)-4-fluorobenzyl alcohol.
Stage 1 : Preparation of 3-(4-bromophenoxy)-4fluorobenzaldehyde
3-Phenoxy-4-fluorobenzaldehyde (2.16g), bromine (1.6g) and dry dichloromethane (20 cm3) were mixed and stirred at the ambient temperature (ca. 22’C) for 2 days. The mixture was then poured onto water and extracted with chloroform.
The organic extracts were combined, washed once with saturated sodium metabisulphite solution and twice with water, then dried over anhydrous magnesium sulphate. The solvent was evaporated under reduced pressure to leave an oil (3.5g). The product was purified by chromatography on
AP 0 0 0 0 3 4
2^3 a silica gel support, eluting with n-hexane containing 50% by volume ethyl acetate, to give 3-(4-bromophenoxy)-4fluorobenzaldehyde (0.65g) as an oil.
LH NMR (CDC13) $ (ppm) : ca. 6.9 (2H,m); 7.3-7.7 (5H,m);
9.9 (lH,s) 19F NMR (CDCl3)d (ppm - relative to CFCI3) : -120.8 (lF,m)
GLC retention time : 6.87 minutes
Stage 2 : Preparation of 3-(4-bromophenoxy)-4-fluorobenzyl alcohol.
This compound was prepared from 3-(4-bromophenoxy)-4fluorobenzyl alcohol by a standard reduction using sodium borohydride.
NMR (CDC13) £ (ppm) : ca 1.7 (1H,broad s); 4.62.
(2H,broad s); 6.8-7.5 (7H,m)
NMR (CDCI3) S (ppm - relative to CFCI3) :
-132.7 (lF,m)
GLC retention time : 7.7 minutes
EXAMPLE 39
This Example illustrates the stages in the preparation of 3-(4-chlorophenoxy)-4-fluorobenzyl alcohol.
Stage 1 : 3-Phenoxy-4-f1uorobenzaldehyde (5g) was dissolved in carbon tetrachloride (50 cm9) containing chlorine (4.25g) and the miture was stirred at room temperature for 48 hours. After pouring into water the mixture was extracted with chloroform. The combined extracts were washed with water then dried over anhydrous magnesium sulphate and the solvent evaporated under reduced pressure to leave an oil (5.5g). This material was purified by high pressure liquid chromatograhy on a silica gel support eluting with n-hexane 10 containing 10% by volume ethyl acetate, to give 3-(4chlorophenoxy)-4-fluorobenzylaldehyde as an oil (1.8g).
1H NMR (CDClj) S (ppm) : 6.95 (lH,m); ca. 7.35 (4H,m);
7.54 (lH,dd); 7.7 (lH,ddd); 9.9 (lH,s)
GLC retention time : 6.25 minutes
Stage 2 : Preparation of 3-(4-chlorophenoxy)-4-fluorobenzyl alcohol
3-(4-Chlorophenoxy)-4-fluorobenzaldehyde (1.8g) was 20 dissolved in methanol (10 cm9) and cooled to 10*C. Sodium borohydride (0.3g) in a mixture of water (3 cm9) and 2 molar sodium hydroxide solution (0.4 cm9) was added dropwise, and the mixture stirred at room temperature for 1¾ hours. The mixture was then acidified with dilute sulphuric acid and extracted with chloroform. The combined organic extracts were washed with water, dried over anhydrous magnesium sulphate and the solvent evaporated under reduced pressure to leave a viscous oil (1.8g). This oil was purified by chromatography on a silica gel support, eluted with n-hexane
AP 0 0 0 0 3 4 containing 25% by volume ethyl acetate to give 3-(4chlorophenoxy)-4-fluorobenzyl alcohol as a white solid (1 ·45g ) .
XH NMR (CDClj) £ (ppm) : 1.7 (1H,broad t); 4.6 (2H,broad d) ; 6.8-7.4 (7H,m) 19F NMR (CDCl^S (ppm - relative to CFC13) : -132.7 (lF,m)
GLC retention time : 7.10 minutes
EXAMPLE 40
This Example illustrates the stages in the preparation of 3-benzyl-4-fluorobenzyl alcohol.
Stage 1 : Preparation of 3-bromo-4-fluorobenzaldehyde
A solution of 4-fluorobenzaldehyde (49.6g) in dry dichloromethane (20 cm3) was added to a cooled (0*C) suspension of powdered aluminium trichloride (90.4g) in dry dichloromethane (100 cm3). Bromine (70.4g) was added, and the mixture heated at the reflux temperature for '16 hours. After cooling, the reaction mixture was carefully poured onto ice and extracted with dichloromethane. The combined organic layers were washed with saturated sodium metabisulphite solution, water and brine, then dried over anhydrous magnesium sulphate. Evaporation of the solvent under reduced pressure gave a dark red oil, which was purified by distillation under reduced pressure, using a 4 Vigreux column to give 3-bromo-4-fluorobenzaldehyde (45.7g) as an oil, boiling point 85-108*C at 8 mmHg.
Stage 2 : Preparation of 2-(3-bromo-4-fluorophenyl)-1,3dioxolane
A mixture of 3-bromo-4-fluorobenzaldehyde (45.7g), ethylene glycol (27.93g), g-toluenesulphonic acid (0.225g) and dry toluene (110 era·3) was heated at the reflux temperature under a Dean and Stark trap. After 4.5 hours, approximately 12 cm3 of water had collected in the trap, and analysis of the reaction mixture by gas liquid chromatography indicated that no starting aldehyde was 10 present. The mixture was cooled and poured into diethyl ether, washed with saturated sodium bicarbonate solution and brine, and dried over anhydrous magnesium sulphate. Evaporation of the solvent under reduced pressure gave a yellow oil, which was purified by distillation under reduced pressure to give 2-(3-bromo-4-fluorophenyl)-1,3-dioxolane (43.56g), boiling point 68-106’C at 0.004 mmHg.
MHz 3h NMR (CDCI3) S (ppm ) j 4.1 (4H,m); 5.8 (lH,s);
7.0-7.7 (3H,m)
Stage 3 : Preparation of 2-(3-benzyl-4-fluorophenyl)-1,320 diqxolane
This compound was prepared by a method analogous to that reported by Minato et al in Tetrahedron Letters, 21,
845, 1980.
Benzyl bromide (2.77g) was added in one addition to a 25 suspension of activated zinc powder (2.1g) in dry tetrahydrofuran (20 cm3) under an atmosphere of nitrogen.
The reaction mixture was sonicated for 2 hours, allowed to stand for 30 minutes and carefully filtered under an £ 0 0 0 OdV atmosphere of nitrogen. The filtered solution was then added to a mixture of 2-(3-oromo-4-fluoropheny1)-1,3dioxolane (lg) and palladium (Pd*) tetrakis triphenyl phosphine (O.OSg) in dry tetrahydrofuran (10 cm3) under an atmosphere of nitrogen. The stirred mixture was heated at the reflux temperature for 48 hours, at which time analysis by gas liquid chromatography showed no trace of starting material. The reaction mixture was cooled and poured into diethyl ether. The organic layer was separated, and washed with ammonium chloride solution, water and brine, then dried over anhydrous magnesium sulphate. Evaporation of the solvent under reduced pressure gave a yellow oil which was purified by column chromatography on a silica gel support, using petroleum ether (boiling range 40-60*C) containing diethyl ether (progressively increased from 10% to 20% by volume) as eluent, to give 2-(3-benzyl-4-fluorophenyl)-1,3dioxolane (0.7g). The product was used without further purification.
HMz lH NMR (CDC13)S (ppm) : 4.0 (6H,m); 5.7 (lH,s);
6.8-7.5 (8H,m)
Stage 4 : Preparation of 3-benzyl-4-fluorobenzaldehyde
A mixture of 2-(3-benzyl-4-fluorophenyl)-1,3-dioxolane (0.7g) acetone (10 cm3), water (1 cm3) and concentrated sulphuric acid (5 drops) was stirred overnight. The reaction mixture was poured into diethyl ether and the organic layer washed with sodium bicarbonate solution, water and brine, then dried over anhydrous magnesium sulphate. Evaporation of the solvents under reduced pressure gave 3benzyl-4-fluorobenzaldehyde (0.59g), which was used without further purification.
LH NMR (CDC13) b (ppm) : 4.10 (2H,s); 7.20 (6H,m);
7.75 (2H,m); 9.90 (lH,s)
IR (liquid film) : 1700 cm'1 (0=0)
Stage 5 : Preparation of 3-benzyl-4-fluorobenzyl alcohol
A solution of 3-benzyl-4-fluorobenzaldehyde (5g) in methanol (75 cm3) was cooled to 0*C. Sodium borohydride (1.34g) was added in portions, and the mixture stirred for 1 hour. The reaction mixture was then poured cautiously into a mixture of water and diethyl ether, and the organic layer was separated, washed with water and brine, and dried over anhydrous magnesium sulphate. Evaporation of the solvents under reduced pressure gave a pale yellow oil which was purified by distillation in a kugelrohr apparatus to give 3benzyl-4-fluorobenzyl alcohol (4.0g).
Boiling point : 120*C at 0.02 mmHg rt t»
NMR (CDCI3) S (ppm) Ϊ 1.7 (1H,broad s); 4.0 (2H,s);
4.6 (2H,s); 7.0-7.3 (8H,m)
IR (liquid film) : 3600-3100 cm“l (OH)
EXAMPLE 41
This Example illustrates the preparation of 420 bromobenzyl methyl ether.
4-Bromobenzyl alcohol (1.87g) was added over 10 minutes to a stirred suspension of sodium hydride (0.24g - used directly in the form of 0.48g of a 50% dispersion in oil) in dry N,N-dimethylformamide (10 cm3) under an atmosphere of nitrogen. Afer evolution of hydrogen had ceased (20 minutes), methyl iodide (1.42g) was added and the reaction mixture was stirred for a further 10 minutes. The mixture was poured into water and the organic layer separated. The aqueous layer was extracted with diethyl ether. The combined organic layers were dried over anhydrous sodium sulphate, and concentrated by evaporation under reduced pressure. The residual, crude product was purified by column chromatography on a silica gel support, eluting with n-hexane containing 12.5% by volume ethyl acetate, to give 4-bromobenzyl methyl ether (1.6g).
GLC retention time : 2.00 minutes.
EXAMPLE 42
This Example illustrates the stages in the preparation of 4-bromo-2-fluorophenetole.
Stage 1 : Preparation of 4-bromo-2-fluorophenol.
A solutipn of bromine (140.6g) in carbon disulphide (50 cm3) wag added over 3 hours to a stirred solution of 2fluorophenol (89.68g) in carbon disulphide (150 cm3), the temperature being maintained at ca. 10*C throughout the addition by external cooling. The reaction mixture was allowed to stand at the ambient temperature (ca. 20*C) for 18 hours, and was then poured into an aqueous solution of sodium metabisulphite (100 cm3). The organic layer was separated, washed with aqueous sodium bicarbonate solution (2 x 100 cm3) and dried over anhydrous sodium sulphate. Removal of the solvent by evaporation under reduced presure gave an oil, which was purified by distillation under reduced pressure to give two fractions, each shown by gas liquid chromatography to contain 97% 4-bromo-2-fluorophenol. Fraction 1 (89.3g) : boiling range 85-86’C (ca. 15 mmHg)
Fraction 2 (47.5g) : boiling range 86-87*C (ca. 15 mmHg)
The fractions were further shown by gas liquid chromatography to contain, respectively, 1% and 1.5% of dibrominated material.
J-H NMR (CDClj) $ (ppm) : 5.3 (1H,broad a); 6.9 (lH,t);
7.1-7.3 (2H,m)
Stage 2 : Preparation of 4-bromo-2-fluorophenetole.
A mixture of 2-fluoro-4-bromophenol (19.lg), sodium hydroxide (6g), ethyl iodide (46.8g), tetra-n-butylammonium bromide (3.2g), dichloromethane (250 cm3) and water (2 50 cm3) was stirred vigorously at the ambient tenperature for 5¾ hours, then allowed to stand for a further 68 hours. The organic layer was separated and the aqueous layer was washed with dichlororaethane; the combined organic layers were then dried over anhydrous sodium sulphate. Jhe solvent was removed by evaporation under reduced pressure at a bath temperature maintained below 40*C. The residual oil was purified by column chromatography on a silica gel support, eluting firstly with n-hexane and secondly with dichloromethane. The product-containing fractions were combined, washed with an aqueous solution of sodium metabisulphite, dried over anhydrous eodim sulphate and concentrated by evaporation under reduced pressure to give 4-bromo-2-fluorophenetole (15.2g) as an oil. The product was shown by gas liquid chromatography to be 93% pure, and was used without further purification.
13ο lai 1H NMR (CDC13) $ (ppm) : 1.45 (3H,t); 4.07 (2H,q);
6.7-7.3 (3H,m) 19F NMR (CDC13) %(ppm - relative to CFC13) : -131.8 (lF,m)
EXAMPLE 43
This Example illustrates the resolution of (+)-1,1,15 trifluoro-2-(4-ethoxyphenyl )-3-(3-phenoxybenzy1oxy)propane.
(+)-1,1,1-trifluoro-2-(4-ethoxypheny1)-3-(3phenoxybenzyloxyJpropane was resolved by high pressure liquid chromatography, using a Pirkle type 1A column (25 cm x 4.9 mm) at -20*C, and n-hexane containing 1% by volume chloroform as eluent, at a flow rate of 0. 7 cm3/minute. Elution was monitored using a UV detector at 220 mm. Two isomers were detected : isomer A (retention time ca. 51 minutes) and isomer B (retention time ca. 54.6 minutes!,. A total of three fractions were collected.
*
Fraction 1 (10 mg) : 92.9% isomer A, 7.1% isomer B
Fraction 2 (17 mg) : 19.7% Isomer A, 80.3% isomer B
Fraction 3 (9 mg) : 12.5% isomer A, 87.1% isomer B
Optical rotations were measured for fraction 1 (at a concentration of lOmg in 1.5 ml) and for fraction 3 (at a concentration of 9 mg in 1.5 ml).
The observed angles of rotation were small, (ca. 0.01*) and similar in magnitude to the limits of determination of the apparatus used. On the basis of repeated observations, isomer A was assigned the dexrorotatory designation : (+)131
- 182 1, 1, 1-tri fluoro-2-(4-ethoxyphenyl)-3-(3-phenoxybenzyloxy) propane, and isomer B the laevorotatory designation : (-)1,1, 1-trifluoro-2-(4-ethoxyphenyl)-3-(3phenoxybenzyloxy Jpropane.
Insecticidal evaluation of fraction 1 and fraction 3 indicates that isomer A is substantially more active than isomer B. It is thus believed that in this series of compounds insecticidal activity is principally associated with the isomer having an absolute configuration corresponding to that of isomer A herein.
EXAMPLE 44
This Example illustrates the insecticidal properties of the Products of this invention.
The activity of the Product was determined using a variety of insect pests. The Product was used in the form of liquid preparations containing 500, 250 or 100 parts per million (ppm) by weight of the Product. The preparations were made by dissolving the Product in acetone and diluting the solutions with water containing 0.01% by weight of a wetting agent sold under the trade name LISSAPOL NX until the liquid preparations contained the required concentration of the Product. Lissapol is a Registered Trade Mark.
The test procedure adopted with regard to each pest was basically the same and comprised supporting a number of the pests on a medium which was usually a host plant or a foodstuff on which the pests feed, and treating either or both the pests and the medium with the preparations. The mortality of the pests was then assessed at periods usually varying from one to three days after the treatment.
AP 0 0 0 0 3 4
Ι3λ - L&5 In the case of the species Musca domestica (housefly), additional tests to determine the knockdown effect of the compounds were performed. Details are given in Table III.
The results of the tests are given in Table IV for each 5 of the Products, at the rate in parts per million given in the second column as a grading of mortality designated as A, B or C wherein A indicates 80-100% mortality or knockdown (70-100% in the case of Spodoptera exigua), B indicates 5079% mortality or knockdown (50-69% in the case of Spodoptera exigua) and C indicates less than 50% mortality or knockdown.
In Table IV the pest organism used is designated by a letter code and the pest species, the support medium or food, and the type and duration of test is given in Table
III.
z
o z—·»
H <n
t* >1
< 0
2 P
P
Q
ci <s «Ο to
Li
4=
Cd
O w
0.
>
E«
44 44 44 0 0 0 44 0 0
G O 0 3 3 3 G •Ό 3
0 0 0 P P P 0 X P
e* 4J 44 44 Ή •H •H 44 G i-C
ω c c c a « a c 0 a
Cd 0 0 0 V V 0 0 c V
E* u U o id cd cd u id cd
Q fa cd Σ O P CL W & Q X3 ω CO Σ
C <0 <u
Λ
4=
G c
V
l.
Cd «44
0 «44 0 44 rd •-d «44
0 0 QiP 0 0 0 0
r-« 0 0 0 Ol 0 0 0
rd Ol 0 •-d
0 a G
O' c Li •H ' c c c
0 0 0 0 44 ' 0 Li 0 Li 0
«44 «44 b 44 44 N a 44 0 44 0 44
0 0 b 44 rd «·*Μ 0 44 O' 44 O' 44
0 0 0 0 •d <TJ ^d 0 3 0 3 0
P u O Cd E Cd u 0 o a O
TABLE III □
P <0
U
Ol
VI ω
w
U ω
Cl,
V)
H
CO ω
E*
4= P
G
C <0 l, ®
EH
Q.
to |*O
Φ
Li
0 g
-4 m Li 0
Qjtn σ> Οι 3 0 •“•lb
0f44 > -» L,
Ή lb
Tl «
c v
Li o>
® c 0 ο ε a u o ? •hm ‘ 3 b b g + g o <a “4 P a
Λ — a
|b
Ti.
a
P «
a ed
P «
«
CM Li O ® c cH o
0 0 Li *4 X a 0 E O
Ό N-i 0 a 3 O m
O £
X 0
U 0 44 Cj0 £
E u
Οι Ή CO co cd > ω ·-< E* e« Φ ω -* J b 0 ω H Q O o
P
EGX ca o
o co a
x.
a
Σ test indicates that both pests and medium were treated and “residual that the medium was treated before infestation with the pests.
χ n 44 ® O 44 0 0 44 o C -H o p u c
X Ή
TABLE IV
COMPOUND NO. RATE (ppm) TU MP NL MD KD MD BG HV SE DB
1 500“ ' A A ' A A A A A A
2 500 C B A C B A C - A
3 2 50 c A A A A A C - A
4 100 - A A A A A A - A
5 500 B A A A A A A - A
6 500 A A A A A A A - A
7 500 A A A A A A C - A
8 500 C A A A A A A A A
9 2 50 B C C A A A A - A
10 250 C B A A A A A A A
11 500 C C A A B B C B C
12 500 C A A A A A A A A
13 100 C A A A A A A A B
14 100 C A A A A -> A A A 'A
15 500 A A A A A A - - A
16 100 C A A A A A A - A
18 250 A A A A A A A A A
19 250 C A A A A A A - A
20 100 A A A A A A A - A
21 500 A A C A A B A A A
22 500 C - A A A A B A A
23 500 C B A A B C C A A
24 100 C A A A A A B A A
25 100 A A A A A A A A A
; 26 100 A B A A A A A - A
1 27 100 A A A C A A A - A
28 100 C A A A A A A A A
29 100 C A A A A A A - A
30 500 C C A A A A A - A
TABLE IV (cont)
COMPOUND NO. RATE (ppm) TU MP NL MD KD MD BG HV SE DB
31 500 c A A A A A A A A
32 500 c B A A A B A A A
33 500 A A A A A A A - A
38 100 C A B C A A A - C
39 250 - C A C C C C - C
40 250 - A A A A A A - A
41 500 - A A A A C A - A
42 250 c A A A A A A - B
43 500 B A A A A B - - C
44 500 C A A A A A A - B
45 250 B C C A C C C - C
46 500 C C C A C C C - C
50 500 ’ C A A A A C A - A
51' 100 c C B C C C A A A
52 500 c c . C A B A B - C
53 500 A A A A A A A - A
59 100 A C A A A A A A
60 100 C B A C C A A A C
61 100 A A A A A A A A A
64 500 C C C B B C A C C
65 500 C c C C C A A B C
75 100 - B A A B C C - A
76 500 - A A A A A A - A
77 250 - A A A A A A - A 1
78 250 1 1 “ C A C C A A - A
79 250 ! c C A A A A A - C
80 500 ; c A A A A A C - A
81 500 c A A A A A - - A
82 500 c A C A A A A - A
83 500 c A A A A A A A A
AP 0 0 0 0 3 4
1SU
Jr*7
TABLE IV (cont)
COMPOUND NO. RATE (ppra) TU MP NL MD KD MD BG HV SE DB
84 500 A A A A A A A A A
112 250 C C C B C C C - A
113 250 - C B A B C C - A
114 100 - C B C C c C - C
116 500 A C C B B c - - C
117 500 C C. C A B c c - C
120 500 C C C A C c c C C
124 500 A C C C C c c - C
126 500 A C C A C c - - C
127 500 C C C A B c c B A
128 500 C C C C B c A A B
129 500 * C 8 A A A c B A C
135 250 C C C A C c A A C
136 500 C C C A A c B C A
137 500 C A C C C c C A C
139 500 - C C A A c A A A
141 500 - C B A A c A - B
142 500 A C C C C c A - C
149 250 - C B C C c B - C
150 250 - B C C C c A - A
163 500 C C A A A B A - A
164 500 A C C B C c C - A
165 500 C C B C C A C - B
167 100 C C C A A A A A B
168 500 C A C C C A A - A
CLAIMS:

Claims (11)

  1. CLAIMS:
    1. A compound of formula :
    CX(Z)-CHX'-OCH2Y (I) wherein W represents one or two substituents selected from halo, alkyl, alkoxy, alkoxyalkyl, haloalkyl and haloalkoxy, or W represents a bidentate group linking
    5 adjacent carbon atoms selected from alkylene and alkylenedioxy; Z represents a fluoroalkyl group of up to two carbon atoms; Y represents a substituted aryl group where each substituent is selected from halo, alkyl, aryl, aralkyl, aryloxy and arylamino; and
    10 either X* is hydrogen and X is selected from hydrogen, halo, hydroxy, alkoxy and aryloxy, or X and X* together represent a second bond between the adjacent carbon atoms.
  2. 2. A compound according to claim 1 wherein Z is
    15 trifluoromethyl, W is fluoro, chloro, bromo, alkyl of up to four carbon atoms, alkoxy of up to four carbon atoms, alkoxyalkyl of up to a total of four carbon atoms, fluoroalkyl of up to two carbon atoms, fluoroalkoxy of up to two carbon atoms, alkylene of
    20 three or four carbon atoms, or alkylenedioxy of up to two carbon atoms, and Y represents an aryl group selected from phenyl, pyridyl and furyl, substituted with fluoro, methyl, phenyl, benzyl, phenoxy, chlorophenoxy, fluorophenoxy, bromophenoxy, or
    25 fluoroanilino.
    APO on 0 3 A
  3. 3. A compound according to claim 1 wherein Z is trifluoromethyl, W is 4-fluoro, 4-chloro, 4-bromo,
    2,4-dichloro, 4-methyl, 4-n-propyl, 4-t-butyl, 4methoxy, 4-ethoxy, 4-methoxymethyl, 4-trifluoromethyl,
    5 4-trifluoromethoxy, 4-difluoromethoxy, 3-fluoro-4ethoxy, 3,4-trimethylene or 3,4-methylenedioxy, X is hydrogen, chloro, fluoro, hydroxy, methoxy or acetoxy, and X' is hydrogen; Y is 3-phenoxyphenyl, 3-(4-chlorophenoxy ) phenyl , 4-fluoro-3-phenoxyphenyl, 3-(4-bromo10 phenoxy)phenyl, 4-fluoro-3-(4-bromophenoxy) phenyl, 4fluoro-3-(4-chlorophenoxy)phenyl, 3-(2,4-difluorophenoxy)phenyl, 3-benzylphenyl, 4-fluoro-3-benzylphenyl, 3-(4-fluorophenylamino) phenyl, 6-phenoxypyrid2-yl, 2-methyl-3-phenylphenyl, 4-methyl-2,3,5,615 tetrafluorophenyl, or 5-benzylfuran-3-yl.
  4. 4. A compound according to claim 1 wherein Z is trifluoromethyl, W is 4-chloro, 4-n-propyl4-t-butyl, 4-trifluoromethoxy, 4-difluoromethoxy, or 3,4trimethylene, Y is 3-phenoxyphenyl, 3-(420 chlorophenoxy)phenyl or 4-fluoro-3-phenoxyphenyl, and
    X and X* Represent a second bond between the adjacent carbon atoms.
  5. 5. A compound according to claim 1 selected from the group of compounds consisting of 1,1,1-trifluoro-2-(42 5 ethoxyphenyl )-3-(4-fluoro-3-phenoxybenzyloxy)propane ,
    1,1,1-trifluoro-2-(4-ethoxyphenyl)-3-[3-(4-chlorophenoxy) benzyloxy jpropane, 1,1,1-trifluoro-2-(4trifluoromethylphenyl)-3-(4-fluoro-3-phenoxybenzyloxy)propane, 1,1,1-tri fluoro-2-(4-trifluoro30 methylphenyl)-3-[3-(4-chlorophenoxy)benzyloxyjpropane,
    1, 1,1-tri fluoro-2-(4-trifluoromethoxyphenyl)-3-(4fluoro-3-phenoxybenzyloxy)propane and 1,1,1-trifluoro2- (4-tri fluoromethoxyphenyl)-3-[3-(4-chlorophenoxy)benzyloxyjpropane.
    ιζλ
    1-40
  6. 6. An insecticidal composition comprising an insecticida1ly effective amount of a compound as defined in claim 1 in association with an insecticidally inert diluent or carrier.
    5
  7. 7. A method of combating insect pests at a locus which comprises applying to the locus an insecticidally effective amount of a composition as defined in claim 6.
  8. 8. A process for preparing a compound of formula :
    OH c(cf3)-ch2-och2y wherein W and Y are as defined in claim 1, comprises either (i) reacting a compound of formula :
    AP 0 0 0 0 3 A
    OH with a compound of formula :
    Y-CH2~HaL or (ii) reacting a compound of formula :
    W
    OH
    Ιυ,Ο with a compound of formula :
    y-ch2oh or (iii) reacting a compound of formula :
    with a compound of formula :
    y-ch2oh and thereafter, if desired converting the product 5 (a) to a compound of formula :
    CF(CF3)-CH2OCH2Y w —Hby reacting with a fluorinating agent; or (b) to a compound of formula :
    CC1 (CF3 ) -CH2-OCH2Y and/or a compound of formula :
    c (CF3 )=<h-OCH2Y \M\
    - 4r4-2 by reaction with an inorganic acid chloride, or (c) to an 0-alkyl derivative by reaction with an alkyl halide and a base, or (d) to an 0-acyl derivative by reaction with an acyl chloride or acyl anhydride, wherein Hal represents chloro or bromine.
  9. 9. A process for preparing a compound of formula :
    CH(CF3)-CH2OCH2Y
    W which comprises treating the corresponding compund of formula :
    CC1(cf3)-ch2och2y
    APO 0 0 0 3 4 with a trialkyltin hydride.
  10. 10. A process for preparing a compound of formula :
    CH(CF3)-ch2-och2y which comprises reacting a compound of formula :
    ch(cf3)-ch2oh with a compound of formula :
    YCH2Hal where Hal represents chloro or bromo
  11. 11. A compound of formula :
    ch(cf3)-ch2oh wherein W is as defined in claim 1.
APAP/P/1986/000041A 1985-08-09 1986-08-08 Insectidical ethers. AP34A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858520027A GB8520027D0 (en) 1985-08-09 1985-08-09 Insecticidal ethers

Publications (2)

Publication Number Publication Date
AP8600041A0 AP8600041A0 (en) 1986-08-01
AP34A true AP34A (en) 1989-01-25

Family

ID=10583547

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1986/000041A AP34A (en) 1985-08-09 1986-08-08 Insectidical ethers.

Country Status (20)

Country Link
US (1) US5196610A (en)
EP (1) EP0211561B1 (en)
JP (5) JPS6242943A (en)
KR (1) KR950004892B1 (en)
CN (1) CN1019191B (en)
AP (1) AP34A (en)
AT (1) ATE73440T1 (en)
AU (1) AU602490B2 (en)
BR (1) BR8603796A (en)
DE (1) DE3684199D1 (en)
EG (1) EG18248A (en)
ES (1) ES2001199A6 (en)
GB (2) GB8520027D0 (en)
HU (3) HU202809B (en)
IL (1) IL79650A0 (en)
MY (1) MY100133A (en)
NZ (1) NZ217014A (en)
OA (1) OA08381A (en)
PH (1) PH23999A (en)
ZA (1) ZA865674B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG48681A3 (en) * 1982-12-14 1991-04-15 Ciba Geigy Ag Fungicide means
US5225607A (en) * 1985-08-09 1993-07-06 Imperial Chemical Industries Plc Insecticidal ethers
DE3602169A1 (en) * 1986-01-22 1987-07-23 Schering Ag NEW ALKANE AND ALKOXYAL CANDERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND INSECTICIDES AND ACARICIDES CONTAINING THESE COMPOUNDS
US4840971A (en) * 1986-04-07 1989-06-20 Sumitomo Chemical Company, Limited Novel ether compound, a process for manufacturing the same, a composition containing the same and a use thereof
GB8617649D0 (en) * 1986-07-18 1986-08-28 Ici Plc Fluorobenzyl esters
DE3628300A1 (en) * 1986-08-21 1988-02-25 Schering Ag ALKANE AND ALKOXYALKANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND INSECTICIDES AND ACARICIDES CONTAINING THESE COMPOUNDS
DE3780291T2 (en) * 1987-01-08 1993-01-07 Ici Plc INSECTICIDE AETHER.
GB8702717D0 (en) * 1987-02-06 1987-03-11 Ici Plc Insecticidal compounds
GB2233650B (en) * 1987-02-06 1991-06-26 Ici Plc Insecticidal ether
JPS6475437A (en) * 1987-09-14 1989-03-22 Sumitomo Chemical Co Optically active alcohols and their production
US5045566A (en) * 1987-11-17 1991-09-03 Ici Americas Inc. Novel imidate insecticides
AU611255B2 (en) * 1987-12-28 1991-06-06 Dowelanco Phenoxyphenoxypropionates, intermediates thereof and methods of preparation
GB8822793D0 (en) * 1988-09-28 1988-11-02 Ici Plc Insecticidal compounds
US4994488A (en) * 1988-10-31 1991-02-19 Ici Americas Inc. Novel imidate insecticides
DE3907784A1 (en) * 1989-03-10 1990-09-13 Hoechst Ag HETEROARYL-ARYL-BUTEN AND BUTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, CONTAINERS THEREOF AND THEIR USE AS A PEST CONTROL
US5120876A (en) * 1989-11-29 1992-06-09 E. I. Du Pont De Nemours And Company Fluorinated sulfones/ketones for nonlinear optics
GB9005467D0 (en) * 1990-03-12 1990-05-09 Ici Plc Process for the preparation of optically active intermediates for insecticidal compounds
GB9103260D0 (en) * 1991-02-15 1991-04-03 Ici Plc Chemical process
DE4401542A1 (en) * 1994-01-20 1995-07-27 Hoechst Schering Agrevo Gmbh Synergistic combinations of ammonium salts
US5601098A (en) * 1995-06-02 1997-02-11 Dimon Incorporated Method and apparatus for applying methoprene to oriental tobacco
AU2002953128A0 (en) * 2002-12-05 2002-12-19 Osmose (Australia) Pty Ltd Surface treatment for wood and wood products
FR2862964B1 (en) * 2003-11-27 2006-12-29 Merck Sante Sas DERIVATIVES OF DIPHENYLAMINE.
CN102524287A (en) * 2011-12-22 2012-07-04 广东中迅农科股份有限公司 Novel formula for controlling thrips
CN106749295B (en) * 2017-01-11 2019-04-12 中国药科大学 A kind of synthetic method of loop coil Oxoindole gamma-butyrolacton class compound

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055997A2 (en) * 1979-03-07 1982-07-14 Imperial Chemical Industries Plc Oxirane and halohydrin compounds
JPS58118534A (en) * 1982-01-08 1983-07-14 Mitsui Toatsu Chem Inc Novel 2-aryl ethyl ether derivative and thioether derivative, its preparation and insecticidal and miticidal agent
EP0094085A1 (en) * 1982-05-12 1983-11-16 Sumitomo Chemical Company, Limited Ether compounds, their production and an insecticidal and/or acaricidal composition containing the same
JPS58198430A (en) * 1982-05-12 1983-11-18 Sumitomo Chem Co Ltd Benzyl phenetyl ether compound, its preparation and insecticide and miticide containing said compound as active component
EP0113640A2 (en) * 1982-12-14 1984-07-18 Ciba-Geigy Ag 1-Azolyl-2-aryl-3-fluoralkan-2-ols as microbicides
EP0179018A1 (en) * 1984-10-17 1986-04-23 Schering Aktiengesellschaft Substituted benzyl ethers, pesticides containing these compounds and processes for their production

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1127340B (en) * 1959-04-24 1962-04-12 Hoechst Ag Process for the preparation of fluorine-containing aromatic ketones
DE2239217A1 (en) * 1972-07-13 1974-01-24 Buckman Labor Inc Substd alkylaryl ketones - as herbicides
CH589408A5 (en) * 1973-04-18 1977-07-15 Ciba Geigy Ag
DE2418571A1 (en) * 1973-04-18 1974-11-14 Ciba Geigy Ag Pesticidal subst. benzyl (thio)ethers - prepd. by reacting subst. benzyl halides or sulphonates with (thio)phenols
CH595065A5 (en) * 1974-04-26 1978-01-31 Ciba Geigy Ag
GB1570982A (en) * 1976-03-05 1980-07-09 Shell Int Research Substituted benzyl ethers and thioethers
US4397864A (en) * 1980-05-02 1983-08-09 Mitsuitoatsu Chemicals Inc. 2-Arylpropyl ether or thioether derivatives and insecticidal and acaricidal agents containing said derivatives
AT375359B (en) * 1980-09-02 1984-07-25 Ici Plc METHOD FOR PRODUCING NEW CONNECTIONS
JPS5764632A (en) * 1980-10-09 1982-04-19 Mitsui Toatsu Chem Inc Novel 2-arylethyl ether derivative and thioether derivative, their production and insecticide and acaricide
SE461790B (en) * 1982-10-19 1990-03-26 Mitsui Toatsu Chemicals PROCEDURE FOR THE PREPARATION OF 3-PHENOXYBENZYL-2- (4-ALCOXYPHENYL) -2-METHYL PROPYLETRES
AU2368484A (en) * 1983-01-25 1984-07-26 Mitsui Toatsu Chemicals Inc. 2-fluoroethoxy-substittuted benzene derivatives
DE3335477A1 (en) * 1983-09-30 1985-04-18 Bayer Ag, 5090 Leverkusen 2-ARYL-2-HALOGENALKYL-OXIRANE
DE3602169A1 (en) * 1986-01-22 1987-07-23 Schering Ag NEW ALKANE AND ALKOXYAL CANDERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND INSECTICIDES AND ACARICIDES CONTAINING THESE COMPOUNDS
US4840971A (en) * 1986-04-07 1989-06-20 Sumitomo Chemical Company, Limited Novel ether compound, a process for manufacturing the same, a composition containing the same and a use thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055997A2 (en) * 1979-03-07 1982-07-14 Imperial Chemical Industries Plc Oxirane and halohydrin compounds
JPS58118534A (en) * 1982-01-08 1983-07-14 Mitsui Toatsu Chem Inc Novel 2-aryl ethyl ether derivative and thioether derivative, its preparation and insecticidal and miticidal agent
EP0094085A1 (en) * 1982-05-12 1983-11-16 Sumitomo Chemical Company, Limited Ether compounds, their production and an insecticidal and/or acaricidal composition containing the same
JPS58198430A (en) * 1982-05-12 1983-11-18 Sumitomo Chem Co Ltd Benzyl phenetyl ether compound, its preparation and insecticide and miticide containing said compound as active component
US4562213A (en) * 1982-05-12 1985-12-31 Sumitomo Chemical Company, Limited Certain phenoxy-benzyloxy ether derivatives and an insecticidal and/or acaricidal composition containing the same and methods of use
EP0113640A2 (en) * 1982-12-14 1984-07-18 Ciba-Geigy Ag 1-Azolyl-2-aryl-3-fluoralkan-2-ols as microbicides
EP0179018A1 (en) * 1984-10-17 1986-04-23 Schering Aktiengesellschaft Substituted benzyl ethers, pesticides containing these compounds and processes for their production

Also Published As

Publication number Publication date
ATE73440T1 (en) 1992-03-15
KR950004892B1 (en) 1995-05-15
JPH0587496B2 (en) 1993-12-16
EP0211561A1 (en) 1987-02-25
BR8603796A (en) 1987-03-17
HU202809B (en) 1991-04-29
PH23999A (en) 1990-02-09
KR870001768A (en) 1987-03-28
DE3684199D1 (en) 1992-04-16
HU900191D0 (en) 1990-03-28
JPH0341044A (en) 1991-02-21
JPH0341048A (en) 1991-02-21
HU202850B (en) 1991-04-29
AP8600041A0 (en) 1986-08-01
CN86105891A (en) 1987-02-25
NZ217014A (en) 1989-04-26
GB8617885D0 (en) 1986-08-28
ZA865674B (en) 1987-03-25
EG18248A (en) 1993-12-31
JPH0341039A (en) 1991-02-21
ES2001199A6 (en) 1988-05-01
JPH0347176A (en) 1991-02-28
HUT41951A (en) 1987-06-29
JPH0466871B2 (en) 1992-10-26
IL79650A0 (en) 1986-12-31
AU6074686A (en) 1987-02-12
GB8520027D0 (en) 1985-09-18
EP0211561B1 (en) 1992-03-11
OA08381A (en) 1988-02-29
CN1019191B (en) 1992-11-25
JPS6242943A (en) 1987-02-24
GB2178739B (en) 1989-12-13
JPH0411533B2 (en) 1992-02-28
GB2178739A (en) 1987-02-18
AU602490B2 (en) 1990-10-18
JPH0460593B2 (en) 1992-09-28
MY100133A (en) 1989-12-18
HU900192D0 (en) 1990-03-28
HU200259B (en) 1990-05-28
US5196610A (en) 1993-03-23

Similar Documents

Publication Publication Date Title
AP34A (en) Insectidical ethers.
US4791139A (en) Diphenyl ether derivatives and their use as insecticides
US4812483A (en) Insecticidal alkenes
EP0271240B1 (en) Fluorobenzyl esters
GB2187452A (en) Insecticidal fluoroalkyl benzene derivatives
US5026727A (en) Insecticidal compounds
US4902814A (en) Fluorobenzyl esters
EP0276558B1 (en) Insecticidal ethers
US5225607A (en) Insecticidal ethers
AP28A (en) Insecticidal alkenes.
US4788348A (en) Insecticidal alkenes
EP0266947B1 (en) Halogenated esters
US5091416A (en) Insecticidal compounds
US4988826A (en) Process for intermediates for insecticidal compounds
GB2210881A (en) Trifluoroacetophenone intermediates
EP0390228A2 (en) Chemical intermediates
GB2233650A (en) Insecticidal ether